[
  {
    "id": 14481,
    "drug": {
      "current_status": "MARKETED",
      "id": 12824,
      "drug_code": 71914,
      "updated_date": "2025-05-15T02:31:26-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254683,
          "ingredient": {
            "id": 3050,
            "ingredient_code": 1197,
            "en_name": "TERCONAZOLE",
            "fr_name": "Terconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247651",
      "brand_name": "TARO-TERCONAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122582001"
    },
    "created_date": "2017-07-01T12:39:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247651",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "G01AG",
    "atc_description": "ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",
    "estimated_end_date": "2017-08-30T00:00:00-04:00",
    "actual_start_date": "2017-06-30T00:00:00-04:00",
    "actual_end_date": "2017-08-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-06T14:50:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-TERCONAZOLE CREAM",
    "en_drug_common_name": "TARO-TERCONAZOLE CREAM",
    "fr_drug_brand_name": "TARO-TERCONAZOLE CREAM",
    "fr_drug_common_name": "TARO-TERCONAZOLE CREAM",
    "en_ingredients": "TERCONAZOLE",
    "fr_ingredients": "Terconazole",
    "drug_strength": "0.4%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "VAGINAL",
    "drug_route_fr": "Vaginale",
    "drug_package_quantity": "45G",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 14489,
    "drug": {
      "current_status": "MARKETED",
      "id": 6788,
      "drug_code": 44266,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253183,
          "ingredient": {
            "id": 1376,
            "ingredient_code": 11389,
            "en_name": "LEUCOVORIN",
            "fr_name": "Leucovorine (Leucovorine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02183005",
      "brand_name": "LEUCOVORIN CALCIUM INJECTION USP",
      "brand_name_fr": "LEUCOVORINE CALCIQUE INJECTABLE USP",
      "descriptor": "50 MG/ 5 ML - SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "T9990",
      "number_of_ais": "1",
      "ai_group_no": "0108436002"
    },
    "created_date": "2017-07-03T14:50:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02183005",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "V03AF",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2017-07-10T00:00:00-04:00",
    "estimated_end_date": "2017-10-18T00:00:00-04:00",
    "actual_end_date": "2017-10-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-18T16:49:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LEUCOVORIN CALCIUM INJECTION USP",
    "en_drug_common_name": "Levoleucovorin Calcium",
    "fr_drug_brand_name": "Leucovorin Calcium",
    "fr_drug_common_name": "Leucovorin Calcium",
    "en_ingredients": "LEUCOVORIN",
    "fr_ingredients": "Leucovorin Calcium",
    "drug_strength": "10MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "1x 5mL VIAL / AMPOULE",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14494,
    "drug": {
      "current_status": "MARKETED",
      "id": 6134,
      "drug_code": 42844,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252983,
          "ingredient": {
            "id": 1592,
            "ingredient_code": 5900,
            "en_name": "METHOTREXATE",
            "fr_name": "Méthotrexate (Méthotrexate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02182777",
      "brand_name": "METHOTREXATE INJECTION USP",
      "brand_name_fr": "MÉTHOTREXATE INJECABLE USP",
      "descriptor": "WITH PRESERVATIVE (MULTIDOSE VIALS)",
      "pediatric_flag": false,
      "accession_number": "P9010",
      "number_of_ais": "1",
      "ai_group_no": "0107545002"
    },
    "created_date": "2017-07-03T15:41:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02182777",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "L01BA",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2017-07-31T00:00:00-04:00",
    "estimated_end_date": "2017-10-16T00:00:00-04:00",
    "actual_start_date": "2017-09-01T00:00:00-04:00",
    "actual_end_date": "2017-09-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-13T18:46:08-04:00",
    "status": "resolved",
    "en_comments": "Product under allocation.\r\nPlease note that the following formats are currently available:\r\n\r\nDIN\t         Product name\t                                     Product Description\t      Package size\r\n2182777\tMETHOTREXATE INJECTION USP \tSolution for Injection, 25 mg/mL, Multidose Vial  \tONCO-TAINTM vial,  1 x 20 mL \r\n\t\t\t\r\n2182955\tMETHOTREXATE INJECTION USP \tSolution for Injection Single-use, 25 mg/mL \tvial, 5 x 2 mL \r\n\t\t\t\r\n2182971\tMETHOTREXATE INJECTION USP \tSolution for Injection Single-use, 25 mg/mL \tONCO-TAINTM vial, 1 x 20 mL \r\n\t\t\t\r\n2422166\tMETHOTREXATE INJECTION USP \tSolution for Injection, 25 mg/mL \t*Syringe, 1 x 0.3 mL \r\n2422174\tMETHOTREXATE INJECTION USP \tSolution for Injection, 25 mg/mL \t*Syringe, 1 x 0.4 mL \r\n2422182\tMETHOTREXATE INJECTION USP \tSolution for Injection, 25 mg/mL \t*Syringe, 1 x 0.6 mL \r\n2422190\tMETHOTREXATE INJECTION USP \tSolution for Injection, 25 mg/mL \t*Syringe, 1 x 0.8 mL \r\n2422204\tMETHOTREXATE INJECTION USP \tSolution for Injection, 25 mg/mL \t*Syringe, 1 x 1 mL",
    "fr_comments": "Produit sous allocation.\r\nVeuillez noter que les formats suivants sont actuellement disponibles :\r\n\r\nDIN\t         Nom du produit\t                             Description du produit\t  Taille de l'emballage\r\n2182777\tMETHOTREXATE INJECTION USP \tSolution pour Injection, 25 mg/mL, ampoule Multidose  ONCO-TAINTM ,  1 x 20 mL \r\n\t\t\t\r\n2182955\tMETHOTREXATE INJECTION USP \tSolution pour Injection Usage Unique, 25 mg/mL \tampoule, 5 x 2 mL \r\n\t\t\t\r\n2182971\tMETHOTREXATE INJECTION USP \tSolution pour Injection Usage unique, 25 mg/mL \tONCO-TAINTM ampoule, 1 x 20 mL \r\n\t\t\t\r\n2422166\tMETHOTREXATE INJECTION USP \tSolution pour Injection, 25 mg/mL \t*Seringue, 1 x 0.3 mL \r\n2422174\tMETHOTREXATE INJECTION USP \tSolution pour Injection, 25 mg/mL \t*Seringue, 1 x 0.4 mL \r\n2422182\tMETHOTREXATE INJECTION USP \tSolution pour Injection, 25 mg/mL \t*Seringue, 1 x 0.6 mL \r\n2422190\tMETHOTREXATE INJECTION USP \tSolution pour Injection, 25 mg/mL \t*Seringue, 1 x 0.8 mL \r\n2422204\tMETHOTREXATE INJECTION USP \tSolution pour Injection, 25 mg/mL \t*Seringue, 1 x 1 mL",
    "en_drug_brand_name": "METHOTREXATE INJECTION USP",
    "en_drug_common_name": "METHOTREXATE",
    "fr_drug_brand_name": "METHOTREXATE",
    "fr_drug_common_name": "METHOTREXATE",
    "en_ingredients": "METHOTREXATE",
    "fr_ingredients": "Méthotrexate",
    "drug_strength": "25MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRA-ARTERIAL\r\nINTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intra-artérielle\r\nIntramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "5x2mL VIAL/AMPOULE",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14497,
    "drug": {
      "current_status": "MARKETED",
      "id": 24196,
      "drug_code": 86822,
      "updated_date": "2025-05-15T02:33:19-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8258708,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02382377",
      "brand_name": "MIDAZOLAM INJECTION USP",
      "brand_name_fr": "MIDAZOLAM INJECTABLE USP",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935002"
    },
    "created_date": "2017-07-03T15:59:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382377",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2017-07-07T00:00:00-04:00",
    "actual_end_date": "2018-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-26T14:11:11-04:00",
    "status": "resolved",
    "en_comments": "Please note that the following formats are currently available:\r\n- MIDAZOLAM 5mg/mL 10x1mL GVL\r\n- MIDAZOLAM 5mg/mL 10x2mL GVL",
    "fr_comments": "Merci de noter que les formats suivants sont actuellement disponibles :\r\n- MIDAZOLAM 5mg/mL 10x1mL GVL\r\n- MIDAZOLAM 5mg/mL 10x2mL GVL",
    "en_drug_brand_name": "MIDAZOLAM INJECTION USP",
    "en_drug_common_name": "MIDAZOLAM",
    "fr_drug_brand_name": "MIDAZOLAM",
    "fr_drug_common_name": "MIDAZOLAM",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "VIAL/AMPOULE",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14500,
    "drug": {
      "current_status": "MARKETED",
      "id": 24194,
      "drug_code": 86821,
      "updated_date": "2025-05-15T02:33:19-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8258707,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02382350",
      "brand_name": "MIDAZOLAM INJECTION USP",
      "brand_name_fr": "MIDOZOLAM INJECTABLE US",
      "descriptor": "PRESERVATIVE-FREE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935001"
    },
    "created_date": "2017-07-03T16:16:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382350",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2017-06-15T00:00:00-04:00",
    "actual_end_date": "2018-01-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-08T03:06:25-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MIDAZOLAM INJECTION USP",
    "en_drug_common_name": "MIDAZOLAM",
    "fr_drug_brand_name": "MIDAZOLAM",
    "fr_drug_common_name": "MIDAZOLAM",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "VIAL/AMPOULE",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 14503,
    "drug": {
      "current_status": "MARKETED",
      "id": 24198,
      "drug_code": 86823,
      "updated_date": "2025-05-15T02:33:19-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8258709,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02382385",
      "brand_name": "MIDAZOLAM INJECTION USP",
      "brand_name_fr": "MIDOZOLAM INJECTABLE USP",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935001"
    },
    "created_date": "2017-07-03T16:22:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382385",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2017-08-02T00:00:00-04:00",
    "actual_end_date": "2018-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-24T17:52:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MIDAZOLAM INJECTION USP",
    "en_drug_common_name": "MIDAZOLAM",
    "fr_drug_brand_name": "MIDAZOLAM",
    "fr_drug_common_name": "MIDAZOLAM",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "VIAL/AMPOULE",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14506,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7188,
      "drug_code": 48885,
      "updated_date": "2025-05-15T03:50:41-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8314742,
          "ingredient": {
            "id": 1596,
            "ingredient_code": 8541,
            "en_name": "VANCOMYCIN",
            "fr_name": "Vancomycine (Chlorhydrate de vancomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02230192",
      "brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
      "brand_name_fr": "CHLORHYDRATE DE VANCOMYCINE POUR INJECTION, USP",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131315009"
    },
    "created_date": "2017-07-03T19:57:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230192",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "J01XA",
    "atc_description": "OTHER ANTIBACTERIALS",
    "estimated_end_date": "2017-09-22T00:00:00-04:00",
    "actual_start_date": "2017-06-14T00:00:00-04:00",
    "actual_end_date": "2017-09-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-25T11:59:49-04:00",
    "status": "resolved",
    "en_comments": "Please be advised that the below format is currently available :\r\nVANCOMYCIN HYDROCHLORIDE 500mg 10x500mg GVL",
    "fr_comments": "Merci de noter que le format suivant est acteullement disponible :\r\nVANCOMYCIN HYDROCHLORIDE 500mg 10x500mg GVL",
    "en_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "en_drug_common_name": "VANCOMYCIN",
    "fr_drug_brand_name": "VANCOMYCIN",
    "fr_drug_common_name": "VANCOMYCIN",
    "en_ingredients": "VANCOMYCIN",
    "fr_ingredients": "VANCOMYCIN",
    "drug_strength": "1000MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10x1g  VIAL/AMPOULES",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 14509,
    "drug": {
      "current_status": "MARKETED",
      "id": 1144,
      "drug_code": 12648,
      "updated_date": "2025-12-03T00:30:30-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8251650,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.01",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251649,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01901915",
      "brand_name": "LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73814",
      "number_of_ais": "2",
      "ai_group_no": "0201284005"
    },
    "created_date": "2017-07-03T20:08:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01901915",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "actual_start_date": "2017-05-16T00:00:00-04:00",
    "actual_end_date": "2018-04-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-04T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "​",
    "en_drug_brand_name": "LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:100 000 INJECTION USP",
    "en_drug_common_name": "LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE",
    "fr_drug_brand_name": "LIDOCAINE HYDROCHLORIDE ET EPINEPHRINE",
    "fr_drug_common_name": "LIDOCAINE HYDROCHLORIDE ET EPINEPHRINE",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE\r\nEPINEPHRINE",
    "fr_ingredients": "Chlorhydrate de lidocaïne\r\nÉpinéphrine",
    "drug_strength": "20MG\r\n10MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "25x20mL VIAL/AMPOULE",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 14560,
    "drug": {
      "current_status": "MARKETED",
      "id": 25424,
      "drug_code": 87868,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259211,
          "ingredient": {
            "id": 2720,
            "ingredient_code": 11899,
            "en_name": "RIZATRIPTAN",
            "fr_name": "Rizatriptan (Benzoate de rizatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02393468",
      "brand_name": "APO-RIZATRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137841001"
    },
    "created_date": "2017-07-04T17:57:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02393468",
    "company_name": "APOTEX INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "actual_start_date": "2017-06-29T00:00:00-04:00",
    "actual_end_date": "2018-01-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-10T13:27:57-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RIZATRIPTAN",
    "en_drug_common_name": "RIZATRIPTAN",
    "fr_drug_brand_name": "APO-RIZATRIPTAN",
    "fr_drug_common_name": "RIZATRIPTAN",
    "en_ingredients": "RIZATRIPTAN",
    "fr_ingredients": "RIZATRIPTAN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14576,
    "drug": {
      "current_status": "MARKETED",
      "id": 23858,
      "drug_code": 86520,
      "updated_date": "2025-05-15T02:33:11-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258586,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379325",
      "brand_name": "MONTELUKAST",
      "brand_name_fr": "MONTÉLUKAST",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823001"
    },
    "created_date": "2017-07-04T18:26:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379325",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "R03DC",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "estimated_end_date": "2017-07-31T00:00:00-04:00",
    "actual_start_date": "2017-07-04T00:00:00-04:00",
    "actual_end_date": "2017-07-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-07-24T13:37:46-04:00",
    "status": "resolved",
    "en_comments": "Delay in replenishment batch",
    "fr_comments": "Retard dans le lot de réapprovisionnement",
    "en_drug_brand_name": "MONTELUKAST",
    "en_drug_common_name": "MONTELUKAST TABS",
    "fr_drug_brand_name": "MONTELUKAST",
    "fr_drug_common_name": "MONTELUKAST COMPRIMES",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "MONTELUKAST",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 14596,
    "drug": {
      "current_status": "MARKETED",
      "id": 31786,
      "drug_code": 94217,
      "updated_date": "2025-05-15T02:35:24-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8261959,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02455366",
      "brand_name": "TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485001"
    },
    "created_date": "2017-07-04T19:58:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02455366",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "actual_start_date": "2017-07-03T00:00:00-04:00",
    "actual_end_date": "2017-11-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-03T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TADALAFIL",
    "en_drug_common_name": "TADALAFIL",
    "fr_drug_brand_name": "TADALAFIL",
    "fr_drug_common_name": "TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14599,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14224,
      "drug_code": 74301,
      "updated_date": "2025-05-15T04:09:12-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8340374,
          "ingredient": {
            "id": 3166,
            "ingredient_code": 11350,
            "en_name": "VINORELBINE",
            "fr_name": "Vinorelbine (Tartrate de vinorelbine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02257777",
      "brand_name": "VINORELBINE TARTRATE FOR INJECTION",
      "brand_name_fr": "TARTRATE DE VINORELBINE POUR INJECTION",
      "descriptor": "1ML AND 5ML SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126071001"
    },
    "created_date": "2017-07-04T20:03:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02257777",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "L01CA",
    "atc_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
    "anticipated_start_date": "2017-07-07T00:00:00-04:00",
    "estimated_end_date": "2017-10-18T00:00:00-04:00",
    "actual_end_date": "2017-10-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-18T16:45:31-04:00",
    "status": "resolved",
    "en_comments": "Please be advised that the below format is currently available:\r\nVINORELBINE 10mg/mL 1x1mL OGVL",
    "fr_comments": "Merci de noter que le format suivant est actuellement disponible :\r\nVINORELBINE 10mg/mL 1x1mL OGVL",
    "en_drug_brand_name": "VINORELBINE TARTRATE FOR INJECTION",
    "en_drug_common_name": "VINORELBINE",
    "fr_drug_brand_name": "VINORELBINE",
    "fr_drug_common_name": "VINORELBINE",
    "en_ingredients": "VINORELBINE",
    "fr_ingredients": "VINORELBINE",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1x5 ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14644,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3834,
      "drug_code": 19356,
      "updated_date": "2025-05-15T03:45:28-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8302944,
          "ingredient": {
            "id": 1548,
            "ingredient_code": 5917,
            "en_name": "BRETYLIUM TOSYLATE",
            "fr_name": "Tosylate de brétylium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02185377",
      "brand_name": "BRETYLIUM TOSYLATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81648",
      "number_of_ais": "1",
      "ai_group_no": "0107636001"
    },
    "created_date": "2017-07-05T15:02:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02185377",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C01BD",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "estimated_end_date": "2017-07-28T00:00:00-04:00",
    "actual_start_date": "2017-07-03T00:00:00-04:00",
    "actual_end_date": "2017-07-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2017-10-18T21:01:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BRETYLIUM TOSYLATE INJECTION USP",
    "en_drug_common_name": "BRETYLIUM",
    "fr_drug_brand_name": "BRETYLIUM",
    "fr_drug_common_name": "BRETYLIUM",
    "en_ingredients": "BRETYLIUM TOSYLATE",
    "fr_ingredients": "Tosylate de brétylium",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "5 X 10ML VIALS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14647,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24036,
      "drug_code": 86669,
      "updated_date": "2025-05-15T04:19:55-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8351291,
          "ingredient": {
            "id": 1254,
            "ingredient_code": 1998,
            "en_name": "ETOPOSIDE",
            "fr_name": "Étoposide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02380935",
      "brand_name": "ETOPOSIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "MULTI-DOSE VIALS OF 100MG(5ML), 200MG(10ML), 500MG(25ML), AND 1G(50ML)",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114567002"
    },
    "created_date": "2017-07-05T15:21:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02380935",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L01CB",
    "atc_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
    "estimated_end_date": "2017-07-28T00:00:00-04:00",
    "actual_start_date": "2017-07-03T00:00:00-04:00",
    "actual_end_date": "2017-07-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-08-03T01:23:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ETOPOSIDE INJECTION USP",
    "en_drug_common_name": "ETOPOSIDE",
    "fr_drug_brand_name": "ETOPOSIDE",
    "fr_drug_common_name": "ETOPOSIDE",
    "en_ingredients": "ETOPOSIDE",
    "fr_ingredients": "Étoposide",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "25ML VIAL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 14659,
    "drug": {
      "current_status": "MARKETED",
      "id": 26720,
      "drug_code": 89013,
      "updated_date": "2025-05-15T02:33:55-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259636,
          "ingredient": {
            "id": 3074,
            "ingredient_code": 13247,
            "en_name": "ALMOTRIPTAN",
            "fr_name": "Almotriptan (Malate d'almotriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02405334",
      "brand_name": "SANDOZ ALMOTRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149521002"
    },
    "created_date": "2017-07-05T15:46:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02405334",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2017-09-20T00:00:00-04:00",
    "actual_start_date": "2017-07-03T00:00:00-04:00",
    "actual_end_date": "2017-09-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-25T21:55:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ALMOTRIPTAN",
    "en_drug_common_name": "ALMOTRIPTAN",
    "fr_drug_brand_name": "ALMOTRIPTAN",
    "fr_drug_common_name": "ALMOTRIPTAN",
    "en_ingredients": "ALMOTRIPTAN",
    "fr_ingredients": "ALMOTRIPTAN",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "BLISTERS OF 6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14695,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23830,
      "drug_code": 86503,
      "updated_date": "2025-05-15T04:19:48-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351195,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379147",
      "brand_name": "MYLAN-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220003"
    },
    "created_date": "2017-07-05T17:30:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379147",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2018-04-18T00:00:00-04:00",
    "actual_start_date": "2018-04-18T00:00:00-04:00",
    "actual_end_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-05T13:31:16-04:00",
    "status": "resolved",
    "en_comments": "discontinued in ID 53621",
    "fr_comments": "discontinued in ID 53621",
    "en_drug_brand_name": "MYLAN-CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "MYLAN-CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14700,
    "drug": {
      "current_status": "MARKETED",
      "id": 21520,
      "drug_code": 83904,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8257682,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353830",
      "brand_name": "MYLAN-LANSOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666002"
    },
    "created_date": "2017-07-05T17:35:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353830",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2018-08-10T00:00:00-04:00",
    "estimated_end_date": "2018-08-30T00:00:00-04:00",
    "actual_start_date": "2018-08-07T00:00:00-04:00",
    "actual_end_date": "2018-08-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-08-15T14:12:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-LANSOPRAZOLE",
    "en_drug_common_name": "LANSOPRAZOLE",
    "fr_drug_brand_name": "MYLAN-LANSOPRAZOLE",
    "fr_drug_common_name": "LANSOPRAZOLE",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "Lansoprazole",
    "drug_strength": "15MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14703,
    "drug": {
      "current_status": "MARKETED",
      "id": 17864,
      "drug_code": 78924,
      "updated_date": "2025-05-15T02:32:04-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8256268,
          "ingredient": {
            "id": 3440,
            "ingredient_code": 20179,
            "en_name": "SITAGLIPTIN",
            "fr_name": "Sitagliptine (Phosphate de sitagliptine monohydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02303922",
      "brand_name": "JANUVIA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152414001"
    },
    "created_date": "2017-07-05T17:56:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02303922",
    "company_name": "MERCK CANADA INC",
    "atc_number": "A10BH",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2017-07-05T00:00:00-04:00",
    "estimated_end_date": "2017-07-14T00:00:00-04:00",
    "actual_start_date": "2017-07-05T00:00:00-04:00",
    "actual_end_date": "2017-07-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-07-15T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "available in 30 tab",
    "fr_comments": "Quantités disponibles en 30 tab",
    "en_drug_brand_name": "JANUVIA",
    "en_drug_common_name": "sitagliptin tablets (as sitagliptin phosphate monohydrate)",
    "fr_drug_brand_name": "JANUVIA",
    "fr_drug_common_name": "\"comprimés de sitagliptine (sous forme de phosphate de sitagliptine monohydraté)\"",
    "en_ingredients": "SITAGLIPTIN",
    "fr_ingredients": "sitagliptine (sous forme de phosphate de sitagliptine monohydraté",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 tab",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 14711,
    "drug": {
      "current_status": "MARKETED",
      "id": 11186,
      "drug_code": 67514,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8254203,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02243596",
      "brand_name": "ASMANEX TWISTHALER",
      "brand_name_fr": "",
      "descriptor": "FOR ORAL INHALATION ONLY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732004"
    },
    "created_date": "2017-07-05T19:11:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243596",
    "company_name": "MERCK CANADA INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2017-07-14T00:00:00-04:00",
    "actual_start_date": "2017-07-05T00:00:00-04:00",
    "actual_end_date": "2017-07-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-07-08T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ASMANEX TWISTHALER",
    "en_drug_common_name": "mometasone furoate dry powder inhaler",
    "fr_drug_brand_name": "ASMANEX TWISTHALER",
    "fr_drug_common_name": "furoate de mométasone inhalateur de poudre sèche",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "400MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "60dose",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 14721,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20436,
      "drug_code": 82047,
      "updated_date": "2025-05-15T04:15:30-04:00",
      "company": {
        "id": 176,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T03:21:45-04:00",
        "company_code": 11642,
        "mfr_code": "",
        "name": "HOSPIRA HEALTHCARE ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / Service à la clientele 1-866-488-6088 option 3"
      },
      "drug_ingredients": [
        {
          "id": 8347744,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02334844",
      "brand_name": "AZITHROMYCIN FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "10 ML FLIP TOP VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072006"
    },
    "created_date": "2017-07-05T19:51:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02334844",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "anticipated_start_date": "2018-03-06T00:00:00-05:00",
    "actual_end_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-24T18:15:55-05:00",
    "status": "avoided_shortage",
    "en_comments": "Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.",
    "en_drug_brand_name": "AZITHROMYCIN FOR INJECTION, USP",
    "en_drug_common_name": "AZITHROMYCIN",
    "fr_drug_brand_name": "AZITHROMYCINE",
    "fr_drug_common_name": "AZITHROMYCINE",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "500MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10x500mg",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14724,
    "drug": {
      "current_status": "MARKETED",
      "id": 10426,
      "drug_code": 65669,
      "updated_date": "2025-12-03T00:30:44-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253936,
          "ingredient": {
            "id": 718,
            "ingredient_code": 10271,
            "en_name": "MEPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de mépivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02241999",
      "brand_name": "CARBOCAINE 1%",
      "brand_name_fr": "",
      "descriptor": "30ML SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100583003"
    },
    "created_date": "2017-07-05T19:53:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241999",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2017-09-28T00:00:00-04:00",
    "actual_end_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-23T20:57:50-05:00",
    "status": "resolved",
    "en_comments": "Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.",
    "en_drug_brand_name": "CARBOCAINE 1%",
    "en_drug_common_name": "CARBOCAINE",
    "fr_drug_brand_name": "CARBOCAINE",
    "fr_drug_common_name": "CARBOCAINE",
    "en_ingredients": "MEPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de mépivacaïne",
    "drug_strength": "1%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nINTRACAUDAL",
    "drug_route_fr": "Épidurale\r\nIntracaudale",
    "drug_package_quantity": "10x30ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14728,
    "drug": {
      "current_status": "MARKETED",
      "id": 10428,
      "drug_code": 65670,
      "updated_date": "2025-12-03T00:30:44-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253937,
          "ingredient": {
            "id": 718,
            "ingredient_code": 10271,
            "en_name": "MEPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de mépivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242000",
      "brand_name": "CARBOCAINE 1%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100583003"
    },
    "created_date": "2017-07-05T19:55:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242000",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2018-03-11T00:00:00-05:00",
    "actual_end_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-23T20:59:54-05:00",
    "status": "avoided_shortage",
    "en_comments": "Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.",
    "en_drug_brand_name": "CARBOCAINE 1%",
    "en_drug_common_name": "CARBOCAINE",
    "fr_drug_brand_name": "CARBOCAINE",
    "fr_drug_common_name": "CARBOCAINE",
    "en_ingredients": "MEPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de mépivacaïne",
    "drug_strength": "1%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "5x50ml",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14731,
    "drug": {
      "current_status": "MARKETED",
      "id": 10430,
      "drug_code": 65671,
      "updated_date": "2025-12-03T00:30:44-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253938,
          "ingredient": {
            "id": 718,
            "ingredient_code": 10271,
            "en_name": "MEPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de mépivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242001",
      "brand_name": "CARBOCAINE 2%",
      "brand_name_fr": "",
      "descriptor": "20ML SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100583002"
    },
    "created_date": "2017-07-05T19:56:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242001",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2017-10-31T00:00:00-04:00",
    "actual_end_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-23T21:00:50-05:00",
    "status": "avoided_shortage",
    "en_comments": "Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.",
    "en_drug_brand_name": "CARBOCAINE 2%",
    "en_drug_common_name": "CARBOCAINE",
    "fr_drug_brand_name": "CARBOCAINE",
    "fr_drug_common_name": "CARBOCAINE",
    "en_ingredients": "MEPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de mépivacaïne",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRACAUDAL\r\nEPIDURAL",
    "drug_route_fr": "Intracaudale\r\nÉpidurale",
    "drug_package_quantity": "10x20ml",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14734,
    "drug": {
      "current_status": "MARKETED",
      "id": 24230,
      "drug_code": 86845,
      "updated_date": "2025-12-03T00:31:56-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8258718,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02382636",
      "brand_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "1/5/50ML SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698001"
    },
    "created_date": "2017-07-05T19:59:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382636",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "actual_start_date": "2017-11-08T00:00:00-05:00",
    "actual_end_date": "2017-12-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-01-09T16:29:51-05:00",
    "status": "resolved",
    "en_comments": "Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.",
    "en_drug_brand_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION USP HP 10",
    "en_drug_common_name": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_drug_brand_name": "Chlorhydrate d'hydromorphone",
    "fr_drug_common_name": "Chlorhydrate d'hydromorphone",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10X1ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14737,
    "drug": {
      "current_status": "MARKETED",
      "id": 24230,
      "drug_code": 86845,
      "updated_date": "2025-12-03T00:31:56-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8258718,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02382636",
      "brand_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "1/5/50ML SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698001"
    },
    "created_date": "2017-07-05T20:01:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382636",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2018-06-24T00:00:00-04:00",
    "actual_end_date": "2017-12-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-12-22T16:07:02-05:00",
    "status": "avoided_shortage",
    "en_comments": "Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.",
    "en_drug_brand_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION USP HP 10",
    "en_drug_common_name": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_drug_brand_name": "Chlorhydrate d'hydromorphone",
    "fr_drug_common_name": "Chlorhydrate d'hydromorphone",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10X5ML",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14740,
    "drug": {
      "current_status": "MARKETED",
      "id": 25146,
      "drug_code": 87646,
      "updated_date": "2025-05-15T02:33:39-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8259110,
          "ingredient": {
            "id": 1838,
            "ingredient_code": 1896,
            "en_name": "LABETALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de labétalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02391090",
      "brand_name": "LABETALOL HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "CHLORHYDRATE DE LABÉTALOL INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116170002"
    },
    "created_date": "2017-07-05T20:03:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02391090",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2017-10-05T00:00:00-04:00",
    "actual_end_date": "2017-11-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-12-15T16:11:52-05:00",
    "status": "resolved",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.",
    "en_drug_brand_name": "LABETALOL HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "LABETALOL HYDROCHLORIDE",
    "fr_drug_brand_name": "Chlorhydrate de labétalol",
    "fr_drug_common_name": "Chlorhydrate de labétalol",
    "en_ingredients": "LABETALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de labétalol",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1X20ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14743,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10418,
      "drug_code": 65651,
      "updated_date": "2025-05-15T04:01:30-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8332063,
          "ingredient": {
            "id": 7231,
            "ingredient_code": 7395,
            "en_name": "NOREPINEPHRINE",
            "fr_name": "Norépinéphrine (Bitartrate de norépinéphrine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02241981",
      "brand_name": "LEVOPHED",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131301001"
    },
    "created_date": "2017-07-05T20:05:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241981",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "C01CA",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "actual_start_date": "2017-08-21T00:00:00-04:00",
    "actual_end_date": "2018-06-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-06-07T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LEVOPHED 1.0 MG/ML",
    "en_drug_common_name": "LEVOPHED",
    "fr_drug_brand_name": "LEVOPHED",
    "fr_drug_common_name": "LEVOPHED",
    "en_ingredients": "NOREPINEPHRINE",
    "fr_ingredients": "NOREPINEPHRINE",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10x4ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14747,
    "drug": {
      "current_status": "MARKETED",
      "id": 1138,
      "drug_code": 12645,
      "updated_date": "2025-12-03T00:30:30-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8251648,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00884154",
      "brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "73810",
      "number_of_ais": "1",
      "ai_group_no": "0101280004"
    },
    "created_date": "2017-07-05T20:08:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00884154",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2018-04-16T00:00:00-04:00",
    "actual_end_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-24T18:16:27-05:00",
    "status": "avoided_shortage",
    "en_comments": "Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.",
    "en_drug_brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP 1%",
    "en_drug_common_name": "LIDOCAINE HYDROCHLORIDE",
    "fr_drug_brand_name": "Chlorhydrate de lidocaïne",
    "fr_drug_common_name": "Chlorhydrate de lidocaïne",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lidocaïne",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "10x2ml",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14750,
    "drug": {
      "current_status": "MARKETED",
      "id": 1138,
      "drug_code": 12645,
      "updated_date": "2025-12-03T00:30:30-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8251648,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00884154",
      "brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "73810",
      "number_of_ais": "1",
      "ai_group_no": "0101280004"
    },
    "created_date": "2017-07-05T20:10:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00884154",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2018-06-15T00:00:00-04:00",
    "actual_end_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-24T18:17:07-05:00",
    "status": "avoided_shortage",
    "en_comments": "Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.",
    "en_drug_brand_name": "LIDOCAINE HYDROCHLORIDE INJECTION USP 1%",
    "en_drug_common_name": "LIDOCAINE HYDROCHLORIDE",
    "fr_drug_brand_name": "Chlorhydrate de lidocaïne",
    "fr_drug_common_name": "Chlorhydrate de lidocaïne",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lidocaïne",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "5x5ml",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14755,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10388,
      "drug_code": 65588,
      "updated_date": "2025-12-03T01:19:14-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8332002,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02241918",
      "brand_name": "MARCAINE",
      "brand_name_fr": "",
      "descriptor": "PRESERVATIVE-FREE, SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108896001"
    },
    "created_date": "2017-07-05T20:17:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241918",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2018-03-27T00:00:00-04:00",
    "actual_end_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-23T21:03:13-05:00",
    "status": "avoided_shortage",
    "en_comments": "Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.",
    "en_drug_brand_name": "MARCAINE 2.5 MG/ML",
    "en_drug_common_name": "MARCAINE",
    "fr_drug_brand_name": "MARCAINE 2.5 MG/ML",
    "fr_drug_common_name": "MARCAINE",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nEPIDURAL",
    "drug_route_fr": "Bloc/Infiltration\r\nÉpidurale",
    "drug_package_quantity": "10x10ml",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14759,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10388,
      "drug_code": 65588,
      "updated_date": "2025-12-03T01:19:14-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8332002,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02241918",
      "brand_name": "MARCAINE",
      "brand_name_fr": "",
      "descriptor": "PRESERVATIVE-FREE, SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108896001"
    },
    "created_date": "2017-07-05T20:18:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241918",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2017-12-10T00:00:00-05:00",
    "actual_end_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-23T21:04:22-05:00",
    "status": "avoided_shortage",
    "en_comments": "Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.",
    "en_drug_brand_name": "MARCAINE 2.5 MG/ML",
    "en_drug_common_name": "MARCAINE",
    "fr_drug_brand_name": "MARCAINE 2.5 MG/ML",
    "fr_drug_common_name": "MARCAINE",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nEPIDURAL",
    "drug_route_fr": "Bloc/Infiltration\r\nÉpidurale",
    "drug_package_quantity": "10x20ml",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14762,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17998,
      "drug_code": 79144,
      "updated_date": "2025-12-03T01:25:33-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8345098,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "50",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02305895",
      "brand_name": "MARCAINE",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE, MULTIDOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108896001"
    },
    "created_date": "2017-07-05T20:20:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02305895",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2017-11-03T00:00:00-04:00",
    "actual_end_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-23T21:02:22-05:00",
    "status": "avoided_shortage",
    "en_comments": "Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.",
    "en_drug_brand_name": "MARCAINE 0.25%",
    "en_drug_common_name": "MARCAINE",
    "fr_drug_brand_name": "MARCAINE 0.25%",
    "fr_drug_common_name": "MARCAINE",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "1x50ml",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14766,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10390,
      "drug_code": 65589,
      "updated_date": "2025-12-03T01:19:14-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8332003,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02241919",
      "brand_name": "MARCAINE",
      "brand_name_fr": "",
      "descriptor": "PRESERVATIVE-FREE, SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108896004"
    },
    "created_date": "2017-07-05T20:22:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241919",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2018-02-05T00:00:00-05:00",
    "actual_end_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-23T21:05:23-05:00",
    "status": "avoided_shortage",
    "en_comments": "Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.",
    "en_drug_brand_name": "MARCAINE 5 MG/ML",
    "en_drug_common_name": "MARCAINE",
    "fr_drug_brand_name": "MARCAINE 5 MG/ML",
    "fr_drug_common_name": "MARCAINE",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne",
    "drug_strength": "5.0MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nEPIDURAL",
    "drug_route_fr": "Bloc/Infiltration\r\nÉpidurale",
    "drug_package_quantity": "10x10ml",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14769,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10390,
      "drug_code": 65589,
      "updated_date": "2025-12-03T01:19:14-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8332003,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02241919",
      "brand_name": "MARCAINE",
      "brand_name_fr": "",
      "descriptor": "PRESERVATIVE-FREE, SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108896004"
    },
    "created_date": "2017-07-05T20:24:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241919",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "N01BB01",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2017-09-21T00:00:00-04:00",
    "actual_end_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-12-19T17:44:43-05:00",
    "status": "resolved",
    "en_comments": "Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.",
    "en_drug_brand_name": "MARCAINE",
    "en_drug_common_name": "MARCAINE",
    "fr_drug_brand_name": "MARCAINE 5 MG/ML",
    "fr_drug_common_name": "MARCAINE",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne",
    "drug_strength": "5.0MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nEPIDURAL",
    "drug_route_fr": "Bloc/Infiltration\r\nÉpidurale",
    "drug_package_quantity": "10x20ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14772,
    "drug": {
      "current_status": "MARKETED",
      "id": 18000,
      "drug_code": 79145,
      "updated_date": "2025-05-15T02:32:06-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8256329,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "50",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02305909",
      "brand_name": "MARCAINE",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE, MULTIDOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108896004"
    },
    "created_date": "2017-07-05T20:27:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02305909",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2018-05-11T00:00:00-04:00",
    "actual_end_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-24T18:09:40-05:00",
    "status": "avoided_shortage",
    "en_comments": "Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.",
    "en_drug_brand_name": "MARCAINE 0.50%",
    "en_drug_common_name": "MARCAINE",
    "fr_drug_brand_name": "MARCAINE 0.50%",
    "fr_drug_common_name": "MARCAINE",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne",
    "drug_strength": "5.0MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration",
    "drug_package_quantity": "1x50ml",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14776,
    "drug": {
      "current_status": "MARKETED",
      "id": 10386,
      "drug_code": 65587,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253931,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "20",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02241917",
      "brand_name": "MARCAINE",
      "brand_name_fr": "",
      "descriptor": "PRESERVATIVE-FREE, SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108896002"
    },
    "created_date": "2017-07-05T20:31:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241917",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2017-12-04T00:00:00-05:00",
    "actual_end_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-24T18:10:32-05:00",
    "status": "avoided_shortage",
    "en_comments": "Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.",
    "en_drug_brand_name": "MARCAINE 7.5 MG/ML",
    "en_drug_common_name": "MARCAINE",
    "fr_drug_brand_name": "MARCAINE 7.5 MG/ML",
    "fr_drug_common_name": "MARCAINE",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nRETROBULBAR",
    "drug_route_fr": "Épidurale\r\nRétrobulbaire",
    "drug_package_quantity": "10x20ml",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14779,
    "drug": {
      "current_status": "MARKETED",
      "id": 10382,
      "drug_code": 65585,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253928,
          "ingredient": {
            "id": 2778,
            "ingredient_code": 8923,
            "en_name": "EPINEPHRINE BITARTRATE",
            "fr_name": "Bitartrate d'épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.182",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "20",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253927,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "20",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02241915",
      "brand_name": "MARCAINE E",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0231290001"
    },
    "created_date": "2017-07-05T20:33:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241915",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2017-09-06T00:00:00-04:00",
    "actual_end_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-24T18:11:14-05:00",
    "status": "resolved",
    "en_comments": "Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.",
    "en_drug_brand_name": "MARCAINE E 2.5 MG/ML",
    "en_drug_common_name": "MARCAINE",
    "fr_drug_brand_name": "MARCAINE E 2.5 MG/ML",
    "fr_drug_common_name": "MARCAINE",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE\r\nEPINEPHRINE BITARTRATE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne\r\nBitartrate d'épinéphrine",
    "drug_strength": "2.5MG\r\n9.1MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nEPIDURAL",
    "drug_route_fr": "Bloc/Infiltration\r\nÉpidurale",
    "drug_package_quantity": "10x20ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14782,
    "drug": {
      "current_status": "MARKETED",
      "id": 10384,
      "drug_code": 65586,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253930,
          "ingredient": {
            "id": 2778,
            "ingredient_code": 8923,
            "en_name": "EPINEPHRINE BITARTRATE",
            "fr_name": "Bitartrate d'épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.182",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "20",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253929,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "20",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02241916",
      "brand_name": "MARCAINE E",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0231290002"
    },
    "created_date": "2017-07-05T20:37:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241916",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2017-07-05T00:00:00-04:00",
    "actual_end_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-11-24T18:11:50-05:00",
    "status": "resolved",
    "en_comments": "Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.",
    "en_drug_brand_name": "MARCAINE E 5.0 MG/ML",
    "en_drug_common_name": "MARCAINE",
    "fr_drug_brand_name": "MARCAINE E 5.0 MG/ML",
    "fr_drug_common_name": "MARCAINE",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE\r\nEPINEPHRINE BITARTRATE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne\r\nBitartrate d'épinéphrine",
    "drug_strength": "5.0MG\r\n9.1MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nEPIDURAL",
    "drug_route_fr": "Bloc/Infiltration\r\nÉpidurale",
    "drug_package_quantity": "10x20ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14785,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10408,
      "drug_code": 65646,
      "updated_date": "2025-05-15T04:01:30-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8332058,
          "ingredient": {
            "id": 1378,
            "ingredient_code": 9401,
            "en_name": "PENTAZOCINE",
            "fr_name": "Pentazocine (Lactate de pentazocine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02241976",
      "brand_name": "TALWIN",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE AMPOULE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108852001"
    },
    "created_date": "2017-07-05T20:38:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241976",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N02AD",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2018-11-23T00:00:00-05:00",
    "actual_end_date": "2018-09-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-09-04T20:06:48-04:00",
    "status": "avoided_shortage",
    "en_comments": "The drug has been discontinued.",
    "fr_comments": "Le médicament a été discontinue.",
    "en_drug_brand_name": "TALWIN 30 MG/ML",
    "en_drug_common_name": "TALWIN",
    "fr_drug_brand_name": "TALWIN 30MG/ML",
    "fr_drug_common_name": "TALWIN",
    "en_ingredients": "PENTAZOCINE",
    "fr_ingredients": "PENTAZOCINE",
    "drug_strength": "30MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "25x1ml",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14789,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23756,
      "drug_code": 86415,
      "updated_date": "2025-05-15T04:19:48-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8351135,
          "ingredient": {
            "id": 1596,
            "ingredient_code": 8541,
            "en_name": "VANCOMYCIN",
            "fr_name": "Vancomycine (Chlorhydrate de vancomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02378337",
      "brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
      "brand_name_fr": "CHLORHYDRATE DE VANCOMYCINE POUR INJECTION, USP",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131315007"
    },
    "created_date": "2017-07-05T20:41:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378337",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "J01XA",
    "atc_description": "OTHER ANTIBACTERIALS",
    "actual_start_date": "2017-09-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-12-22T06:00:04-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "en_drug_common_name": "VANCOMYCIN HYDROCHLORIDE",
    "fr_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE",
    "fr_drug_common_name": "VANCOMYCIN HYDROCHLORIDE",
    "en_ingredients": "VANCOMYCIN",
    "fr_ingredients": "VANCOMYCIN HYDROCHLORIDE",
    "drug_strength": "5G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1x5g",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 14792,
    "drug": {
      "current_status": "MARKETED",
      "id": 22592,
      "drug_code": 85113,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8258140,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02366282",
      "brand_name": "PRO-LANSOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666001"
    },
    "created_date": "2017-07-05T20:42:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02366282",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2017-10-17T00:00:00-04:00",
    "actual_start_date": "2017-07-17T00:00:00-04:00",
    "actual_end_date": "2017-10-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-19T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LANSOPRAZOLE",
    "en_drug_common_name": "LANSOPRAZOLE",
    "fr_drug_brand_name": "LANSOPRAZOLE",
    "fr_drug_common_name": "LANSOPRAZOLE",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "Lansoprazole",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100-500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14814,
    "drug": {
      "current_status": "MARKETED",
      "id": 17018,
      "drug_code": 78032,
      "updated_date": "2025-05-15T02:31:55-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256000,
          "ingredient": {
            "id": 76,
            "ingredient_code": 626,
            "en_name": "CHLORHEXIDINE GLUCONATE",
            "fr_name": "Gluconate de chlorhexidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8255999,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02294990",
      "brand_name": "INSTILLAGEL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252212001"
    },
    "created_date": "2017-07-06T13:42:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02294990",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2017-07-17T00:00:00-04:00",
    "estimated_end_date": "2017-07-18T00:00:00-04:00",
    "actual_start_date": "2017-07-10T00:00:00-04:00",
    "actual_end_date": "2017-07-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-18T13:49:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "INSTILLAGEL",
    "en_drug_common_name": "INSTILLAGEL LIDO2% CHLORHEX 0.05%",
    "fr_drug_brand_name": "INSTILLAGEL",
    "fr_drug_common_name": "INSTILLAGEL LIDO2% CHLORHEX 0.05%",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE\r\nCHLORHEXIDINE GLUCONATE",
    "fr_ingredients": "Chlorhydrate de lidocaïne\r\nGluconate de chlorhexidine",
    "drug_strength": "2%\r\n0.05%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "10X6mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 14829,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15240,
      "drug_code": 75761,
      "updated_date": "2025-05-15T04:10:34-04:00",
      "company": {
        "id": 190,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 5181,
        "mfr_code": "SRO08",
        "name": "EMD SERONO, A DIVISION OF EMD INC., CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2695 NORTH SHERIDAN WAY, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5K 2N6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8341754,
          "ingredient": {
            "id": 2144,
            "ingredient_code": 7364,
            "en_name": "SOMATROPIN",
            "fr_name": "Somatropine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8.8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02272083",
      "brand_name": "SAIZEN 8.8MG (5.83MG/ML)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131827005"
    },
    "created_date": "2017-07-06T19:24:20-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02272083",
    "company_name": "EMD SERONO A DIVISION OF EMD INC CANADA",
    "atc_number": "H01AC",
    "atc_description": "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",
    "discontinuation_date": "2017-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Product is discontinued. Other formats of SAIZEN are still available, please contact Customer Service at 1 800-387-9749.",
    "fr_discontinuation_comments": "Le produit est discontinué. D'autres formats de Saizen sont toujours disponibles, veuillez s'il vous plaît contacter le service à la clientèle au 1 800-387-9749.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-04T18:42:54-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "SAIZEN 8.8MG (5.83MG/ML)",
    "en_drug_common_name": "somatropin",
    "fr_drug_brand_name": "SAIZEN 8.8MG (5.83MG/ML)",
    "fr_drug_common_name": "somatropine",
    "en_ingredients": "SOMATROPIN",
    "fr_ingredients": "SOMATROPINE",
    "drug_strength": "8.8MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "1 vial / fiole",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 14833,
    "drug": {
      "current_status": "MARKETED",
      "id": 4294,
      "drug_code": 20256,
      "updated_date": "2025-12-03T00:30:34-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8252691,
          "ingredient": {
            "id": 36161,
            "ingredient_code": 23888,
            "en_name": "HEPATITIS A VIRUS, INACTIVATED",
            "fr_name": "Virus inactivé contre l'hépatite a, inactivé"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1440",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02187078",
      "brand_name": "HAVRIX 1440",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE PREFILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "82560",
      "number_of_ais": "1",
      "ai_group_no": "0165325001"
    },
    "created_date": "2017-07-06T19:33:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02187078",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07BC",
    "atc_description": "VIRAL VACCINES",
    "estimated_end_date": "2017-07-10T00:00:00-04:00",
    "actual_start_date": "2017-07-05T00:00:00-04:00",
    "actual_end_date": "2017-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-07-11T14:10:06-04:00",
    "status": "resolved",
    "en_comments": "Vial format is available as a substitute.",
    "fr_comments": "Les fioles sont disponibles comme substitut",
    "en_drug_brand_name": "HAVRIX - SUS IM 1440 ELISA UNITS/ML",
    "en_drug_common_name": "Hepatitis A vaccine, inactivated",
    "fr_drug_brand_name": "HAVRIX 1440",
    "fr_drug_common_name": "Vaccin contre l’hépatite A, inactivé",
    "en_ingredients": "HEPATITIS A VACCINE, INACTIVATED",
    "fr_ingredients": "Vaccin contre l'hépatite A, inactivé",
    "drug_strength": "1440UNIT",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "1's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 14850,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28722,
      "drug_code": 90846,
      "updated_date": "2025-05-15T04:22:24-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8354578,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02423766",
      "brand_name": "MIDAZOLAM INJECTION",
      "brand_name_fr": "",
      "descriptor": "5MG/ML; 15MG/3ML; 50MG/10ML SINGLE USE AMPOULES",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935001"
    },
    "created_date": "2017-07-06T20:23:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423766",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "anticipated_start_date": "2017-07-14T00:00:00-04:00",
    "estimated_end_date": "2017-10-20T00:00:00-04:00",
    "actual_end_date": "2017-10-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-10-06T14:58:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "Midazolam",
    "fr_drug_brand_name": "MIDAZOLAM INJECTION",
    "fr_drug_common_name": "Midazolam",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14854,
    "drug": {
      "current_status": "MARKETED",
      "id": 23866,
      "drug_code": 86529,
      "updated_date": "2025-05-15T02:33:11-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8258590,
          "ingredient": {
            "id": 2406,
            "ingredient_code": 11431,
            "en_name": "TOPOTECAN",
            "fr_name": "Topotécane (Chlorhydrate de topotécan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02379422",
      "brand_name": "TOPOTECAN HYDROCHLORIDE FOR INJECTION",
      "brand_name_fr": "CHLORHYDRATE DE TOPOTÉCAN POUR INJECTION",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132984002"
    },
    "created_date": "2017-07-06T20:28:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379422",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "L01XX",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "anticipated_start_date": "2017-07-12T00:00:00-04:00",
    "estimated_end_date": "2017-08-30T00:00:00-04:00",
    "actual_end_date": "2017-08-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-08-30T16:40:37-04:00",
    "status": "resolved",
    "en_comments": "Resolved August 29, 2017",
    "fr_comments": "Résolu le 29 août 2017",
    "en_drug_brand_name": "TOPOTECAN HYDROCHLORIDE FOR INJECTION",
    "en_drug_common_name": "Topotecan",
    "fr_drug_brand_name": "TOPOTECAN HYDROCHLORIDE FOR INJECTION",
    "fr_drug_common_name": "Topotecan",
    "en_ingredients": "TOPOTECAN",
    "fr_ingredients": "TOPOTECAN",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "5 x 4mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 14864,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1462,
      "drug_code": 13156,
      "updated_date": "2025-05-15T03:39:24-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8291045,
          "ingredient": {
            "id": 712,
            "ingredient_code": 6469,
            "en_name": "GOLD SODIUM THIOMALATE",
            "fr_name": "Aurothiomalate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01927620",
      "brand_name": "MYOCHRYSINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74458",
      "number_of_ais": "1",
      "ai_group_no": "0107427003"
    },
    "created_date": "2017-07-06T20:33:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01927620",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "M01CB",
    "atc_description": "SPECIFIC ANTIRHEUMATIC AGENTS",
    "anticipated_start_date": "2017-07-07T00:00:00-04:00",
    "actual_start_date": "2017-07-07T00:00:00-04:00",
    "actual_end_date": "2017-08-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-08-04T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Manufacturing Delay",
    "fr_comments": "Délai de fabrication",
    "en_drug_brand_name": "MYOCHRYSINE",
    "en_drug_common_name": "Myochrysine",
    "fr_drug_brand_name": "Myochrysine",
    "fr_drug_common_name": "Myochrysine",
    "en_ingredients": "GOLD SODIUM THIOMALATE",
    "fr_ingredients": "Aurothiomalate de sodium",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14873,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30660,
      "drug_code": 92698,
      "updated_date": "2025-05-15T04:23:59-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8355965,
          "ingredient": {
            "id": 2680,
            "ingredient_code": 11865,
            "en_name": "CELECOXIB",
            "fr_name": "Célécoxib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442639",
      "brand_name": "SDZ CELECOXIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137043001"
    },
    "created_date": "2017-07-06T21:49:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02442639",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "M01AH",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2018-02-26T00:00:00-05:00",
    "actual_start_date": "2017-07-03T00:00:00-04:00",
    "actual_end_date": "2018-03-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-03-03T06:00:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SDZ CELECOXIB",
    "en_drug_common_name": "CELECOXIB",
    "fr_drug_brand_name": "CELECOXIB",
    "fr_drug_common_name": "CELECOXIB",
    "en_ingredients": "CELECOXIB",
    "fr_ingredients": "Célécoxib",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14876,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13116,
      "drug_code": 72503,
      "updated_date": "2025-05-15T04:07:41-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8338848,
          "ingredient": {
            "id": 2658,
            "ingredient_code": 11847,
            "en_name": "CITALOPRAM",
            "fr_name": "Citalopram (Bromhydrate de citalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248170",
      "brand_name": "SANDOZ CITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136243001"
    },
    "created_date": "2017-07-06T21:52:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248170",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2017-08-14T00:00:00-04:00",
    "actual_start_date": "2017-07-03T00:00:00-04:00",
    "actual_end_date": "2017-08-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-09-06T20:46:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ CITALOPRAM",
    "en_drug_common_name": "CITALOPRAM",
    "fr_drug_brand_name": "CITALOPRAM",
    "fr_drug_common_name": "CITALOPRAM",
    "en_ingredients": "CITALOPRAM",
    "fr_ingredients": "CITALOPRAM",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 14879,
    "drug": {
      "current_status": "CANCELLED PRE MARKET",
      "id": 12084,
      "drug_code": 70042,
      "updated_date": "2025-05-15T04:04:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8336485,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "360",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245922",
      "brand_name": "SANDOZ DILTIAZEM T",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863009"
    },
    "created_date": "2017-07-06T21:54:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245922",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "actual_start_date": "2017-07-03T00:00:00-04:00",
    "actual_end_date": "2019-09-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-04-01T13:50:45-04:00",
    "status": "resolved",
    "en_comments": "Stock available at some wholesalers/Inventaire disponible chez certains grossistes",
    "en_drug_brand_name": "SANDOZ DILTIAZEM T",
    "en_drug_common_name": "DILTIAZEM",
    "fr_drug_brand_name": "DILTIAZEM",
    "fr_drug_common_name": "DILTIAZEM",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "360MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 14896,
    "drug": {
      "current_status": "MARKETED",
      "id": 7226,
      "drug_code": 4899,
      "updated_date": "2025-12-03T00:30:22-05:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250685,
          "ingredient": {
            "id": 2328,
            "ingredient_code": 6299,
            "en_name": "ACETAZOLAMIDE",
            "fr_name": "Acétazolamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00545015",
      "brand_name": "ACETAZOLAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59078",
      "number_of_ais": "1",
      "ai_group_no": "0107512001"
    },
    "created_date": "2017-07-07T10:56:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00545015",
    "company_name": "AA PHARMA INC",
    "atc_number": "S01EC",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2017-07-17T00:00:00-04:00",
    "actual_start_date": "2017-07-06T00:00:00-04:00",
    "actual_end_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-13T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACETAZOLAMIDE",
    "en_drug_common_name": "ACETAZOLAMIDE",
    "fr_drug_brand_name": "ACETAZOLAMIDE",
    "fr_drug_common_name": "ACETAZOLAMIDE",
    "en_ingredients": "ACETAZOLAMIDE",
    "fr_ingredients": "Acétazolamide",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 Bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 14909,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19600,
      "drug_code": 80969,
      "updated_date": "2025-12-03T01:26:33-05:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8346891,
          "ingredient": {
            "id": 2334,
            "ingredient_code": 11262,
            "en_name": "GEMCITABINE",
            "fr_name": "Gemcitabine (Chlorhydrate de gemcitabine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02324210",
      "brand_name": "GEMCITABINE FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133122003"
    },
    "created_date": "2017-07-07T13:50:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02324210",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2017-07-05T00:00:00-04:00",
    "estimated_end_date": "2017-09-29T00:00:00-04:00",
    "actual_start_date": "2017-07-05T00:00:00-04:00",
    "actual_end_date": "2017-09-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-11-24T19:17:46-05:00",
    "status": "resolved",
    "en_drug_brand_name": "GEMCITABINE FOR INJECTION",
    "en_drug_common_name": "GEMCITABINE",
    "fr_drug_brand_name": "GEMCITABINE POUR SOLUTION",
    "fr_drug_common_name": "GEMCITABINE POUR SOLUTION",
    "en_ingredients": "GEMCITABINE",
    "fr_ingredients": "GEMCITABINE",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1 G POWDER IN A VIAL     |     1 G DE POUDRE DANS UN FLACON",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 14916,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 4818,
      "drug_code": 2645,
      "updated_date": "2025-05-15T03:25:22-04:00",
      "company": {
        "id": 246,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5192,
        "mfr_code": "SSP50",
        "name": "SEPTODONT",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "58 RUE DU PONT DE CRETEIL",
        "province": "VAL-DE-MARNE",
        "country": "FRANCE",
        "city": "ST-MAUR-DES-FOSSES",
        "postal_code": "94107",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8273634,
          "ingredient": {
            "id": 1794,
            "ingredient_code": 5821,
            "en_name": "ALUMINUM CHLORIDE",
            "fr_name": "Chlorure d'aluminium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8273633,
          "ingredient": {
            "id": 1796,
            "ingredient_code": 6977,
            "en_name": "OXYQUINOLINE SULFATE",
            "fr_name": "Sulfate d'oxyquinoline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00379638",
      "brand_name": "RACESTYPTINE SOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "50749",
      "number_of_ais": "2",
      "ai_group_no": "0211489001"
    },
    "created_date": "2017-07-07T14:06:04-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00379638",
    "company_name": "SEPTODONT",
    "atc_number": "A01",
    "atc_description": "STOMATOLOGICAL PREPARATIONS",
    "discontinuation_date": "2017-07-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-08T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "RACESTYPTINE SOL",
    "en_drug_common_name": "Aluminum Chloride (25%), 8-Hydroxy quinoline sulfate (0.1%)",
    "fr_drug_brand_name": "RACESTYPTINE SOL",
    "fr_drug_common_name": "Aluminum Chloride (25%), 8-Hydroxy quinoline sulfate (0.1%)",
    "en_ingredients": "ALUMINUM CHLORIDE\r\nOXYQUINOLINE SULFATE",
    "fr_ingredients": "Chlorure d'aluminium\r\nSulfate d'oxyquinoline",
    "drug_strength": "25G\r\n100MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "DENTAL",
    "drug_route_fr": "Dentaire",
    "drug_package_quantity": "0.44 fl oz",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 14927,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1084,
      "drug_code": 1248,
      "updated_date": "2025-05-15T03:24:13-04:00",
      "company": {
        "id": 246,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5192,
        "mfr_code": "SSP50",
        "name": "SEPTODONT",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "58 RUE DU PONT DE CRETEIL",
        "province": "VAL-DE-MARNE",
        "country": "FRANCE",
        "city": "ST-MAUR-DES-FOSSES",
        "postal_code": "94107",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8271590,
          "ingredient": {
            "id": 616,
            "ingredient_code": 3836,
            "en_name": "DISODIUM EDETATE",
            "fr_name": "Édétate disodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8271589,
          "ingredient": {
            "id": 182,
            "ingredient_code": 7145,
            "en_name": "CETRIMONIUM BROMIDE",
            "fr_name": "Bromure de cétrimonium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "00229636",
      "brand_name": "LARGAL ULTRA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "38140",
      "number_of_ais": "2",
      "ai_group_no": "0206866001"
    },
    "created_date": "2017-07-07T14:34:58-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00229636",
    "company_name": "SEPTODONT",
    "atc_number": "A01AD",
    "atc_description": "STOMATOLOGICAL PREPARATIONS",
    "discontinuation_date": "2017-07-07T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-07-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-08T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "LARGAL ULTRA",
    "en_drug_common_name": "Disodium Edetate, Cetrimonium Bromide",
    "fr_drug_brand_name": "LARGAL ULTRA",
    "fr_drug_common_name": "Disodium Edetate, Cetrimonium Bromide",
    "en_ingredients": "CETRIMONIUM BROMIDE\r\nDISODIUM EDETATE",
    "fr_ingredients": "Bromure de cétrimonium\r\nÉdétate disodique",
    "drug_strength": "750MG\r\n15G",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "DENTAL",
    "drug_route_fr": "Dentaire",
    "drug_package_quantity": "13 mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 14973,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 5046,
      "drug_code": 2977,
      "updated_date": "2025-05-15T03:25:38-04:00",
      "company": {
        "id": 246,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5192,
        "mfr_code": "SSP50",
        "name": "SEPTODONT",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "58 RUE DU PONT DE CRETEIL",
        "province": "VAL-DE-MARNE",
        "country": "FRANCE",
        "city": "ST-MAUR-DES-FOSSES",
        "postal_code": "94107",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8274265,
          "ingredient": {
            "id": 1826,
            "ingredient_code": 10230,
            "en_name": "THYMOL",
            "fr_name": "Thymol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8274264,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8274263,
          "ingredient": {
            "id": 1700,
            "ingredient_code": 9125,
            "en_name": "CAMPHOR",
            "fr_name": "Camphre"
          },
          "ingredient_supplied_ind": "I",
          "strength": "649",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8274262,
          "ingredient": {
            "id": 1888,
            "ingredient_code": 17827,
            "en_name": "PARACHLOROPHENOL",
            "fr_name": "Parachlorophénol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "00379689",
      "brand_name": "CRESOPHENE LIQ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "52333",
      "number_of_ais": "4",
      "ai_group_no": "0412848001"
    },
    "created_date": "2017-07-07T18:30:34-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00379689",
    "company_name": "SEPTODONT",
    "atc_number": "A01AC",
    "atc_description": "STOMATOLOGICAL PREPARATIONS",
    "discontinuation_date": "2017-07-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-08T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "CRESOPHENE LIQ",
    "en_drug_common_name": "Camphor, Dexamethasone, Parachlorophenol, Thymol",
    "fr_drug_brand_name": "CRESOPHENE LIQ",
    "fr_drug_common_name": "Camphor, Dexamethasone, Parachlorophenol, Thymol",
    "en_ingredients": "THYMOL\r\nDEXAMETHASONE\r\nCAMPHOR\r\nPARACHLOROPHENOL",
    "fr_ingredients": "Thymol\r\nDexaméthasone\r\nCamphre\r\nParachlorophénol",
    "drug_strength": "50MG\r\n1MG\r\n649MG\r\n300MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "DENTAL",
    "drug_route_fr": "Dentaire",
    "drug_package_quantity": "13 mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 15021,
    "drug": {
      "current_status": "MARKETED",
      "id": 330,
      "drug_code": 10863,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 17330,
        "created_date": "2024-05-09T01:45:09-04:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 19068,
        "mfr_code": "",
        "name": "VANTIVE ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6675 MILLCREEK DRIVE, UNIT 2",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 5M4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251412,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "538",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251411,
          "ingredient": {
            "id": 8,
            "ingredient_code": 1074,
            "en_name": "SODIUM LACTATE",
            "fr_name": "Lactate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "448",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251410,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251409,
          "ingredient": {
            "id": 12,
            "ingredient_code": 49,
            "en_name": "MAGNESIUM CHLORIDE",
            "fr_name": "Chlorure de magnésium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5.08",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251408,
          "ingredient": {
            "id": 14,
            "ingredient_code": 51,
            "en_name": "CALCIUM CHLORIDE",
            "fr_name": "Chlorure de calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "18.3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00865095",
      "brand_name": "DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70980",
      "number_of_ais": "5",
      "ai_group_no": "0500162036"
    },
    "created_date": "2017-07-10T13:32:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00865095",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05",
    "atc_description": "HEMODIALYTICS AND HEMOFILTRATES",
    "anticipated_start_date": "2017-07-21T00:00:00-04:00",
    "estimated_end_date": "2017-07-28T00:00:00-04:00",
    "actual_start_date": "2017-07-21T00:00:00-04:00",
    "actual_end_date": "2017-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-01T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "We have a substitute product available (JB9416)which is the same concentration however different fill volume (2L).  Please contact Baxter Customer Service for further information on the alternate product to use temporarily if needed.  We are monitoring this closely and will do everything possible to avoid an actual backorder.",
    "fr_comments": "Nous offrons un produit de rechange (JB9416) qui présente la même concentration, mais dont le volume est différent (2 L).  Si vous avez besoin d’autres renseignements sur l’utilisation temporaire du produit de rechange, veuillez communiquer avec le Service à la clientèle de Baxter.  Nous effectuons un suivi étroit de la situation et faisons tout en notre pouvoir pour éviter une réelle rupture de stock.",
    "en_drug_brand_name": "DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM",
    "en_drug_common_name": "DIANEAL,PD4 1.5% 1.5L TWIN BAG",
    "fr_drug_brand_name": "DIANEAL,PD4 1.5% 1.5L TWIN BAG",
    "fr_drug_common_name": "DIANEAL,PD4 1.5% 1.5L TWIN BAG",
    "en_ingredients": "SODIUM LACTATE\r\nDEXTROSE\r\nMAGNESIUM CHLORIDE\r\nCALCIUM CHLORIDE\r\nSODIUM CHLORIDE",
    "fr_ingredients": "Lactate de sodium\r\nDextrose\r\nChlorure de magnésium\r\nChlorure de calcium\r\nChlorure de sodium",
    "drug_strength": "448MG\r\n1.5G\r\n5.08MG\r\n18.3MG\r\n538MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "DIALYSIS",
    "drug_route_fr": "Dialyse",
    "drug_package_quantity": "1.5L BAGS, 6/box",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 15024,
    "drug": {
      "current_status": "DORMANT",
      "id": 21374,
      "drug_code": 83777,
      "updated_date": "2025-05-15T06:55:41-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368452,
          "ingredient": {
            "id": 1142,
            "ingredient_code": 9806,
            "en_name": "LYSINE",
            "fr_name": "Lysine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.48",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368451,
          "ingredient": {
            "id": 1022,
            "ingredient_code": 938,
            "en_name": "L-ARGININE",
            "fr_name": "L-arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.34",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368450,
          "ingredient": {
            "id": 392,
            "ingredient_code": 7217,
            "en_name": "METHIONINE",
            "fr_name": "Méhionine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.21",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368449,
          "ingredient": {
            "id": 1456,
            "ingredient_code": 943,
            "en_name": "L-LEUCINE",
            "fr_name": "L-leucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.07",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368448,
          "ingredient": {
            "id": 12,
            "ingredient_code": 49,
            "en_name": "MAGNESIUM CHLORIDE",
            "fr_name": "Chlorure de magnésium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.81",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368447,
          "ingredient": {
            "id": 1028,
            "ingredient_code": 944,
            "en_name": "L-ISOLEUCINE",
            "fr_name": "L-isoleucine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.21",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368446,
          "ingredient": {
            "id": 14,
            "ingredient_code": 51,
            "en_name": "CALCIUM CHLORIDE",
            "fr_name": "Chlorure de calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.52",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368445,
          "ingredient": {
            "id": 1450,
            "ingredient_code": 8872,
            "en_name": "GLUTAMIC ACID",
            "fr_name": "Acide glutamique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.21",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368444,
          "ingredient": {
            "id": 2684,
            "ingredient_code": 11968,
            "en_name": "SODIUM ACETATE TRIHYDRATE",
            "fr_name": "Acétate de sodium trihydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.50",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368443,
          "ingredient": {
            "id": 378,
            "ingredient_code": 10237,
            "en_name": "HISTIDINE",
            "fr_name": "Histidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.64",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368442,
          "ingredient": {
            "id": 1494,
            "ingredient_code": 2963,
            "en_name": "ALANINE",
            "fr_name": "Alanine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6.41",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368441,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "154",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368440,
          "ingredient": {
            "id": 3664,
            "ingredient_code": 4771,
            "en_name": "SODIUM GLYCEROPHOSPHATE",
            "fr_name": "Glycérophosphate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.67",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368439,
          "ingredient": {
            "id": 1454,
            "ingredient_code": 942,
            "en_name": "L-PHENYLALANINE",
            "fr_name": "L-phénylalanine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.07",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368438,
          "ingredient": {
            "id": 1452,
            "ingredient_code": 9397,
            "en_name": "L-ASPARTIC ACID",
            "fr_name": "Acide L-aspartique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.28",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368437,
          "ingredient": {
            "id": 3634,
            "ingredient_code": 6627,
            "en_name": "OLIVE OIL",
            "fr_name": "Huile d'olive"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368436,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.74",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368435,
          "ingredient": {
            "id": 224,
            "ingredient_code": 8865,
            "en_name": "GLYCINE",
            "fr_name": "Glycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.07",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368434,
          "ingredient": {
            "id": 1026,
            "ingredient_code": 941,
            "en_name": "L-THREONINE",
            "fr_name": "L-thréonine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.21",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368433,
          "ingredient": {
            "id": 398,
            "ingredient_code": 9927,
            "en_name": "SERINE",
            "fr_name": "Sérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.75",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368432,
          "ingredient": {
            "id": 1404,
            "ingredient_code": 3289,
            "en_name": "SOYBEAN OIL",
            "fr_name": "Huile de soja"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368431,
          "ingredient": {
            "id": 1020,
            "ingredient_code": 935,
            "en_name": "L-PROLINE",
            "fr_name": "L-proline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.64",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368430,
          "ingredient": {
            "id": 1018,
            "ingredient_code": 897,
            "en_name": "L-TYROSINE",
            "fr_name": "L-tyrosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.11",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368429,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.24",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        },
        {
          "id": 8368428,
          "ingredient": {
            "id": 1024,
            "ingredient_code": 939,
            "en_name": "L-VALINE",
            "fr_name": "L-valine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.83",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "L",
          "base": false
        }
      ],
      "din": "02352516",
      "brand_name": "OLIMEL 4.4% E",
      "brand_name_fr": "",
      "descriptor": "EMULSION FOR INFUSION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "25",
      "ai_group_no": "2552744003"
    },
    "created_date": "2017-07-10T15:41:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02352516",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2017-07-07T00:00:00-04:00",
    "estimated_end_date": "2017-08-15T00:00:00-04:00",
    "actual_start_date": "2017-07-07T00:00:00-04:00",
    "actual_end_date": "2017-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-08-16T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Customers can use the following alternate code upon their clinical judgement\r\n•\tOlimel 5.7% E- CJDB3WP1E\r\n•\tOlimel 5.7% E- CJDB3WP1F\r\n•\tOlimel 5.7% E- CJDB3WP1G",
    "fr_comments": "En s’appuyant sur leur jugement clinique, les clients peuvent utiliser un des codes de produit de rechange suivants : \r\n• Olimel à 5,7 % E- CJDB3WP1E\r\n• Olimel à 5,7 % E- CJDB3WP1F\r\n• Olimel à 5,7 % E- CJDB3WP1G",
    "en_drug_brand_name": "OLIMEL 4.4% E",
    "en_drug_common_name": "OLIMEL 4.4% E",
    "fr_drug_brand_name": "OLIMEL 4.4% E",
    "fr_drug_common_name": "OLIMEL 4.4% E",
    "en_ingredients": "HISTIDINE\r\nTRYPTOPHAN\r\nSODIUM ACETATE TRIHYDRATE\r\nALANINE\r\nSOYBEAN OIL\r\nDEXTROSE\r\nSODIUM GLYCEROPHOSPHATE\r\nMAGNESIUM CHLORIDE\r\nCALCIUM CHLORIDE\r\nPOTASSIUM CHLORIDE\r\nOLIVE OIL\r\nMETHIONINE\r\nGLYCINE\r\nGLUTAMIC ACID\r\nL-TYROSINE\r\nL-PROLINE\r\nL-ARGININE\r\nL-VALINE\r\nL-ASPARTIC ACID\r\nL-THREONINE\r\nL-PHENYLALANINE\r\nL-LEUCINE\r\nL-ISOLEUCINE\r\nLYSINE\r\nSERINE",
    "fr_ingredients": "Histidine\r\nTryptophane\r\nAcétate de sodium trihydraté\r\nAlanine\r\nHuile de soja\r\nDextrose\r\nGlycérophosphate de sodium\r\nChlorure de magnésium\r\nChlorure de calcium\r\nChlorure de potassium\r\nHuile d'olive\r\nMéhionine\r\nGlycine\r\nAcide glutamique\r\nL-tyrosine\r\nL-proline\r\nL-arginine\r\nL-valine\r\nAcide L-aspartique\r\nL-thréonine\r\nL-phénylalanine\r\nL-leucine\r\nL-isoleucine\r\nLysine\r\nSérine",
    "drug_strength": "2.64G\r\n0.74G\r\n1.50G\r\n6.41G\r\n8G\r\n154G\r\n3.67G\r\n0.81G\r\n0.52G\r\n2.24G\r\n32G\r\n2.21G\r\n3.07G\r\n2.21G\r\n0.11G\r\n2.64G\r\n4.34G\r\n2.83G\r\n1.28G\r\n2.21G\r\n3.07G\r\n3.07G\r\n2.21G\r\n3.48G\r\n1.75G",
    "drug_dosage_form": "EMULSION",
    "drug_dosage_form_fr": "Émulsion",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1000mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 15035,
    "drug": {
      "current_status": "MARKETED",
      "id": 10270,
      "drug_code": 65259,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253890,
          "ingredient": {
            "id": 2190,
            "ingredient_code": 1381,
            "en_name": "FENOFIBRATE",
            "fr_name": "Fénofibrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02241602",
      "brand_name": "LIPIDIL SUPRA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118895004"
    },
    "created_date": "2017-07-10T17:22:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241602",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "C10AB",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2017-09-08T00:00:00-04:00",
    "actual_end_date": "2018-01-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2018-01-11T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LIPIDIL SUPRA",
    "en_drug_common_name": "LIPIDIL SUPRA",
    "fr_drug_brand_name": "LIPIDIL SUPRA",
    "fr_drug_common_name": "LIPIDIL SUPRA",
    "en_ingredients": "FENOFIBRATE",
    "fr_ingredients": "Fénofibrate",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3x10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15049,
    "drug": {
      "current_status": "MARKETED",
      "id": 10364,
      "drug_code": 65503,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253919,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        },
        {
          "id": 8253918,
          "ingredient": {
            "id": 1006,
            "ingredient_code": 7498,
            "en_name": "NORETHINDRONE ACETATE",
            "fr_name": "Acétate de noréthindrone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02241837",
      "brand_name": "ESTALIS 250/50 MCG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0242942006"
    },
    "created_date": "2017-07-10T19:35:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241837",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "G03FA",
    "atc_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
    "anticipated_start_date": "2017-08-28T00:00:00-04:00",
    "estimated_end_date": "2018-01-17T00:00:00-05:00",
    "actual_start_date": "2017-08-23T00:00:00-04:00",
    "actual_end_date": "2018-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-01-18T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ESTALIS 250/50 MCG",
    "en_drug_common_name": "ESTALIS 250/50UG 8'S",
    "fr_drug_brand_name": "ESTALIS 250/50UG 8'S",
    "fr_drug_common_name": "ESTALIS 250/50UG 8'S",
    "en_ingredients": "ESTRADIOL\r\nNORETHINDRONE ACETATE",
    "fr_ingredients": "Estradiol\r\nAcétate de noréthindrone",
    "drug_strength": "0.51MG\r\n4.8MG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "8'S",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15053,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2026,
      "drug_code": 14273,
      "updated_date": "2025-05-15T03:40:27-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8293226,
          "ingredient": {
            "id": 1058,
            "ingredient_code": 1215,
            "en_name": "BENAZEPRIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bénazépril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00885835",
      "brand_name": "LOTENSIN 5MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75843",
      "number_of_ais": "1",
      "ai_group_no": "0122438001"
    },
    "created_date": "2017-07-10T20:35:26-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00885835",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2017-07-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Inventory depleted",
    "fr_supply_disruption_mitigation": "Inventaire épuisé",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-09-26T17:52:47-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "LOTENSIN 5MG",
    "en_drug_common_name": "LOTENSIN 5MG",
    "fr_drug_brand_name": "LOTENSIN 5MG",
    "fr_drug_common_name": "LOTENSIN 5MG",
    "en_ingredients": "BENAZEPRIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bénazépril",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "2 X 14",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 15056,
    "drug": {
      "current_status": "MARKETED",
      "id": 908,
      "drug_code": 12168,
      "updated_date": "2025-05-15T02:30:52-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251591,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00783625",
      "brand_name": "12% SODIUM CHLORDIE PROCESSING SOLUTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73191",
      "number_of_ais": "1",
      "ai_group_no": "0100053039"
    },
    "created_date": "2017-07-10T22:10:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00783625",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05CB",
    "atc_description": "IRRIGATING SOLUTIONS",
    "anticipated_start_date": "2017-07-10T00:00:00-04:00",
    "estimated_end_date": "2017-12-18T00:00:00-05:00",
    "actual_start_date": "2017-07-10T00:00:00-04:00",
    "actual_end_date": "2017-12-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-19T18:49:54-05:00",
    "status": "resolved",
    "en_comments": "For further questions regarding this product, please contact Baxter Customer Service at 1-888-719-9955 or Medical Information at 1-855-584-1368",
    "fr_comments": "For further questions regarding this product, please contact Baxter Customer Service at 1-888-719-9955 or Medical Information at 1-855-584-1368",
    "en_drug_brand_name": "SODIUM CHLORIDE 12% USP",
    "en_drug_common_name": "12% Sodium Chloride Solution",
    "fr_drug_brand_name": "12% Sodium Chloride Solution",
    "fr_drug_common_name": "12% Sodium Chloride Solution",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "12G",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "IRRIGATION",
    "drug_route_fr": "Irrigation",
    "drug_package_quantity": "Product Code 4B7874Q, 150 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15059,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 910,
      "drug_code": 12169,
      "updated_date": "2025-05-15T03:38:39-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8289393,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.6",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00783633",
      "brand_name": "1.6% SODIUM CHLORDIE PROCESSING SOLUTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73192",
      "number_of_ais": "1",
      "ai_group_no": "0100053035"
    },
    "created_date": "2017-07-10T22:12:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00783633",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05CB",
    "atc_description": "IRRIGATING SOLUTIONS",
    "anticipated_start_date": "2017-07-10T00:00:00-04:00",
    "estimated_end_date": "2017-12-18T00:00:00-05:00",
    "actual_start_date": "2017-07-10T00:00:00-04:00",
    "actual_end_date": "2017-12-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-19T18:49:13-05:00",
    "status": "resolved",
    "en_comments": "For further questions regarding this product, please contact Baxter Customer Service at 1-888-719-9955 or Medical Information at 1-855-584-1368",
    "fr_comments": "For further questions regarding this product, please contact Baxter Customer Service at 1-888-719-9955 or Medical Information at 1-855-584-1368",
    "en_drug_brand_name": "SODIUM CHLORIDE 1.6% SOLUTION USP",
    "en_drug_common_name": "1.6% Sodium Chloride Solution",
    "fr_drug_brand_name": "1.6% Sodium Chloride Solution",
    "fr_drug_common_name": "1.6% Sodium Chloride Solution",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "1.6G",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "IRRIGATION",
    "drug_route_fr": "Irrigation",
    "drug_package_quantity": "Product Code 4B7871, 2000 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15085,
    "drug": {
      "current_status": "MARKETED",
      "id": 8814,
      "drug_code": 60940,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253531,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237601",
      "brand_name": "PMS-ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847001"
    },
    "created_date": "2017-07-11T13:32:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237601",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-10-16T00:00:00-04:00",
    "estimated_end_date": "2018-06-14T00:00:00-04:00",
    "actual_start_date": "2017-11-08T00:00:00-05:00",
    "actual_end_date": "2018-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-05-18T19:00:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ATENOLOL",
    "en_drug_common_name": "ATENOLOL",
    "fr_drug_brand_name": "PMS-ATENOLOL",
    "fr_drug_common_name": "ATENOLOL",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15088,
    "drug": {
      "current_status": "MARKETED",
      "id": 8814,
      "drug_code": 60940,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253531,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237601",
      "brand_name": "PMS-ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847001"
    },
    "created_date": "2017-07-11T13:34:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237601",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-08-26T00:00:00-04:00",
    "estimated_end_date": "2018-04-10T00:00:00-04:00",
    "actual_start_date": "2017-07-19T00:00:00-04:00",
    "actual_end_date": "2018-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-04-19T12:51:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ATENOLOL",
    "en_drug_common_name": "ATENOLOL",
    "fr_drug_brand_name": "PMS-ATENOLOL",
    "fr_drug_common_name": "ATENOLOL",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15091,
    "drug": {
      "current_status": "MARKETED",
      "id": 12342,
      "drug_code": 70768,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254547,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246581",
      "brand_name": "PMS-ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847004"
    },
    "created_date": "2017-07-11T13:34:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246581",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-09-14T00:00:00-04:00",
    "estimated_end_date": "2018-05-12T00:00:00-04:00",
    "actual_start_date": "2017-10-11T00:00:00-04:00",
    "actual_end_date": "2018-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-04-19T13:05:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ATENOLOL",
    "en_drug_common_name": "ATENOLOL",
    "fr_drug_brand_name": "PMS-ATENOLOL",
    "fr_drug_common_name": "ATENOLOL",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15094,
    "drug": {
      "current_status": "MARKETED",
      "id": 8812,
      "drug_code": 60939,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253530,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237600",
      "brand_name": "PMS-ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847002"
    },
    "created_date": "2017-07-11T13:35:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237600",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-08-02T00:00:00-04:00",
    "estimated_end_date": "2018-03-01T00:00:00-05:00",
    "actual_start_date": "2017-08-02T00:00:00-04:00",
    "actual_end_date": "2017-12-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2017-12-08T19:42:39-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ATENOLOL",
    "en_drug_common_name": "ATENOLOL",
    "fr_drug_brand_name": "PMS-ATENOLOL",
    "fr_drug_common_name": "ATENOLOL",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15097,
    "drug": {
      "current_status": "MARKETED",
      "id": 4074,
      "drug_code": 19827,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252574,
          "ingredient": {
            "id": 1182,
            "ingredient_code": 2143,
            "en_name": "CYCLOBENZAPRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de cyclobenzaprine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02212048",
      "brand_name": "PMS-CYCLOBENZAPRINE - TAB 10MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82125",
      "number_of_ais": "1",
      "ai_group_no": "0112363001"
    },
    "created_date": "2017-07-11T13:39:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02212048",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M03BX",
    "atc_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
    "anticipated_start_date": "2017-09-11T00:00:00-04:00",
    "estimated_end_date": "2018-04-26T00:00:00-04:00",
    "actual_start_date": "2017-09-11T00:00:00-04:00",
    "actual_end_date": "2018-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-19T13:22:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-CYCLOBENZAPRINE - TAB 10MG",
    "en_drug_common_name": "CYCLOBENZAPRINE",
    "fr_drug_brand_name": "PMS-CYCLOBENZAPRINE - TAB 10MG",
    "fr_drug_common_name": "CYCLOBENZAPRINE",
    "en_ingredients": "CYCLOBENZAPRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de cyclobenzaprine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15100,
    "drug": {
      "current_status": "MARKETED",
      "id": 4074,
      "drug_code": 19827,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252574,
          "ingredient": {
            "id": 1182,
            "ingredient_code": 2143,
            "en_name": "CYCLOBENZAPRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de cyclobenzaprine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02212048",
      "brand_name": "PMS-CYCLOBENZAPRINE - TAB 10MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82125",
      "number_of_ais": "1",
      "ai_group_no": "0112363001"
    },
    "created_date": "2017-07-11T13:40:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02212048",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M03BX",
    "atc_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
    "anticipated_start_date": "2018-06-09T00:00:00-04:00",
    "actual_start_date": "2018-05-04T00:00:00-04:00",
    "actual_end_date": "2020-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-10T10:55:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-CYCLOBENZAPRINE - TAB 10MG",
    "en_drug_common_name": "CYCLOBENZAPRINE",
    "fr_drug_brand_name": "PMS-CYCLOBENZAPRINE - TAB 10MG",
    "fr_drug_common_name": "CYCLOBENZAPRINE",
    "en_ingredients": "CYCLOBENZAPRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de cyclobenzaprine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 15104,
    "drug": {
      "current_status": "MARKETED",
      "id": 17714,
      "drug_code": 78792,
      "updated_date": "2025-05-15T02:32:03-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256227,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02302624",
      "brand_name": "PMS-DICLOFENAC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114417002"
    },
    "created_date": "2017-07-11T13:41:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02302624",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_start_date": "2017-10-07T00:00:00-04:00",
    "estimated_end_date": "2018-05-04T00:00:00-04:00",
    "actual_start_date": "2017-10-07T00:00:00-04:00",
    "actual_end_date": "2018-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-18T19:12:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-DICLOFENAC",
    "en_drug_common_name": "DICLOFENAC",
    "fr_drug_brand_name": "PMS-DICLOFENAC",
    "fr_drug_common_name": "DICLOFENAC",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15107,
    "drug": {
      "current_status": "DORMANT",
      "id": 21724,
      "drug_code": 84096,
      "updated_date": "2025-05-15T06:55:42-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368478,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "180",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02355760",
      "brand_name": "PMS-DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863007"
    },
    "created_date": "2017-07-11T13:43:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02355760",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "hc_updated_date": "2020-06-09T15:05:58-04:00",
    "anticipated_start_date": "2017-07-19T00:00:00-04:00",
    "actual_start_date": "2017-12-18T00:00:00-05:00",
    "actual_end_date": "2020-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-09T15:06:00-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued",
    "en_drug_brand_name": "PMS-DILTIAZEM CD",
    "en_drug_common_name": "DILTIAZEM",
    "fr_drug_brand_name": "PMS-DILTIAZEM CD",
    "fr_drug_common_name": "DILTIAZEM",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "180MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED-DELIVERY)",
    "drug_dosage_form_fr": "Capsule (à libération contrôlée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 15110,
    "drug": {
      "current_status": "DORMANT",
      "id": 21724,
      "drug_code": 84096,
      "updated_date": "2025-05-15T06:55:42-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368478,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "180",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02355760",
      "brand_name": "PMS-DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863007"
    },
    "created_date": "2017-07-11T13:44:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02355760",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "hc_updated_date": "2020-06-09T15:06:47-04:00",
    "actual_start_date": "2017-07-03T00:00:00-04:00",
    "actual_end_date": "2020-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-09T15:06:50-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued",
    "en_drug_brand_name": "PMS-DILTIAZEM CD",
    "en_drug_common_name": "DILTIAZEM",
    "fr_drug_brand_name": "PMS-DILTIAZEM CD",
    "fr_drug_common_name": "DILTIAZEM",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "180MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED-DELIVERY)",
    "drug_dosage_form_fr": "Capsule (à libération contrôlée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 15114,
    "drug": {
      "current_status": "MARKETED",
      "id": 29380,
      "drug_code": 91389,
      "updated_date": "2025-05-15T02:34:28-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260658,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429446",
      "brand_name": "PMS-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350001"
    },
    "created_date": "2017-07-11T13:47:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429446",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-08-15T00:00:00-04:00",
    "estimated_end_date": "2018-01-10T00:00:00-05:00",
    "actual_start_date": "2017-08-15T00:00:00-04:00",
    "actual_end_date": "2017-12-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-18T15:12:40-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-DULOXETINE",
    "en_drug_common_name": "DULOXETINE",
    "fr_drug_brand_name": "PMS-DULOXETINE",
    "fr_drug_common_name": "DULOXETINE",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "Duloxétine",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15119,
    "drug": {
      "current_status": "MARKETED",
      "id": 29382,
      "drug_code": 91391,
      "updated_date": "2025-05-15T02:34:28-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260659,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429454",
      "brand_name": "PMS-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350002"
    },
    "created_date": "2017-07-11T13:48:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429454",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2017-07-03T00:00:00-04:00",
    "actual_end_date": "2017-08-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-11T18:25:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-DULOXETINE",
    "en_drug_common_name": "DULOXETINE",
    "fr_drug_brand_name": "PMS-DULOXETINE",
    "fr_drug_common_name": "DULOXETINE",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "Duloxétine",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 15122,
    "drug": {
      "current_status": "MARKETED",
      "id": 29382,
      "drug_code": 91391,
      "updated_date": "2025-05-15T02:34:28-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260659,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429454",
      "brand_name": "PMS-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350002"
    },
    "created_date": "2017-07-11T13:50:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429454",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-09-14T00:00:00-04:00",
    "estimated_end_date": "2017-09-20T00:00:00-04:00",
    "actual_start_date": "2017-09-14T00:00:00-04:00",
    "actual_end_date": "2017-07-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-12T17:15:59-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "PMS-DULOXETINE",
    "en_drug_common_name": "DULOEXTINE",
    "fr_drug_brand_name": "PMS-DULOXETINE",
    "fr_drug_common_name": "DULOXETINE",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "Duloxétine",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15125,
    "drug": {
      "current_status": "MARKETED",
      "id": 27888,
      "drug_code": 90087,
      "updated_date": "2025-05-15T02:34:07-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260131,
          "ingredient": {
            "id": 1522,
            "ingredient_code": 1966,
            "en_name": "NIFEDIPINE",
            "fr_name": "Nifédipine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02416301",
      "brand_name": "PMS-NIFEDIPINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115253005"
    },
    "created_date": "2017-07-11T13:51:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02416301",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C08CA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "estimated_end_date": "2019-12-03T00:00:00-05:00",
    "actual_start_date": "2017-07-03T00:00:00-04:00",
    "actual_end_date": "2019-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2019-04-26T14:44:00-04:00",
    "status": "resolved",
    "en_comments": "PLEASE REFER TO REPORT # 77490",
    "fr_comments": "Produit non lancé - pas de date de lancement en ce moment",
    "en_drug_brand_name": "PMS-NIFEDIPINE ER",
    "en_drug_common_name": "NIFEDIPINE ER",
    "fr_drug_brand_name": "PMS-NIFEDIPINE ER",
    "fr_drug_common_name": "NIFEDIPINE ER",
    "en_ingredients": "NIFEDIPINE",
    "fr_ingredients": "Nifédipine",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 15128,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18308,
      "drug_code": 79591,
      "updated_date": "2025-05-15T04:13:47-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8345504,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310260",
      "brand_name": "PMS-OMEPRAZOLE DR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2017-07-11T13:52:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310260",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2017-11-08T00:00:00-05:00",
    "actual_start_date": "2017-07-03T00:00:00-04:00",
    "actual_end_date": "2017-11-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-18T18:51:37-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-OMEPRAZOLE DR",
    "en_drug_common_name": "OMEPRAZOLE",
    "fr_drug_brand_name": "PMS-OMEPRAZOLE DR",
    "fr_drug_common_name": "OMEPRAZOLE",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 15131,
    "drug": {
      "current_status": "MARKETED",
      "id": 18280,
      "drug_code": 79560,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256411,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02309912",
      "brand_name": "PMS-OXYCODONE CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107552006"
    },
    "created_date": "2017-07-11T13:54:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02309912",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2017-07-31T00:00:00-04:00",
    "actual_start_date": "2017-07-03T00:00:00-04:00",
    "actual_end_date": "2017-12-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2017-12-18T19:10:43-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-OXYCODONE CR",
    "en_drug_common_name": "OXYCODONE CR",
    "fr_drug_brand_name": "PMS-OXYCODONE CR",
    "fr_drug_common_name": "OXYCODONE CR",
    "en_ingredients": "OXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'oxycodone",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 15135,
    "drug": {
      "current_status": "MARKETED",
      "id": 18124,
      "drug_code": 79355,
      "updated_date": "2025-05-15T02:32:07-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256360,
          "ingredient": {
            "id": 2294,
            "ingredient_code": 11086,
            "en_name": "PANTOPRAZOLE",
            "fr_name": "Pantoprazole (Pantoprazole sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02307871",
      "brand_name": "PMS-PANTOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133229001"
    },
    "created_date": "2017-07-11T13:56:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02307871",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2017-08-04T00:00:00-04:00",
    "actual_end_date": "2017-07-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-25T14:04:28-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "PMS-PANTOPRAZOLE",
    "en_drug_common_name": "PANTOPRAZOLE",
    "fr_drug_brand_name": "PMS-PANTOPRAZOLE",
    "fr_drug_common_name": "PANTOPRAZOLE",
    "en_ingredients": "PANTOPRAZOLE",
    "fr_ingredients": "PANTOPRAZOLE",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15138,
    "drug": {
      "current_status": "MARKETED",
      "id": 22084,
      "drug_code": 84460,
      "updated_date": "2025-05-15T02:32:51-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257911,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359596",
      "brand_name": "PMS-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121001"
    },
    "created_date": "2017-07-11T13:57:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359596",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2017-07-26T00:00:00-04:00",
    "actual_start_date": "2017-07-03T00:00:00-04:00",
    "actual_end_date": "2017-09-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2017-09-18T19:25:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "PMS-PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 15141,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10592,
      "drug_code": 66172,
      "updated_date": "2025-12-03T01:19:25-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8332470,
          "ingredient": {
            "id": 1612,
            "ingredient_code": 11096,
            "en_name": "RANITIDINE",
            "fr_name": "Rantidine (Chlorhydrate de ranitidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02242453",
      "brand_name": "PMS-RANITIDINE 150 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115150002"
    },
    "created_date": "2017-07-11T13:58:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242453",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2017-07-18T00:00:00-04:00",
    "actual_start_date": "2017-07-03T00:00:00-04:00",
    "actual_end_date": "2017-07-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-25T14:21:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-RANITIDINE 150 MG",
    "en_drug_common_name": "RANITIDINE",
    "fr_drug_brand_name": "PMS-RANITIDINE 150 MG",
    "fr_drug_common_name": "RANITIDINE",
    "en_ingredients": "RANITIDINE",
    "fr_ingredients": "RANITIDINE",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 15144,
    "drug": {
      "current_status": "MARKETED",
      "id": 23778,
      "drug_code": 86435,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258568,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378566",
      "brand_name": "PMS-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963003"
    },
    "created_date": "2017-07-11T13:59:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378566",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-08-28T00:00:00-04:00",
    "estimated_end_date": "2018-01-10T00:00:00-05:00",
    "actual_start_date": "2017-08-28T00:00:00-04:00",
    "actual_end_date": "2018-01-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2018-01-26T17:02:34-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "PMS-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15147,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15030,
      "drug_code": 75465,
      "updated_date": "2025-12-03T01:23:44-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8341406,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02269279",
      "brand_name": "PMS-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415003"
    },
    "created_date": "2017-07-11T14:02:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02269279",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2017-07-03T00:00:00-04:00",
    "actual_end_date": "2020-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-08T20:36:00-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued. Transitioned to phama-SIMVASTATIN DIN (02469995)",
    "fr_comments": "Product to be discontinued. Transitioned to phama-SIMVASTATIN DIN (02469995)",
    "en_drug_brand_name": "PMS-SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN",
    "fr_drug_brand_name": "PMS-SIMVASTATIN",
    "fr_drug_common_name": "SIMVASTATIN",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 15252,
    "drug": {
      "current_status": "MARKETED",
      "id": 29698,
      "drug_code": 9172,
      "updated_date": "2025-12-03T00:30:26-05:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251125,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00771376",
      "brand_name": "AA-DILTIAZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68042",
      "number_of_ais": "1",
      "ai_group_no": "0115863001"
    },
    "created_date": "2017-07-11T15:14:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00771376",
    "company_name": "APOTEX INC",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2018-10-19T00:00:00-04:00",
    "actual_start_date": "2017-07-10T00:00:00-04:00",
    "actual_end_date": "2018-09-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-28T14:55:45-04:00",
    "status": "resolved",
    "en_comments": "APO-DILTIAZ 30 MG FCT 500 BTL  available",
    "en_drug_brand_name": "APO DILTIAZ TAB 30MG",
    "en_drug_common_name": "DILTIAZEM",
    "fr_drug_brand_name": "APO DILTIAZ TAB 30MG",
    "fr_drug_common_name": "DILTIAZEM",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15268,
    "drug": {
      "current_status": "MARKETED",
      "id": 12452,
      "drug_code": 71082,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254584,
          "ingredient": {
            "id": 2190,
            "ingredient_code": 1381,
            "en_name": "FENOFIBRATE",
            "fr_name": "Fénofibrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246859",
      "brand_name": "AA-FENO-SUPER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118895002"
    },
    "created_date": "2017-07-11T15:22:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246859",
    "company_name": "APOTEX INC",
    "atc_number": "C10AB",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2019-05-24T00:00:00-04:00",
    "actual_start_date": "2018-07-16T00:00:00-04:00",
    "actual_end_date": "2019-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-25T05:00:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FENO-SUPER",
    "en_drug_common_name": "FENOFIBRATE",
    "fr_drug_brand_name": "APO-FENO-SUPER",
    "fr_drug_common_name": "FENOFIBRATE",
    "en_ingredients": "FENOFIBRATE",
    "fr_ingredients": "Fénofibrate",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 15271,
    "drug": {
      "current_status": "MARKETED",
      "id": 22874,
      "drug_code": 85401,
      "updated_date": "2025-05-15T02:32:58-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258276,
          "ingredient": {
            "id": 1582,
            "ingredient_code": 122,
            "en_name": "LAMIVUDINE",
            "fr_name": "Lamivudine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02369060",
      "brand_name": "APO-LAMIVUDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128157005"
    },
    "created_date": "2017-07-11T15:24:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02369060",
    "company_name": "APOTEX INC",
    "atc_number": "J05AF",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2017-09-15T00:00:00-04:00",
    "actual_start_date": "2017-07-10T00:00:00-04:00",
    "actual_end_date": "2017-08-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-31T12:16:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LAMIVUDINE",
    "en_drug_common_name": "LAMIVUDINE",
    "fr_drug_brand_name": "APO-LAMIVUDINE",
    "fr_drug_common_name": "LAMIVUDINE",
    "en_ingredients": "LAMIVUDINE",
    "fr_ingredients": "Lamivudine",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 15370,
    "drug": {
      "current_status": "MARKETED",
      "id": 16412,
      "drug_code": 77207,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255851,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02286629",
      "brand_name": "APO-MIRTAZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928002"
    },
    "created_date": "2017-07-11T17:06:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02286629",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2017-10-20T00:00:00-04:00",
    "actual_start_date": "2017-07-10T00:00:00-04:00",
    "actual_end_date": "2017-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-17T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MIRTAZAPINE",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "APO-MIRTAZAPINE",
    "fr_drug_common_name": "MIRTAZAPINE",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15375,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20980,
      "drug_code": 83100,
      "updated_date": "2025-12-03T01:27:36-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8348527,
          "ingredient": {
            "id": 2884,
            "ingredient_code": 12149,
            "en_name": "RABEPRAZOLE SODIUM",
            "fr_name": "Rabéprazole sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02345587",
      "brand_name": "APO-RABEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143681002"
    },
    "created_date": "2017-07-11T17:12:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02345587",
    "company_name": "APOTEX INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2017-07-31T00:00:00-04:00",
    "actual_start_date": "2017-07-10T00:00:00-04:00",
    "actual_end_date": "2017-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-27T13:21:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RABEPRAZOLE",
    "en_drug_common_name": "RABEPRAZOLE",
    "fr_drug_brand_name": "APO-RABEPRAZOLE",
    "fr_drug_common_name": "RABEPRAZOLE",
    "en_ingredients": "RABEPRAZOLE SODIUM",
    "fr_ingredients": "Rabéprazole sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 15409,
    "drug": {
      "current_status": "MARKETED",
      "id": 28560,
      "drug_code": 90680,
      "updated_date": "2025-05-15T02:34:15-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260361,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02422085",
      "brand_name": "APO-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485003"
    },
    "created_date": "2017-07-11T18:14:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02422085",
    "company_name": "APOTEX INC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2017-12-28T00:00:00-05:00",
    "actual_start_date": "2017-07-10T00:00:00-04:00",
    "actual_end_date": "2017-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-07T14:24:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TADALAFIL",
    "en_drug_common_name": "TADALAFIL",
    "fr_drug_brand_name": "APO-TADALAFIL",
    "fr_drug_common_name": "TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15412,
    "drug": {
      "current_status": "DORMANT",
      "id": 9084,
      "drug_code": 61782,
      "updated_date": "2025-12-03T02:32:17-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367337,
          "ingredient": {
            "id": 1486,
            "ingredient_code": 2115,
            "en_name": "VALPROIC ACID",
            "fr_name": "Acide valproïque (Valproate de sodium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02238370",
      "brand_name": "APO-VALPROIC ACID ORAL SOLUTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112996002"
    },
    "created_date": "2017-07-11T18:16:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238370",
    "company_name": "APOTEX INC",
    "atc_number": "N03AG",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2017-08-25T00:00:00-04:00",
    "actual_start_date": "2017-07-10T00:00:00-04:00",
    "actual_end_date": "2017-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-18T16:00:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-VALPROIC SYRUP",
    "en_drug_common_name": "VALPROIC ACID",
    "fr_drug_brand_name": "APO-VALPROIC SYRUP",
    "fr_drug_common_name": "VALPROIC ACID",
    "en_ingredients": "VALPROIC ACID",
    "fr_ingredients": "Acide valproïque",
    "drug_strength": "50MG",
    "drug_dosage_form": "SYRUP",
    "drug_dosage_form_fr": "Sirop",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "450 ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 15420,
    "drug": {
      "current_status": "MARKETED",
      "id": 27334,
      "drug_code": 89589,
      "updated_date": "2025-12-03T00:32:21-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259883,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259882,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02411261",
      "brand_name": "APO-AMLODIPINE-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251555002"
    },
    "created_date": "2017-07-11T18:25:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02411261",
    "company_name": "APOTEX INC",
    "atc_number": "C10BX",
    "atc_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
    "estimated_end_date": "2017-08-25T00:00:00-04:00",
    "actual_start_date": "2017-07-10T00:00:00-04:00",
    "actual_end_date": "2017-08-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-08T17:18:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMLODIPINE-ATORVASTATIN",
    "en_drug_common_name": "AMLODIPINE - ATORVASTATIN",
    "fr_drug_brand_name": "APO-AMLODIPINE-ATORVASTATIN",
    "fr_drug_common_name": "AMLODIPINE-ATORVASTATIN",
    "en_ingredients": "AMLODIPINE\r\nATORVASTATIN",
    "fr_ingredients": "AMLODIPINE-ATORVASTATIN",
    "drug_strength": "5MG\r\n20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 15441,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14732,
      "drug_code": 75043,
      "updated_date": "2025-05-15T04:10:04-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8341023,
          "ingredient": {
            "id": 1410,
            "ingredient_code": 20259,
            "en_name": "EPIRUBICIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'épirubicine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02264927",
      "brand_name": "EPIRUBICIN HYDROCHLORIDE INJECTION",
      "brand_name_fr": "CHLORHYDRATE D'ÉPIRUBICINE INJECTABLE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116901002"
    },
    "created_date": "2017-07-11T19:40:39-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02264927",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "L01DB",
    "atc_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
    "discontinuation_date": "2017-09-04T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-09-05T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "EPIRUBICIN HYDROCHLORIDE INJECTION",
    "en_drug_common_name": "Epirubicin",
    "fr_drug_brand_name": "EPIRUBICIN HYDROCHLORIDE INJECTION",
    "fr_drug_common_name": "Epirubicin",
    "en_ingredients": "EPIRUBICIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'épirubicine",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "5mL & 25mL & 100mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 15446,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17168,
      "drug_code": 78198,
      "updated_date": "2025-05-15T04:12:37-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8344230,
          "ingredient": {
            "id": 2924,
            "ingredient_code": 732,
            "en_name": "PACLITAXEL",
            "fr_name": "Paclitaxel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02296624",
      "brand_name": "PACLITAXEL FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124214001"
    },
    "created_date": "2017-07-11T19:47:32-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02296624",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "L01CD",
    "atc_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
    "discontinuation_date": "2018-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-02-01T06:00:14-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "PACLITAXEL FOR INJECTION",
    "en_drug_common_name": "Paclitaxel",
    "fr_drug_brand_name": "PACLITAXEL FOR INJECTION",
    "fr_drug_common_name": "Paclitaxel",
    "en_ingredients": "PACLITAXEL",
    "fr_ingredients": "Paclitaxel",
    "drug_strength": "6MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "5mL & 16.7mL & 50mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 15451,
    "drug": {
      "current_status": "MARKETED",
      "id": 10560,
      "drug_code": 66036,
      "updated_date": "2025-12-03T00:30:45-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254008,
          "ingredient": {
            "id": 2674,
            "ingredient_code": 1400,
            "en_name": "AMIODARONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amiodarone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242325",
      "brand_name": "AMIODARONE HYDROCHLORIDE FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118593002"
    },
    "created_date": "2017-07-11T20:52:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242325",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C01BD",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "anticipated_start_date": "2017-08-01T00:00:00-04:00",
    "estimated_end_date": "2017-08-18T00:00:00-04:00",
    "actual_end_date": "2017-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-18T20:56:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AMIODARONE HYDROCHLORIDE FOR INJECTION",
    "en_drug_common_name": "AMIODARONE",
    "fr_drug_brand_name": "AMIODARONE",
    "fr_drug_common_name": "AMIODARONE",
    "en_ingredients": "AMIODARONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amiodarone",
    "drug_strength": "50MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "9ML VIAL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15454,
    "drug": {
      "current_status": "MARKETED",
      "id": 30080,
      "drug_code": 92127,
      "updated_date": "2025-05-15T02:34:39-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8260953,
          "ingredient": {
            "id": 3398,
            "ingredient_code": 20139,
            "en_name": "OXALIPLATIN",
            "fr_name": "Oxaliplatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02436957",
      "brand_name": "OXALIPLATIN INJECTION",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152220003"
    },
    "created_date": "2017-07-11T21:01:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02436957",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L01XA",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "estimated_end_date": "2017-07-31T00:00:00-04:00",
    "actual_start_date": "2017-07-11T00:00:00-04:00",
    "actual_end_date": "2017-07-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-08-03T01:26:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OXALIPLATIN INJECTION",
    "en_drug_common_name": "OXALIPLATIN",
    "fr_drug_brand_name": "OXALIPLATIN",
    "fr_drug_common_name": "OXALIPLATIN",
    "en_ingredients": "OXALIPLATIN",
    "fr_ingredients": "Oxaliplatine",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10ML VIAL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 15457,
    "drug": {
      "current_status": "MARKETED",
      "id": 19296,
      "drug_code": 80560,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256745,
          "ingredient": {
            "id": 2924,
            "ingredient_code": 732,
            "en_name": "PACLITAXEL",
            "fr_name": "Paclitaxel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02320150",
      "brand_name": "PACLITAXEL INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124214001"
    },
    "created_date": "2017-07-11T21:02:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02320150",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L01CD",
    "atc_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
    "anticipated_start_date": "2017-07-19T00:00:00-04:00",
    "estimated_end_date": "2017-07-31T00:00:00-04:00",
    "actual_end_date": "2017-07-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-08-03T01:27:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PACLITAXEL INJECTION USP",
    "en_drug_common_name": "PACLITAXEL",
    "fr_drug_brand_name": "TAXOL",
    "fr_drug_common_name": "PACLITAXEL",
    "en_ingredients": "PACLITAXEL",
    "fr_ingredients": "Paclitaxel",
    "drug_strength": "6MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "50ML VIAL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 15460,
    "drug": {
      "current_status": "MARKETED",
      "id": 19296,
      "drug_code": 80560,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256745,
          "ingredient": {
            "id": 2924,
            "ingredient_code": 732,
            "en_name": "PACLITAXEL",
            "fr_name": "Paclitaxel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02320150",
      "brand_name": "PACLITAXEL INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124214001"
    },
    "created_date": "2017-07-11T21:04:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02320150",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L01CD",
    "atc_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
    "anticipated_start_date": "2017-07-11T00:00:00-04:00",
    "estimated_end_date": "2017-08-18T00:00:00-04:00",
    "actual_end_date": "2017-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2017-10-25T21:47:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PACLITAXEL INJECTION USP",
    "en_drug_common_name": "PACLITAXEL",
    "fr_drug_brand_name": "TAXOL",
    "fr_drug_common_name": "PACLITAXEL",
    "en_ingredients": "PACLITAXEL",
    "fr_ingredients": "Paclitaxel",
    "drug_strength": "6MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "5 X 5ML VIAL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15463,
    "drug": {
      "current_status": "MARKETED",
      "id": 17876,
      "drug_code": 78939,
      "updated_date": "2025-05-15T02:32:04-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256270,
          "ingredient": {
            "id": 3442,
            "ingredient_code": 8280,
            "en_name": "PHENOBARBITAL SODIUM",
            "fr_name": "Phénobarbital sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02304082",
      "brand_name": "PHENOBARBITAL SODIUM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105985003"
    },
    "created_date": "2017-07-11T21:07:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02304082",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N03AA",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-07-21T00:00:00-04:00",
    "estimated_end_date": "2017-10-27T00:00:00-04:00",
    "actual_start_date": "2017-07-17T00:00:00-04:00",
    "actual_end_date": "2017-10-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-10-27T13:55:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PHENOBARBITAL SODIUM INJECTION, USP",
    "en_drug_common_name": "PHENOBARBITAL",
    "fr_drug_brand_name": "PHENOBARBITAL",
    "fr_drug_common_name": "PHENOBARBITAL",
    "en_ingredients": "PHENOBARBITAL SODIUM",
    "fr_ingredients": "Phénobarbital sodique",
    "drug_strength": "30MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "10 X 1ML AMPOULE",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15466,
    "drug": {
      "current_status": "MARKETED",
      "id": 25556,
      "drug_code": 87976,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259229,
          "ingredient": {
            "id": 1596,
            "ingredient_code": 8541,
            "en_name": "VANCOMYCIN",
            "fr_name": "Vancomycine (Chlorhydrate de vancomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02394626",
      "brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "SINGLE-DOSE VIAL. FOR IV INFUSION ONLY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131315003"
    },
    "created_date": "2017-07-11T21:10:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394626",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01XA",
    "atc_description": "OTHER ANTIBACTERIALS",
    "anticipated_start_date": "2017-07-19T00:00:00-04:00",
    "estimated_end_date": "2017-08-18T00:00:00-04:00",
    "actual_end_date": "2017-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-10-25T22:36:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "en_drug_common_name": "VANCOMYCIN",
    "fr_drug_brand_name": "VANCOCYN",
    "fr_drug_common_name": "VANCOMYCIN",
    "en_ingredients": "VANCOMYCIN",
    "fr_ingredients": "VANCOMYCIN",
    "drug_strength": "500MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10VIALS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15469,
    "drug": {
      "current_status": "MARKETED",
      "id": 12998,
      "drug_code": 72248,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254748,
          "ingredient": {
            "id": 1902,
            "ingredient_code": 7387,
            "en_name": "VASOPRESSIN",
            "fr_name": "Vasopressine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02247938",
      "brand_name": "VASOPRESSIN INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106469001"
    },
    "created_date": "2017-07-11T21:12:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247938",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "H01BA",
    "atc_description": "POSTERIOR PITUITARY LOBE HORMONES",
    "anticipated_start_date": "2017-07-11T00:00:00-04:00",
    "estimated_end_date": "2017-07-31T00:00:00-04:00",
    "actual_end_date": "2017-07-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-08-03T01:31:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VASOPRESSIN INJECTION USP",
    "en_drug_common_name": "VASOPRESSIN",
    "fr_drug_brand_name": "PRESSYN",
    "fr_drug_common_name": "VASOPRESSIN",
    "en_ingredients": "VASOPRESSIN",
    "fr_ingredients": "Vasopressine",
    "drug_strength": "20UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nSous-cutanée",
    "drug_package_quantity": "5ML VIAL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 15472,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 31548,
      "drug_code": 93867,
      "updated_date": "2025-05-15T04:24:27-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8356590,
          "ingredient": {
            "id": 4148,
            "ingredient_code": 22694,
            "en_name": "ASUNAPREVIR",
            "fr_name": "Asunaprévir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452294",
      "brand_name": "SUNVEPRA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0157870001"
    },
    "created_date": "2017-07-11T21:15:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452294",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "J05AE",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2017-07-24T00:00:00-04:00",
    "estimated_end_date": "2017-11-30T00:00:00-05:00",
    "actual_start_date": "2017-07-21T00:00:00-04:00",
    "actual_end_date": "2017-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-10-17T05:00:07-04:00",
    "status": "resolved",
    "en_comments": "Product deleted as of Oct. 16th, 2017",
    "fr_comments": "Discontinué le 16 oct. 2017",
    "en_drug_brand_name": "SUNVEPRA",
    "en_drug_common_name": "Asunaprevir",
    "fr_drug_brand_name": "SUNVEPRA",
    "fr_drug_common_name": "ASUNAPREVIR",
    "en_ingredients": "ASUNAPREVIR",
    "fr_ingredients": "Asunaprévir",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 BTL x 56",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15501,
    "drug": {
      "current_status": "MARKETED",
      "id": 49646,
      "drug_code": 92881,
      "updated_date": "2025-12-03T00:32:52-05:00",
      "company": {
        "id": 1964,
        "created_date": "2017-03-09T20:00:09-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 16391,
        "mfr_code": "",
        "name": "LINEPHARMA INTERNATIONAL LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16 UPPER WOBURN PLACE",
        "province": "GREATER LONDON",
        "country": "UNITED KINGDOM",
        "city": "LONDON",
        "postal_code": "WC1H0BS",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261359,
          "ingredient": {
            "id": 930,
            "ingredient_code": 1859,
            "en_name": "MISOPROSTOL",
            "fr_name": "Misoprostol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261358,
          "ingredient": {
            "id": 6186,
            "ingredient_code": 22628,
            "en_name": "MIFEPRISTONE",
            "fr_name": "MIFÉPRISTONE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02444038",
      "brand_name": "MIFEGYMISO",
      "brand_name_fr": "MIFÉGYMISO",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0257170001"
    },
    "created_date": "2017-07-12T15:07:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02444038",
    "company_name": "LINEPHARMA INTERNATIONAL LIMITED",
    "atc_number": "G03XB",
    "atc_description": "OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM",
    "anticipated_start_date": "2017-07-10T00:00:00-04:00",
    "estimated_end_date": "2017-07-18T00:00:00-04:00",
    "actual_start_date": "2017-07-10T00:00:00-04:00",
    "actual_end_date": "2017-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-10T18:47:35-05:00",
    "status": "resolved",
    "en_comments": "Linepharma International Limited considers that this shortage situation has a very low impact on public health since product is due to be made available in less than one week in Canada.",
    "fr_comments": "Linepharma International Limited considère que cette situation de pénurie n'a qu'un impact très minime en santé publique car le produit sera de nouveau disponible sur le marché canadien dans moins d'une semaine.",
    "en_drug_brand_name": "MIFEGYMISO",
    "en_drug_common_name": "Mifepristone / Misoprostol",
    "fr_drug_brand_name": "MIFEGYMISO",
    "fr_drug_common_name": "Mifepristone / Misoprostol",
    "en_ingredients": "MISOPROSTOL\r\nMIFEPRISTONE",
    "fr_ingredients": "Mifepristone\r\nMisoprostol",
    "drug_strength": "200MCG\r\n200MG",
    "drug_dosage_form": "KIT\r\nTABLET",
    "drug_dosage_form_fr": "Trousse\r\nComprimé",
    "drug_route": "BUCCAL\r\nORAL",
    "drug_route_fr": "Buccale\r\nOrale",
    "drug_package_quantity": "Combipack (1 box of 1 tablet of mifepristone 200 mg tablet + 1 box of 4 tablets of 200 µg misoprostol)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15518,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23920,
      "drug_code": 86583,
      "updated_date": "2025-05-15T04:19:50-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8351231,
          "ingredient": {
            "id": 2614,
            "ingredient_code": 11793,
            "en_name": "ZOLMITRIPTAN",
            "fr_name": "Zolmitriptan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379988",
      "brand_name": "ZOLMITRIPTAN ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134381001"
    },
    "created_date": "2017-07-12T15:21:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379988",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "actual_start_date": "2017-07-12T00:00:00-04:00",
    "actual_end_date": "2019-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-01-10T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ZOLMITRIPTAN ODT",
    "en_drug_common_name": "ZOLMITRIPTAN ODT",
    "fr_drug_brand_name": "ZOLMITRIPTAN ODT",
    "fr_drug_common_name": "ZOLMITRIPTAN ODT",
    "en_ingredients": "ZOLMITRIPTAN",
    "fr_ingredients": "Zolmitriptan",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 15521,
    "drug": {
      "current_status": "MARKETED",
      "id": 22522,
      "drug_code": 85002,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8258086,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258085,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02365170",
      "brand_name": "IRBESARTAN-HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086002"
    },
    "created_date": "2017-07-12T15:22:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02365170",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2018-04-05T00:00:00-04:00",
    "actual_end_date": "2018-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-05-09T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IRBESARTAN-HCTZ",
    "en_drug_common_name": "IRBESARTAN-HCTZ",
    "fr_drug_brand_name": "IRBESARTAN-HCTZ",
    "fr_drug_common_name": "IRBESARTAN-HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "12.5MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15524,
    "drug": {
      "current_status": "MARKETED",
      "id": 11222,
      "drug_code": 67606,
      "updated_date": "2025-12-03T00:30:48-05:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8254211,
          "ingredient": {
            "id": 486,
            "ingredient_code": 7746,
            "en_name": "HEPATITIS B SURFACE ANTIGEN",
            "fr_name": "Antigène de surface du virus de l'hépatite b (recombiné)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02243676",
      "brand_name": "RECOMBIVAX HB",
      "brand_name_fr": "",
      "descriptor": "PRESERVATIVE-FREE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119570001"
    },
    "created_date": "2017-07-12T18:16:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243676",
    "company_name": "MERCK CANADA INC",
    "atc_number": "J07BC",
    "atc_description": "VIRAL VACCINES",
    "anticipated_start_date": "2017-08-02T00:00:00-04:00",
    "estimated_end_date": "2017-09-18T00:00:00-04:00",
    "actual_start_date": "2017-08-02T00:00:00-04:00",
    "actual_end_date": "2017-08-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-13T00:31:39-04:00",
    "status": "resolved",
    "en_comments": "Limited Quantities available / Quantités limitées disponibles",
    "fr_comments": "Limited Quantities available / Quantités limitées disponibles",
    "en_drug_brand_name": "RECOMBIVAX HB     -(PRESERVATIVE FREE)",
    "en_drug_common_name": "(hepatitis B vaccine [recombinant])",
    "fr_drug_brand_name": "RECOMBIVAX hb",
    "fr_drug_common_name": "(vaccin contre l’hépatite B [ADN recombiné])",
    "en_ingredients": "HEPATITIS B SURFACE ANTIGEN",
    "fr_ingredients": "HEPATITIS B SURFACE ANTIGEN (RECOMBINANT) 10 MCG / ML",
    "drug_strength": "10MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "5MCG/0.5ML 1DOSE VIAL (Ped)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15541,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9218,
      "drug_code": 62106,
      "updated_date": "2025-05-15T03:57:44-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8326745,
          "ingredient": {
            "id": 2174,
            "ingredient_code": 1751,
            "en_name": "INTERFERON ALFA-2B",
            "fr_name": "Interféron alfa-2b"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02238675",
      "brand_name": "INTRON A",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118647003"
    },
    "created_date": "2017-07-12T18:50:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238675",
    "company_name": "MERCK CANADA INC",
    "atc_number": "L03AB",
    "atc_description": "IMMUNOSTIMULANTS",
    "anticipated_start_date": "2017-08-03T00:00:00-04:00",
    "estimated_end_date": "2017-08-04T00:00:00-04:00",
    "actual_end_date": "2017-08-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-11T01:19:00-04:00",
    "status": "avoided_shortage",
    "en_comments": "Limited Quantities available / Quantités limitées disponibles",
    "fr_comments": "Limited Quantities available / Quantités limitées disponibles",
    "en_drug_brand_name": "INTRON A",
    "en_drug_common_name": "interferon alfa-2b solution for injection",
    "fr_drug_brand_name": "INTRON A",
    "fr_drug_common_name": "interféron alfa-2b solution injectable",
    "en_ingredients": "INTERFERON ALFA-2B",
    "fr_ingredients": "Interféron alfa-2b",
    "drug_strength": "10000000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "1X10MIU HSA FREE VIAL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15614,
    "drug": {
      "current_status": "MARKETED",
      "id": 10086,
      "drug_code": 64697,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8253833,
          "ingredient": {
            "id": 2740,
            "ingredient_code": 11923,
            "en_name": "TEMOZOLOMIDE",
            "fr_name": "Témozolomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02241094",
      "brand_name": "TEMODAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138781002"
    },
    "created_date": "2017-07-12T19:27:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241094",
    "company_name": "MERCK CANADA INC",
    "atc_number": "L01AX",
    "atc_description": "ALKYLATINGAGENTS",
    "estimated_end_date": "2017-08-07T00:00:00-04:00",
    "actual_start_date": "2017-07-04T00:00:00-04:00",
    "actual_end_date": "2017-07-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-07-28T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Limited Quantities available / Quantités limitées disponibles",
    "fr_comments": "Limited Quantities available / Quantités limitées disponibles",
    "en_drug_brand_name": "TEMODAL",
    "en_drug_common_name": "temozolomide capsules",
    "fr_drug_brand_name": "TEMODAL",
    "fr_drug_common_name": "capsules de témozolomide",
    "en_ingredients": "TEMOZOLOMIDE",
    "fr_ingredients": "Témozolomide",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "5CAP SACHET",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 15623,
    "drug": {
      "current_status": "MARKETED",
      "id": 5608,
      "drug_code": 37244,
      "updated_date": "2025-05-15T02:31:01-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252896,
          "ingredient": {
            "id": 2012,
            "ingredient_code": 8447,
            "en_name": "PENICILLIN G",
            "fr_name": "Pénicilline G"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02220261",
      "brand_name": "PENICILLIN G SODIUM FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4725",
      "number_of_ais": "1",
      "ai_group_no": "0131382004"
    },
    "created_date": "2017-07-12T19:36:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02220261",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J01CE",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "actual_start_date": "2017-07-12T00:00:00-04:00",
    "actual_end_date": "2018-03-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-07T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "The product is available to all customers through all distribution channels without any volume restrictions",
    "fr_comments": "Le produit est donc disponible pour tous les clients par le biais de tous nos réseaux de distribution, et ce, sans restriction de volume.",
    "en_drug_brand_name": "PENICILLIN G SODIUM FOR INJECTION, USP",
    "en_drug_common_name": "PENICILLIN G SODIUM",
    "fr_drug_brand_name": "Pénicilline G sodique pour injection",
    "fr_drug_common_name": "Pénicilline G sodique",
    "en_ingredients": "PENICILLIN G",
    "fr_ingredients": "Pénicilline G",
    "drug_strength": "1000000UNIT",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "1 million unit SD vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15628,
    "drug": {
      "current_status": "MARKETED",
      "id": 27216,
      "drug_code": 89462,
      "updated_date": "2025-05-15T02:33:59-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259813,
          "ingredient": {
            "id": 3122,
            "ingredient_code": 11309,
            "en_name": "CEFTRIAXONE",
            "fr_name": "Ceftriaxone (Ceftriaxone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "BAG",
          "base": false
        }
      ],
      "din": "02409968",
      "brand_name": "CEFTRIAXONE FOR INJECTION",
      "brand_name_fr": "CEFTRIAXONE POUR INJECTION",
      "descriptor": "SMARTPACK BULK PACKAGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0117292009"
    },
    "created_date": "2017-07-12T19:42:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02409968",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J01DD",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2018-05-18T00:00:00-04:00",
    "actual_start_date": "2017-12-11T00:00:00-05:00",
    "actual_end_date": "2018-05-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-24T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Shortage Resolved.",
    "fr_comments": "Pénurie résolue",
    "en_drug_brand_name": "CEFTRIAXONE FOR INJECTION",
    "en_drug_common_name": "Ceftriaxone for Injection 100g SmartPak",
    "fr_drug_brand_name": "Ceftriaxone pour injection en SmartPak de 100g",
    "fr_drug_common_name": "Ceftriaxone pour injection en SmartPak de 100g",
    "en_ingredients": "CEFTRIAXONE",
    "fr_ingredients": "Ceftriaxone",
    "drug_strength": "100G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "100g SmartPak",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15631,
    "drug": {
      "current_status": "MARKETED",
      "id": 13282,
      "drug_code": 72855,
      "updated_date": "2025-05-15T02:31:30-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8254820,
          "ingredient": {
            "id": 1004,
            "ingredient_code": 11340,
            "en_name": "PAROXETINE",
            "fr_name": "Paroxétine (Chlorhydrate de paroxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02248503",
      "brand_name": "PAXIL CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123131005"
    },
    "created_date": "2017-07-12T20:46:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248503",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2017-08-17T00:00:00-04:00",
    "actual_start_date": "2017-08-07T00:00:00-04:00",
    "actual_end_date": "2017-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2017-08-19T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PAXIL CR",
    "en_drug_common_name": "paroxetine controlled release tablets",
    "fr_drug_brand_name": "PAXIL CR",
    "fr_drug_common_name": "comprimés de paroxétine à libération contrôlée",
    "en_ingredients": "PAROXETINE",
    "fr_ingredients": "paroxétine",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 15646,
    "drug": {
      "current_status": "MARKETED",
      "id": 14104,
      "drug_code": 74135,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8255093,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "45",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02256126",
      "brand_name": "MYLAN-MIRTAZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928003"
    },
    "created_date": "2017-07-13T13:13:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02256126",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-08-12T00:00:00-04:00",
    "estimated_end_date": "2017-10-06T00:00:00-04:00",
    "actual_start_date": "2017-07-31T00:00:00-04:00",
    "actual_end_date": "2017-10-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-11T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-MIRTAZAPINE",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "MYLAN-MIRTAZAPINE",
    "fr_drug_common_name": "MIRTAZAPINE",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "45MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15649,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11178,
      "drug_code": 67506,
      "updated_date": "2025-05-15T04:03:09-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8333934,
          "ingredient": {
            "id": 62,
            "ingredient_code": 9412,
            "en_name": "NITROGLYCERIN",
            "fr_name": "Nitroglycérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02243588",
      "brand_name": "MYLAN-NITRO SUBLINGUAL SPRAY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103615009"
    },
    "created_date": "2017-07-13T13:22:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243588",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C01DA",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "anticipated_start_date": "2018-04-18T00:00:00-04:00",
    "estimated_end_date": "2018-05-22T00:00:00-04:00",
    "actual_start_date": "2018-04-18T00:00:00-04:00",
    "actual_end_date": "2018-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-05-23T14:07:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-NITRO SUBLINGUAL SPRAY",
    "en_drug_common_name": "NITRO SUBLINGUAL SPRAY",
    "fr_drug_brand_name": "MYLAN-NITRO SUBLINGUAL SPRAY",
    "fr_drug_common_name": "NITRO SUBLINGUAL SPRAY",
    "en_ingredients": "NITROGLYCERIN",
    "fr_ingredients": "Nitroglycérine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "SUBLINGUAL",
    "drug_route_fr": "Sublinguale",
    "drug_package_quantity": "1BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15693,
    "drug": {
      "current_status": "MARKETED",
      "id": 14848,
      "drug_code": 75233,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255323,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02266938",
      "brand_name": "TARO-CLINDAMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105830004"
    },
    "created_date": "2017-07-13T19:39:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02266938",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D10AF",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2019-04-12T00:00:00-04:00",
    "actual_start_date": "2017-09-15T00:00:00-04:00",
    "actual_end_date": "2019-04-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-04-09T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLINDAMYCIN",
    "en_drug_common_name": "TARO-CLINDAMYCIN",
    "fr_drug_brand_name": "TARO-CLINDAMYCIN",
    "fr_drug_common_name": "TARO-CLINDAMYCIN",
    "en_ingredients": "CLINDAMYCIN",
    "fr_ingredients": "CLINDAMYCIN",
    "drug_strength": "1%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "30 ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 15697,
    "drug": {
      "current_status": "MARKETED",
      "id": 14848,
      "drug_code": 75233,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255323,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02266938",
      "brand_name": "TARO-CLINDAMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105830004"
    },
    "created_date": "2017-07-13T19:40:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02266938",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D10AF",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2019-04-12T00:00:00-04:00",
    "actual_start_date": "2017-09-05T00:00:00-04:00",
    "actual_end_date": "2019-04-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-04-15T14:24:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLINDAMYCIN",
    "en_drug_common_name": "TARO-CLINDAMYCIN",
    "fr_drug_brand_name": "TARO-CLINDAMYCIN",
    "fr_drug_common_name": "TARO-CLINDAMYCIN",
    "en_ingredients": "CLINDAMYCIN",
    "fr_ingredients": "CLINDAMYCIN",
    "drug_strength": "1%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "60 ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 15722,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20564,
      "drug_code": 8229,
      "updated_date": "2025-05-15T03:32:24-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8283358,
          "ingredient": {
            "id": 3614,
            "ingredient_code": 7577,
            "en_name": "FLUOROMETHOLONE ACETATE",
            "fr_name": "Acétate de fluorométholone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "00756784",
      "brand_name": "FLAREX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "66547",
      "number_of_ais": "1",
      "ai_group_no": "0119742001"
    },
    "created_date": "2017-07-13T20:17:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00756784",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01BA",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2017-07-17T00:00:00-04:00",
    "actual_start_date": "2017-06-15T00:00:00-04:00",
    "actual_end_date": "2017-07-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-07-27T21:06:55-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FLAREX",
    "en_drug_common_name": "FLAREX 0.1% SUSP 5ML",
    "fr_drug_brand_name": "FLAREX",
    "fr_drug_common_name": "FLAREX 0.1% SUSP 5ML",
    "en_ingredients": "FLUOROMETHOLONE ACETATE",
    "fr_ingredients": "Acétate de fluorométholone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "5 ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 15737,
    "drug": {
      "current_status": "MARKETED",
      "id": 11810,
      "drug_code": 69384,
      "updated_date": "2025-12-03T00:30:49-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254382,
          "ingredient": {
            "id": 2508,
            "ingredient_code": 7485,
            "en_name": "TESTOSTERONE",
            "fr_name": "Testostérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245345",
      "brand_name": "ANDROGEL",
      "brand_name_fr": "",
      "descriptor": "2.5 G GEL PER PACK",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106405004"
    },
    "created_date": "2017-07-14T12:51:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245345",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "G03BA",
    "atc_description": "ANDROGENS",
    "anticipated_start_date": "2017-08-01T00:00:00-04:00",
    "actual_start_date": "2017-08-08T00:00:00-04:00",
    "actual_end_date": "2017-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-18T16:02:11-04:00",
    "status": "resolved",
    "en_comments": "2.5 g sachet.",
    "fr_comments": "2.5 g sachet",
    "en_drug_brand_name": "ANDROGEL",
    "en_drug_common_name": "ANDROGEL",
    "fr_drug_brand_name": "ANDROGEL",
    "fr_drug_common_name": "ANDROGEL",
    "en_ingredients": "TESTOSTERONE",
    "fr_ingredients": "Testostérone",
    "drug_strength": "1%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15753,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27008,
      "drug_code": 89255,
      "updated_date": "2025-05-15T04:21:14-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8353227,
          "ingredient": {
            "id": 3862,
            "ingredient_code": 3812,
            "en_name": "ARSENIC TRIOXIDE",
            "fr_name": "Trioxyde d'arsénic"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "10",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02407833",
      "brand_name": "TRISENOX",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE AMPOULES",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108756003"
    },
    "created_date": "2017-07-14T16:55:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02407833",
    "company_name": "LUNDBECK CANADA INC",
    "atc_number": "L01XX",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "anticipated_start_date": "2017-09-08T00:00:00-04:00",
    "estimated_end_date": "2018-07-20T00:00:00-04:00",
    "actual_start_date": "2017-09-08T00:00:00-04:00",
    "actual_end_date": "2018-07-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-30T18:07:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TRISENOX",
    "en_drug_common_name": "Arsenic Trioxide for Injection",
    "fr_drug_brand_name": "Trisenox",
    "fr_drug_common_name": "Trioxyde d’arsenic pour injection",
    "en_ingredients": "ARSENIC TRIOXIDE",
    "fr_ingredients": "Trioxyde d'arsenic",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 mg/10mL ampoule",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15779,
    "drug": {
      "current_status": "MARKETED",
      "id": 10636,
      "drug_code": 66247,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254027,
          "ingredient": {
            "id": 2810,
            "ingredient_code": 2142,
            "en_name": "BUTORPHANOL TARTRATE",
            "fr_name": "Tartrate de butorphanol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242504",
      "brand_name": "BUTORPHANOL NASAL SPRAY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112394002"
    },
    "created_date": "2017-07-14T20:01:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242504",
    "company_name": "AA PHARMA INC",
    "atc_number": "N02AF",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2017-09-15T00:00:00-04:00",
    "actual_start_date": "2017-07-14T00:00:00-04:00",
    "actual_end_date": "2017-09-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-15T12:24:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BUTORPHANOL NASAL SPRAY",
    "en_drug_common_name": "Butorphanol Nasal Spray",
    "fr_drug_brand_name": "Butorphanol Nasal Spray",
    "fr_drug_common_name": "Butorphanol Nasal Spray",
    "en_ingredients": "BUTORPHANOL TARTRATE",
    "fr_ingredients": "Tartrate de butorphanol",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "NASAL",
    "drug_route_fr": "Nasale",
    "drug_package_quantity": "2.5 ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 15804,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24496,
      "drug_code": 87110,
      "updated_date": "2025-05-15T04:20:09-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351593,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02385473",
      "brand_name": "AZITHROMYCIN FOR INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072006"
    },
    "created_date": "2017-07-17T13:37:03-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02385473",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "en_discontinuation_comments": "Last Lot # 7602631 and Expires 31-Jul-17",
    "fr_discontinuation_comments": "Last Lot # 7602631 and Expires 31-Jul-17",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-02-15T19:28:11-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "AZITHROMYCIN FOR INJECTION, USP",
    "en_drug_common_name": "AZITHROMYCIN FOR INJECTION, USP",
    "fr_drug_brand_name": "AZITHROMYCIN FOR INJECTION, USP",
    "fr_drug_common_name": "AZITHROMYCIN FOR INJECTION, USP",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "500MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10VL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 15811,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24380,
      "drug_code": 87013,
      "updated_date": "2025-05-15T04:20:06-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351518,
          "ingredient": {
            "id": 3044,
            "ingredient_code": 1218,
            "en_name": "BISOPROLOL FUMARATE",
            "fr_name": "Fumarate de bisoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02384418",
      "brand_name": "MYLAN-BISOPROLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122418001"
    },
    "created_date": "2017-07-17T13:47:15-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02384418",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T13:47:53-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-BISOPROLOL",
    "en_drug_common_name": "BISOPROLOL",
    "fr_drug_brand_name": "MYLAN-BISOPROLOL",
    "fr_drug_common_name": "BISOPROLOL",
    "en_ingredients": "BISOPROLOL FUMARATE",
    "fr_ingredients": "Fumarate de bisoprolol",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 15816,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24382,
      "drug_code": 87014,
      "updated_date": "2025-05-15T04:20:06-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351519,
          "ingredient": {
            "id": 3044,
            "ingredient_code": 1218,
            "en_name": "BISOPROLOL FUMARATE",
            "fr_name": "Fumarate de bisoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02384426",
      "brand_name": "MYLAN-BISOPROLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122418002"
    },
    "created_date": "2017-07-17T13:53:33-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02384426",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T13:54:13-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-BISOPROLOL",
    "en_drug_common_name": "BISOPROLOL",
    "fr_drug_brand_name": "MYLAN-BISOPROLOL",
    "fr_drug_common_name": "BISOPROLOL",
    "en_ingredients": "BISOPROLOL FUMARATE",
    "fr_ingredients": "Fumarate de bisoprolol",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 15824,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21062,
      "drug_code": 83296,
      "updated_date": "2025-05-15T04:16:49-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8348652,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347571",
      "brand_name": "MYLAN-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683001"
    },
    "created_date": "2017-07-17T14:00:56-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02347571",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "en_discontinuation_comments": "Last Lot # 3046315R and Expired 28-Feb-17. Resolved/Discontinued in ID 9105",
    "fr_discontinuation_comments": "Last Lot # 3046315R and Expired 28-Feb-17. Resolved/Discontinued in ID 9105",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-02-15T19:40:35-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "MYLAN-CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 15833,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13504,
      "drug_code": 73227,
      "updated_date": "2025-05-15T04:08:03-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8339492,
          "ingredient": {
            "id": 688,
            "ingredient_code": 8318,
            "en_name": "CLARITHROMYCIN",
            "fr_name": "Clarithromycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248856",
      "brand_name": "MYLAN-CLARITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123752001"
    },
    "created_date": "2017-07-17T14:23:26-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02248856",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T14:23:51-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-CLARITHROMYCIN",
    "en_drug_common_name": "CLARITHROMYCIN",
    "fr_drug_brand_name": "MYLAN-CLARITHROMYCIN",
    "fr_drug_common_name": "CLARITHROMYCIN",
    "en_ingredients": "CLARITHROMYCIN",
    "fr_ingredients": "Clarithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 15836,
    "drug": {
      "current_status": "MARKETED",
      "id": 17864,
      "drug_code": 78924,
      "updated_date": "2025-05-15T02:32:04-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8256268,
          "ingredient": {
            "id": 3440,
            "ingredient_code": 20179,
            "en_name": "SITAGLIPTIN",
            "fr_name": "Sitagliptine (Phosphate de sitagliptine monohydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02303922",
      "brand_name": "JANUVIA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152414001"
    },
    "created_date": "2017-07-17T14:25:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02303922",
    "company_name": "MERCK CANADA INC",
    "atc_number": "A10BH",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2017-07-18T00:00:00-04:00",
    "estimated_end_date": "2017-07-20T00:00:00-04:00",
    "actual_start_date": "2017-07-06T00:00:00-04:00",
    "actual_end_date": "2017-07-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-11T19:52:35-04:00",
    "status": "resolved",
    "en_comments": "available in 30 tab",
    "fr_comments": "Quantités disponibles en 30 tab",
    "en_drug_brand_name": "JANUVIA",
    "en_drug_common_name": "sitagliptin tablets (as sitagliptin phosphate monohydrate)",
    "fr_drug_brand_name": "JANUVIA",
    "fr_drug_common_name": "comprimés de sitagliptine (sous forme de phosphate de sitagliptine monohydraté)",
    "en_ingredients": "SITAGLIPTIN",
    "fr_ingredients": "SITAGLIPTINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 tab",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 15872,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13506,
      "drug_code": 73228,
      "updated_date": "2025-05-15T04:08:03-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8339493,
          "ingredient": {
            "id": 688,
            "ingredient_code": 8318,
            "en_name": "CLARITHROMYCIN",
            "fr_name": "Clarithromycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248857",
      "brand_name": "MYLAN-CLARITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123752002"
    },
    "created_date": "2017-07-17T17:11:48-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02248857",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T17:12:32-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-CLARITHROMYCIN",
    "en_drug_common_name": "CLARITHROMYCIN",
    "fr_drug_brand_name": "MYLAN-CLARITHROMYCIN",
    "fr_drug_common_name": "CLARITHROMYCIN",
    "en_ingredients": "CLARITHROMYCIN",
    "fr_ingredients": "Clarithromycine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 15897,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9754,
      "drug_code": 63736,
      "updated_date": "2025-05-15T03:59:23-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8329160,
          "ingredient": {
            "id": 2190,
            "ingredient_code": 1381,
            "en_name": "FENOFIBRATE",
            "fr_name": "Fénofibrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240210",
      "brand_name": "MYLAN-FENOFIBRATE MICRO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118895001"
    },
    "created_date": "2017-07-17T17:20:25-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02240210",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AB",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T17:21:17-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-FENOFIBRATE MICRO",
    "en_drug_common_name": "FENOFIBRATE MICRO",
    "fr_drug_brand_name": "MYLAN-FENOFIBRATE MICRO",
    "fr_drug_common_name": "FENOFIBRATE MICRO",
    "en_ingredients": "FENOFIBRATE",
    "fr_ingredients": "Fénofibrate",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 15913,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14500,
      "drug_code": 74778,
      "updated_date": "2025-05-15T04:09:48-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8340785,
          "ingredient": {
            "id": 3064,
            "ingredient_code": 1744,
            "en_name": "FOSINOPRIL SODIUM",
            "fr_name": "Fosinopril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02262401",
      "brand_name": "MYLAN-FOSINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122777001"
    },
    "created_date": "2017-07-17T17:28:48-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02262401",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T17:29:21-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-FOSINOPRIL",
    "en_drug_common_name": "FOSINOPRIL",
    "fr_drug_brand_name": "MYLAN-FOSINOPRIL",
    "fr_drug_common_name": "FOSINOPRIL",
    "en_ingredients": "FOSINOPRIL SODIUM",
    "fr_ingredients": "Fosinopril sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 15916,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14502,
      "drug_code": 74779,
      "updated_date": "2025-05-15T04:09:48-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8340786,
          "ingredient": {
            "id": 3064,
            "ingredient_code": 1744,
            "en_name": "FOSINOPRIL SODIUM",
            "fr_name": "Fosinopril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02262428",
      "brand_name": "MYLAN-FOSINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122777002"
    },
    "created_date": "2017-07-17T17:30:33-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02262428",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T17:31:14-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-FOSINOPRIL",
    "en_drug_common_name": "FOSINOPRIL",
    "fr_drug_brand_name": "MYLAN-FOSINOPRIL",
    "fr_drug_common_name": "FOSINOPRIL",
    "en_ingredients": "FOSINOPRIL SODIUM",
    "fr_ingredients": "Fosinopril sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 15937,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15436,
      "drug_code": 76037,
      "updated_date": "2025-05-15T04:10:48-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8342024,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02274833",
      "brand_name": "MYLAN-LISINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121550003"
    },
    "created_date": "2017-07-17T17:40:31-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02274833",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T17:40:59-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-LISINOPRIL",
    "en_drug_common_name": "LISINOPRIL",
    "fr_drug_brand_name": "MYLAN-LISINOPRIL",
    "fr_drug_common_name": "LISINOPRIL",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 15944,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15438,
      "drug_code": 76038,
      "updated_date": "2025-05-15T04:10:48-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8342025,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02274841",
      "brand_name": "MYLAN-LISINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121550001"
    },
    "created_date": "2017-07-17T17:42:39-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02274841",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T17:43:14-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-LISINOPRIL",
    "en_drug_common_name": "LISINOPRIL",
    "fr_drug_brand_name": "MYLAN-LISINOPRIL",
    "fr_drug_common_name": "LISINOPRIL",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 15953,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23732,
      "drug_code": 86385,
      "updated_date": "2025-05-15T04:19:48-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351108,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8351107,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378078",
      "brand_name": "MYLAN-LOSARTAN HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168001"
    },
    "created_date": "2017-07-17T17:50:08-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02378078",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "discontinuation_date": "2018-05-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 7037. Last Lot # 3057282 and Expires 31-Jul-18",
    "fr_discontinuation_comments": "Discontinued in shortage ID 7037. Last Lot # 3057282 and Expires 31-Jul-18",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-05-02T17:37:23-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-LOSARTAN HCTZ",
    "en_drug_common_name": "LOSARTAN HCTZ",
    "fr_drug_brand_name": "MYLAN-LOSARTAN HCTZ",
    "fr_drug_common_name": "LOSARTAN HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 30BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 15956,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23734,
      "drug_code": 86386,
      "updated_date": "2025-05-15T04:19:48-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351110,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8351109,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378086",
      "brand_name": "MYLAN-LOSARTAN HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168003"
    },
    "created_date": "2017-07-17T17:52:19-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02378086",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "discontinuation_date": "2018-05-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-05-02T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in ID 7031. Last Lot # 3057283 and Expires 31-Jul-18",
    "fr_discontinuation_comments": "Discontinued in ID 7031. Last Lot # 3057283 and Expires 31-Jul-18",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-05-02T15:50:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-LOSARTAN HCTZ",
    "en_drug_common_name": "LOSARTAN HCTZ",
    "fr_drug_brand_name": "MYLAN-LOSARTAN HCTZ",
    "fr_drug_common_name": "LOSARTAN HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BL, 100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 15959,
    "drug": {
      "current_status": "MARKETED",
      "id": 26534,
      "drug_code": 88837,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259581,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02403587",
      "brand_name": "APO-MOMETASONE",
      "brand_name_fr": "",
      "descriptor": "AQUEOUS SUSPENSION. 140 DOSES.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732002"
    },
    "created_date": "2017-07-17T17:52:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403587",
    "company_name": "APOTEX INC",
    "atc_number": "R01AD",
    "atc_description": "DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",
    "estimated_end_date": "2017-08-18T00:00:00-04:00",
    "actual_start_date": "2017-07-17T00:00:00-04:00",
    "actual_end_date": "2017-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-18T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MOMETASONE",
    "en_drug_common_name": "MOMETASONE",
    "fr_drug_brand_name": "APO-MOMETASONE",
    "fr_drug_common_name": "MOMETASONE",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "50MCG",
    "drug_dosage_form": "SPRAY, METERED DOSE",
    "drug_dosage_form_fr": "Pulvérisation, à dose mesurée",
    "drug_route": "NASAL",
    "drug_route_fr": "Nasale",
    "drug_package_quantity": "50MCG/SPRY 140MS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 15962,
    "drug": {
      "current_status": "MARKETED",
      "id": 31718,
      "drug_code": 94104,
      "updated_date": "2025-05-15T02:35:23-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261914,
          "ingredient": {
            "id": 590,
            "ingredient_code": 4922,
            "en_name": "VITAMIN D3",
            "fr_name": "Vitamine D3"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2800",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261913,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02454467",
      "brand_name": "APO-ALENDRONATE/VITAMIN D3",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251575001"
    },
    "created_date": "2017-07-17T17:55:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02454467",
    "company_name": "APOTEX INC",
    "atc_number": "M05BB",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2018-05-31T00:00:00-04:00",
    "actual_start_date": "2017-11-13T00:00:00-05:00",
    "actual_end_date": "2018-04-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-06T19:00:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ALENDRONATE/VITAMIN D3",
    "en_drug_common_name": "ALENDRONATE",
    "fr_drug_brand_name": "APO-ALENDRONATE/VITAMIN D3",
    "fr_drug_common_name": "ALENDRONATE",
    "en_ingredients": "ALENDRONIC ACID\r\nVITAMIN D3",
    "fr_ingredients": "Vitamine D3",
    "drug_strength": "70MG\r\n2800UNIT",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15971,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23736,
      "drug_code": 86387,
      "updated_date": "2025-05-15T04:19:48-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351112,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8351111,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378094",
      "brand_name": "MYLAN-LOSARTAN HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168002"
    },
    "created_date": "2017-07-17T18:02:28-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02378094",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "discontinuation_date": "2018-05-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-05-02T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in Shortage in ID 7034. Last Lot # 3057285 and Expires 31-Jul-18",
    "fr_discontinuation_comments": "Discontinued in Shortage in ID 7034. Last Lot # 3057285 and Expires 31-Jul-18",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-05-02T17:33:33-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-LOSARTAN HCTZ",
    "en_drug_common_name": "LOSARTAN HCTZ",
    "fr_drug_brand_name": "MYLAN-LOSARTAN HCTZ",
    "fr_drug_common_name": "LOSARTAN HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "25MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 30BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 15973,
    "drug": {
      "current_status": "MARKETED",
      "id": 11790,
      "drug_code": 69270,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254377,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245246",
      "brand_name": "APO-INDAPAMIDE 1.25 MG TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115402002"
    },
    "created_date": "2017-07-17T18:02:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245246",
    "company_name": "APOTEX INC",
    "atc_number": "C03BA",
    "atc_description": "LOW-CEILING DIURETICS, EXCL THIAZIDES",
    "estimated_end_date": "2017-12-20T00:00:00-05:00",
    "actual_start_date": "2017-07-17T00:00:00-04:00",
    "actual_end_date": "2017-12-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-14T18:58:33-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-INDAPAMIDE 1.25 MG TABLETS",
    "en_drug_common_name": "INDAPAMIDE",
    "fr_drug_brand_name": "APO-INDAPAMIDE 1.25 MG TABLETS",
    "fr_drug_common_name": "INDAPAMIDE",
    "en_ingredients": "INDAPAMIDE",
    "fr_ingredients": "Indapamide",
    "drug_strength": "1.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 15993,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11000,
      "drug_code": 66997,
      "updated_date": "2025-05-15T04:02:50-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8333446,
          "ingredient": {
            "id": 2160,
            "ingredient_code": 1290,
            "en_name": "LOVASTATIN",
            "fr_name": "Lovastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243127",
      "brand_name": "MYLAN-LOVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0120669002"
    },
    "created_date": "2017-07-17T18:21:05-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02243127",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T18:21:34-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-LOVASTATIN",
    "en_drug_common_name": "LOVASTATIN",
    "fr_drug_brand_name": "MYLAN-LOVASTATIN",
    "fr_drug_common_name": "LOVASTATIN",
    "en_ingredients": "LOVASTATIN",
    "fr_ingredients": "Lovastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 15995,
    "drug": {
      "current_status": "MARKETED",
      "id": 22344,
      "drug_code": 84741,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257998,
          "ingredient": {
            "id": 3240,
            "ingredient_code": 11780,
            "en_name": "TAMSULOSIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tamsulosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362406",
      "brand_name": "APO-TAMSULOSIN CR",
      "brand_name_fr": "",
      "descriptor": "CONTROLLED-RELEASE TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133680001"
    },
    "created_date": "2017-07-17T18:21:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362406",
    "company_name": "APOTEX INC",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2017-11-10T00:00:00-05:00",
    "actual_start_date": "2017-07-17T00:00:00-04:00",
    "actual_end_date": "2017-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-24T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TAMSULOSIN CR",
    "en_drug_common_name": "TAMSULOSIN",
    "fr_drug_brand_name": "APO-TAMSULOSIN CR",
    "fr_drug_common_name": "TAMSULOSIN",
    "en_ingredients": "TAMSULOSIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tamsulosine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16000,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11002,
      "drug_code": 66999,
      "updated_date": "2025-05-15T04:02:50-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8333449,
          "ingredient": {
            "id": 2160,
            "ingredient_code": 1290,
            "en_name": "LOVASTATIN",
            "fr_name": "Lovastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243129",
      "brand_name": "MYLAN-LOVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0120669001"
    },
    "created_date": "2017-07-17T18:22:40-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02243129",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T18:23:00-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-LOVASTATIN",
    "en_drug_common_name": "LOVASTATIN",
    "fr_drug_brand_name": "MYLAN-LOVASTATIN",
    "fr_drug_common_name": "LOVASTATIN",
    "en_ingredients": "LOVASTATIN",
    "fr_ingredients": "Lovastatine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16009,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24240,
      "drug_code": 86852,
      "updated_date": "2025-05-15T04:20:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351436,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02382709",
      "brand_name": "MYLAN-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783003"
    },
    "created_date": "2017-07-17T18:28:32-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02382709",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T18:28:52-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE ODT",
    "fr_drug_brand_name": "MYLAN-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE ODT",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16012,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24242,
      "drug_code": 86853,
      "updated_date": "2025-05-15T04:20:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351437,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02382717",
      "brand_name": "MYLAN-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2017-07-17T18:29:39-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02382717",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T18:29:57-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE ODT",
    "fr_drug_brand_name": "MYLAN-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE ODT",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16015,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24244,
      "drug_code": 86854,
      "updated_date": "2025-05-15T04:20:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351438,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02382725",
      "brand_name": "MYLAN-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783005"
    },
    "created_date": "2017-07-17T18:30:38-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02382725",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T18:31:13-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE ODT",
    "fr_drug_brand_name": "MYLAN-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE ODT",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16018,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24246,
      "drug_code": 86855,
      "updated_date": "2025-05-15T04:20:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351439,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02382733",
      "brand_name": "MYLAN-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783006"
    },
    "created_date": "2017-07-17T18:31:49-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02382733",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T18:32:12-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE ODT",
    "fr_drug_brand_name": "MYLAN-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE ODT",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16029,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14170,
      "drug_code": 74231,
      "updated_date": "2025-05-15T04:09:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8340303,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02257092",
      "brand_name": "MYLAN-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563001"
    },
    "created_date": "2017-07-17T18:38:56-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02257092",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T18:39:19-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "MYLAN-PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16032,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14174,
      "drug_code": 74233,
      "updated_date": "2025-05-15T04:09:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8340305,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02257114",
      "brand_name": "MYLAN-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2017-07-17T18:40:09-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02257114",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T18:40:33-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "MYLAN-PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16039,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27066,
      "drug_code": 89315,
      "updated_date": "2025-05-15T04:21:19-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8353264,
          "ingredient": {
            "id": 2884,
            "ingredient_code": 12149,
            "en_name": "RABEPRAZOLE SODIUM",
            "fr_name": "Rabéprazole sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02408392",
      "brand_name": "MYLAN-RABEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143681001"
    },
    "created_date": "2017-07-17T18:44:59-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02408392",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "discontinuation_date": "2017-12-01T00:00:00-05:00",
    "anticipated_discontinuation_date": "2017-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Last Lot # 3052217 and Expires 28-Feb-18. Resolved/discontinued in ID 9016",
    "fr_discontinuation_comments": "Last Lot # 3052217 and Expires 28-Feb-18. Resolved/discontinued in ID 9016",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-02-15T19:35:35-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-RABEPRAZOLE",
    "en_drug_common_name": "RABEPRAZOLE",
    "fr_drug_brand_name": "MYLAN-RABEPRAZOLE",
    "fr_drug_common_name": "RABEPRAZOLE",
    "en_ingredients": "RABEPRAZOLE SODIUM",
    "fr_ingredients": "Rabéprazole sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16042,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27068,
      "drug_code": 89316,
      "updated_date": "2025-05-15T04:21:19-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8353265,
          "ingredient": {
            "id": 2884,
            "ingredient_code": 12149,
            "en_name": "RABEPRAZOLE SODIUM",
            "fr_name": "Rabéprazole sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02408406",
      "brand_name": "MYLAN-RABEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143681002"
    },
    "created_date": "2017-07-17T18:59:22-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02408406",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "en_discontinuation_comments": "Last Lot # 3051408 and Expires 28-Feb-18. Resolved/discontinued in ID 9188",
    "fr_discontinuation_comments": "Last Lot # 3051408 and Expires 28-Feb-18. Resolved/discontinued in ID 9188",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-02-15T19:37:05-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-RABEPRAZOLE",
    "en_drug_common_name": "RABEPRAZOLE",
    "fr_drug_brand_name": "MYLAN-RABEPRAZOLE",
    "fr_drug_common_name": "RABEPRAZOLE",
    "en_ingredients": "RABEPRAZOLE SODIUM",
    "fr_ingredients": "Rabéprazole sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16049,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25906,
      "drug_code": 88270,
      "updated_date": "2025-05-15T04:20:46-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8352455,
          "ingredient": {
            "id": 2640,
            "ingredient_code": 11819,
            "en_name": "RISEDRONATE SODIUM",
            "fr_name": "Risédronate sodique (Hémipentahydrate de risédronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02397773",
      "brand_name": "MYLAN-RISEDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135301005"
    },
    "created_date": "2017-07-17T19:03:21-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02397773",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T19:03:45-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-RISEDRONATE",
    "en_drug_common_name": "RISEDRONATE",
    "fr_drug_brand_name": "MYLAN-RISEDRONATE",
    "fr_drug_common_name": "RISEDRONATE",
    "en_ingredients": "RISEDRONATE SODIUM",
    "fr_ingredients": "Risédronate sodique",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16054,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7580,
      "drug_code": 50319,
      "updated_date": "2025-05-15T03:51:26-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8315927,
          "ingredient": {
            "id": 1234,
            "ingredient_code": 1294,
            "en_name": "SELEGILINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de sélégiline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02231036",
      "brand_name": "MYLAN-SELEGILINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131374001"
    },
    "created_date": "2017-07-17T19:07:03-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02231036",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N04BD",
    "atc_description": "DOPAMINERGIC AGENTS",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T19:07:33-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-SELEGILINE",
    "en_drug_common_name": "SELEGILINE",
    "fr_drug_brand_name": "MYLAN-SELEGILINE",
    "fr_drug_common_name": "SELEGILINE",
    "en_ingredients": "SELEGILINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de sélégiline",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16057,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25314,
      "drug_code": 87785,
      "updated_date": "2025-05-15T04:20:33-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351975,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392593",
      "brand_name": "MYL-SILDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261003"
    },
    "created_date": "2017-07-17T19:09:12-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02392593",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "fr_supply_disruption_mitigation": "There is no saleable inventory remaining.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-17T19:10:40-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYL-SILDENAFIL",
    "en_drug_common_name": "SILDENAFIL",
    "fr_drug_brand_name": "MYL-SILDENAFIL",
    "fr_drug_common_name": "SILDENAFIL",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "SILDENAFIL",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BT, 4BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16061,
    "drug": {
      "current_status": "MARKETED",
      "id": 5732,
      "drug_code": 3781,
      "updated_date": "2025-12-03T00:30:21-05:00",
      "company": {
        "id": 16,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 3594,
        "mfr_code": "ALC08",
        "name": "ALCON CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2665 MEADOWPINE BLVD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 8C7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250560,
          "ingredient": {
            "id": 12448,
            "ingredient_code": 13442,
            "en_name": "FLUORESCEIN",
            "fr_name": "Fluorescéine (Fluoroscéine sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "00505005",
      "brand_name": "FLUORESCITE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "55467",
      "number_of_ais": "1",
      "ai_group_no": "0160251001"
    },
    "created_date": "2017-07-17T19:28:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00505005",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "V04",
    "atc_description": "OTHER DIAGNOSTIC AGENTS",
    "estimated_end_date": "2017-08-23T00:00:00-04:00",
    "actual_start_date": "2017-07-17T00:00:00-04:00",
    "actual_end_date": "2017-08-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-08-31T21:27:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FLUORESCITE",
    "en_drug_common_name": "FLUORESCITE 10% 5mg vial (1x12)",
    "fr_drug_brand_name": "FLUORESCITE 10% 5ML VIAL",
    "fr_drug_common_name": "FLUORESCITE 10% 5ML VIAL",
    "en_ingredients": "FLUORESCEIN SODIUM",
    "fr_ingredients": "Fluoroscéine sodique",
    "drug_strength": "10%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1 x 12",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 16068,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3984,
      "drug_code": 19648,
      "updated_date": "2025-05-15T03:45:42-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8303642,
          "ingredient": {
            "id": 1588,
            "ingredient_code": 917,
            "en_name": "ACARBOSE",
            "fr_name": "Acarbose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02190885",
      "brand_name": "GLUCOBAY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81945",
      "number_of_ais": "1",
      "ai_group_no": "0123099002"
    },
    "created_date": "2017-07-17T20:44:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02190885",
    "company_name": "BAYER INC",
    "atc_number": "A10BF",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2017-07-13T00:00:00-04:00",
    "estimated_end_date": "2017-09-15T00:00:00-04:00",
    "actual_start_date": "2017-07-13T00:00:00-04:00",
    "actual_end_date": "2017-09-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-15T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Product is available in the market.",
    "en_drug_brand_name": "GLUCOBAY",
    "en_drug_common_name": "Acarbose",
    "fr_drug_brand_name": "Glucobay",
    "fr_drug_common_name": "Acarbose",
    "en_ingredients": "ACARBOSE",
    "fr_ingredients": "Acarbose",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "120",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 16073,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3990,
      "drug_code": 19655,
      "updated_date": "2025-05-15T03:45:44-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8303648,
          "ingredient": {
            "id": 1588,
            "ingredient_code": 917,
            "en_name": "ACARBOSE",
            "fr_name": "Acarbose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02190893",
      "brand_name": "GLUCOBAY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81952",
      "number_of_ais": "1",
      "ai_group_no": "0123099001"
    },
    "created_date": "2017-07-17T20:53:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02190893",
    "company_name": "BAYER INC",
    "atc_number": "A10BF",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2017-07-13T00:00:00-04:00",
    "estimated_end_date": "2017-08-25T00:00:00-04:00",
    "actual_start_date": "2017-07-13T00:00:00-04:00",
    "actual_end_date": "2017-08-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-25T15:56:45-04:00",
    "status": "resolved",
    "en_comments": "Product available in the market.",
    "en_drug_brand_name": "GLUCOBAY",
    "en_drug_common_name": "Acarbose",
    "fr_drug_brand_name": "Glucobay",
    "fr_drug_common_name": "Acarbose",
    "en_ingredients": "ACARBOSE",
    "fr_ingredients": "Acarbose",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "120 Tablets",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 16077,
    "drug": {
      "current_status": "MARKETED",
      "id": 11382,
      "drug_code": 67891,
      "updated_date": "2025-05-15T02:31:15-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8254250,
          "ingredient": {
            "id": 2798,
            "ingredient_code": 11463,
            "en_name": "FOLLITROPIN BETA",
            "fr_name": "Follitropine bêta"
          },
          "ingredient_supplied_ind": "I",
          "strength": "833",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02243948",
      "brand_name": "PUREGON",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141201009"
    },
    "created_date": "2017-07-17T21:22:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243948",
    "company_name": "MERCK CANADA INC",
    "atc_number": "G03GA",
    "atc_description": "GONADOTROPHINS AND OTHER OVULATION STIMULANTS",
    "actual_start_date": "2017-07-21T00:00:00-04:00",
    "actual_end_date": "2017-09-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-09-12T12:53:15-04:00",
    "status": "resolved",
    "en_comments": "Quantities available in 300IU & 900IU",
    "fr_comments": "Quantités disponibles en 300UI & 900UI",
    "en_drug_brand_name": "PUREGON",
    "en_drug_common_name": "follitropin beta Solution for injection-cartriges",
    "fr_drug_brand_name": "PUREGON",
    "fr_drug_common_name": "Solution pour injection en cartouches (FSH rec.) follitropine bêta",
    "en_ingredients": "FOLLITROPIN BETA",
    "fr_ingredients": "Follitropine bêta",
    "drug_strength": "833UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "600IU/0.72ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16096,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6532,
      "drug_code": 43459,
      "updated_date": "2025-05-15T03:49:54-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8312985,
          "ingredient": {
            "id": 2194,
            "ingredient_code": 2165,
            "en_name": "CIMETIDINE",
            "fr_name": "Cimétidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02227460",
      "brand_name": "MYLAN-CIMETIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9798",
      "number_of_ais": "1",
      "ai_group_no": "0111925004"
    },
    "created_date": "2017-07-18T12:10:33-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02227460",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "discontinuation_date": "2017-09-07T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "The last lot expires on 30-Apr-2018.",
    "fr_supply_disruption_mitigation": "The last lot expires on 30-Apr-2018.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-09-08T13:39:47-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-CIMETIDINE",
    "en_drug_common_name": "CIMETIDINE",
    "fr_drug_brand_name": "MYLAN-CIMETIDINE",
    "fr_drug_common_name": "CIMETIDINE",
    "en_ingredients": "CIMETIDINE",
    "fr_ingredients": "Cimétidine",
    "drug_strength": "600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 500BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16099,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7760,
      "drug_code": 50821,
      "updated_date": "2025-05-15T03:51:55-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8316707,
          "ingredient": {
            "id": 526,
            "ingredient_code": 10128,
            "en_name": "AZATHIOPRINE",
            "fr_name": "Azathioprine (Azathioprine sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02231491",
      "brand_name": "MYLAN-AZATHIOPRINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101830001"
    },
    "created_date": "2017-07-18T12:16:22-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02231491",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "L04AX",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "discontinuation_date": "2017-11-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Last Lot expires 31-Jan-2018",
    "fr_discontinuation_comments": "Last Lot expires 31-Jan-2018",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-02T17:59:23-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-AZATHIOPRINE",
    "en_drug_common_name": "AZATHIOPRINE",
    "fr_drug_brand_name": "MYLAN-AZATHIOPRINE",
    "fr_drug_common_name": "AZATHIOPRINE",
    "en_ingredients": "AZATHIOPRINE",
    "fr_ingredients": "Azathioprine",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16105,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21056,
      "drug_code": 83290,
      "updated_date": "2025-05-15T04:16:49-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8348649,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347512",
      "brand_name": "MYLAN-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683003"
    },
    "created_date": "2017-07-18T12:19:52-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02347512",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2017-12-01T00:00:00-05:00",
    "anticipated_discontinuation_date": "2017-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Last Lot # 3063832 and Expires 28-Feb-18. Resolved/discontinued in ID 9261",
    "fr_discontinuation_comments": "Last Lot # 3063832 and Expires 28-Feb-18. Resolved/discontinued in ID 9261",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-02-15T19:42:49-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "MYLAN-CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "3.125MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16108,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21058,
      "drug_code": 83292,
      "updated_date": "2025-05-15T04:16:49-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8348650,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347520",
      "brand_name": "MYLAN-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683004"
    },
    "created_date": "2017-07-18T12:21:39-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02347520",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2017-12-01T00:00:00-05:00",
    "anticipated_discontinuation_date": "2017-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Last Lot # 3063827 and Expires 28-Feb-18. Resolved/discontinued in ID 9271",
    "fr_discontinuation_comments": "Last Lot # 3063827 and Expires 28-Feb-18. Resolved/discontinued in ID 9271",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-02-15T19:42:00-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "MYLAN-CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "6.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16111,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21060,
      "drug_code": 83294,
      "updated_date": "2025-05-15T04:16:49-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8348651,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347555",
      "brand_name": "MYLAN-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683005"
    },
    "created_date": "2017-07-18T12:23:03-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02347555",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2017-12-01T00:00:00-05:00",
    "anticipated_discontinuation_date": "2017-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Last Lot # 3063829 and Expires 28-Feb-18, Resolved/Discontinued in ID 9276",
    "fr_discontinuation_comments": "Last Lot # 3063829 and Expires 28-Feb-18, Resolved/Discontinued in ID 9276",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-02-15T19:41:18-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "MYLAN-CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16117,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22062,
      "drug_code": 84449,
      "updated_date": "2025-05-15T04:17:42-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8349532,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359472",
      "brand_name": "MYLAN-DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548001"
    },
    "created_date": "2017-07-18T12:39:38-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02359472",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2018-05-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 9303. Last Lot #  8039450 and Expires 31-Jul-18",
    "fr_discontinuation_comments": "Discontinued in shortage ID 9303. Last Lot #  8039450 and Expires 31-Jul-18",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-05-02T15:43:31-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-DONEPEZIL",
    "en_drug_common_name": "DONEPEZIL",
    "fr_drug_brand_name": "MYLAN-DONEPEZIL",
    "fr_drug_common_name": "DONEPEZIL",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16120,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22064,
      "drug_code": 84450,
      "updated_date": "2025-05-15T04:17:42-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8349533,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359480",
      "brand_name": "MYLAN-DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548002"
    },
    "created_date": "2017-07-18T12:41:11-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02359480",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2018-03-01T00:00:00-05:00",
    "anticipated_discontinuation_date": "2018-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 10066. Last Lot # 8046946 and Expires 31-May-18",
    "fr_discontinuation_comments": "Discontinued in shortage ID 10066. Last Lot # 8046946 and Expires 31-May-18",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-03-02T06:00:09-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-DONEPEZIL",
    "en_drug_common_name": "DONEPEZIL",
    "fr_drug_brand_name": "MYLAN-DONEPEZIL",
    "fr_drug_common_name": "DONEPEZIL",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16123,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25066,
      "drug_code": 87578,
      "updated_date": "2025-05-15T04:20:23-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351867,
          "ingredient": {
            "id": 2882,
            "ingredient_code": 12126,
            "en_name": "ENTACAPONE",
            "fr_name": "Entacapone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02390337",
      "brand_name": "MYLAN-ENTACAPONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143623001"
    },
    "created_date": "2017-07-18T12:43:04-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02390337",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N04BX",
    "atc_description": "DOPAMINERGIC AGENTS",
    "discontinuation_date": "2017-11-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Last Lot expires 31-Jan-2018",
    "fr_discontinuation_comments": "Last Lot expires 31-Jan-2018",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-02T18:02:38-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-ENTACAPONE",
    "en_drug_common_name": "ENTACAPONE",
    "fr_drug_brand_name": "MYLAN-ENTACAPONE",
    "fr_drug_common_name": "ENTACAPONE",
    "en_ingredients": "ENTACAPONE",
    "fr_ingredients": "Entacapone",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16126,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7000,
      "drug_code": 47424,
      "updated_date": "2025-05-15T03:50:13-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8313547,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02229519",
      "brand_name": "MYLAN-GLICLAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934001"
    },
    "created_date": "2017-07-18T12:45:12-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02229519",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2017-12-01T00:00:00-05:00",
    "anticipated_discontinuation_date": "2017-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-12-02T06:00:11-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-GLICLAZIDE",
    "en_drug_common_name": "GLICLAZIDE",
    "fr_drug_brand_name": "MYLAN-GLICLAZIDE",
    "fr_drug_common_name": "GLICLAZIDE",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 60BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16129,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15440,
      "drug_code": 76039,
      "updated_date": "2025-05-15T04:10:48-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8342026,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02274868",
      "brand_name": "MYLAN-LISINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121550002"
    },
    "created_date": "2017-07-18T12:46:55-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02274868",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2018-04-02T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-04-02T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued under shortage ID 9222. Mar-2018 Last lot 3055901 expires 30-jun-18",
    "fr_discontinuation_comments": "Discontinued under shortage ID 9222. Mar-2018 Last lot 3055901 expires 30-jun-18",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-04-03T05:00:12-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-LISINOPRIL",
    "en_drug_common_name": "LISINOPRIL",
    "fr_drug_brand_name": "MYLAN-LISINOPRIL",
    "fr_drug_common_name": "LISINOPRIL",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16132,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14094,
      "drug_code": 74120,
      "updated_date": "2025-05-15T04:09:01-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8340207,
          "ingredient": {
            "id": 2560,
            "ingredient_code": 11764,
            "en_name": "MELOXICAM",
            "fr_name": "Méloxicam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02255987",
      "brand_name": "MYLAN-MELOXICAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131676003"
    },
    "created_date": "2017-07-18T12:49:05-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02255987",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "M01AC",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2018-06-07T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "discontinued in shortage ID 44891. Last lot KA56344 exp 31-aug-2015",
    "fr_discontinuation_comments": "discontinued in shortage ID 44891. Last lot KA56344 exp 31-aug-2015",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-06-08T14:27:21-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-MELOXICAM",
    "en_drug_common_name": "MELOXICAM",
    "fr_drug_brand_name": "MYLAN-MELOXICAM",
    "fr_drug_common_name": "MELOXICAM",
    "en_ingredients": "MELOXICAM",
    "fr_ingredients": "Méloxicam",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16135,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14096,
      "drug_code": 74121,
      "updated_date": "2025-05-15T04:09:01-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8340208,
          "ingredient": {
            "id": 2560,
            "ingredient_code": 11764,
            "en_name": "MELOXICAM",
            "fr_name": "Méloxicam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02255995",
      "brand_name": "MYLAN-MELOXICAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131676004"
    },
    "created_date": "2017-07-18T12:51:02-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02255995",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "M01AC",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2018-06-07T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "discontinued in shortage ID 10070. Last lot KA56345 exp 31-aug-2015",
    "fr_discontinuation_comments": "discontinued in shortage ID 10070. Last lot KA56345 exp 31-aug-2015",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-06-08T14:26:29-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-MELOXICAM",
    "en_drug_common_name": "MELOXICAM",
    "fr_drug_brand_name": "MYLAN-MELOXICAM",
    "fr_drug_common_name": "MELOXICAM",
    "en_ingredients": "MELOXICAM",
    "fr_ingredients": "Méloxicam",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16138,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24014,
      "drug_code": 86652,
      "updated_date": "2025-05-15T04:19:53-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351282,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02380749",
      "brand_name": "MYLAN-MONTELUKAST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823003"
    },
    "created_date": "2017-07-18T12:53:41-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02380749",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "R03DC",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "discontinuation_date": "2017-09-07T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "The last lot expires on 30-Nov-2017.",
    "fr_supply_disruption_mitigation": "The last lot expires on 30-Nov-2017.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-09-08T14:17:15-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-MONTELUKAST",
    "en_drug_common_name": "MONTELUKAST",
    "fr_drug_brand_name": "MYLAN-MONTELUKAST",
    "fr_drug_common_name": "MONTELUKAST",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "MONTELUKAST",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16142,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24016,
      "drug_code": 86653,
      "updated_date": "2025-05-15T04:19:53-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351283,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02380757",
      "brand_name": "MYLAN-MONTELUKAST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823001"
    },
    "created_date": "2017-07-18T12:55:41-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02380757",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "R03DC",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "discontinuation_date": "2018-02-01T00:00:00-05:00",
    "anticipated_discontinuation_date": "2018-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Last Lot # 3051411 and Expires 30-Apr-18. Resolved/Discontinued in ID 9241",
    "fr_discontinuation_comments": "Last Lot # 3051411 and Expires 30-Apr-18. Resolved/Discontinued in ID 9241",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-02-15T19:10:31-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-MONTELUKAST",
    "en_drug_common_name": "MONTELUKAST",
    "fr_drug_brand_name": "MYLAN-MONTELUKAST",
    "fr_drug_common_name": "MONTELUKAST",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "MONTELUKAST",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16145,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22784,
      "drug_code": 85319,
      "updated_date": "2025-05-15T04:18:37-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8350211,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02368226",
      "brand_name": "MYLAN-MONTELUKAST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823002"
    },
    "created_date": "2017-07-18T12:57:15-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02368226",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "R03DC",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "discontinuation_date": "2017-12-01T00:00:00-05:00",
    "anticipated_discontinuation_date": "2017-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-12-02T06:00:12-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-MONTELUKAST",
    "en_drug_common_name": "MONTELUKAST",
    "fr_drug_brand_name": "MYLAN-MONTELUKAST",
    "fr_drug_common_name": "MONTELUKAST",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "MONTELUKAST",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 30BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16148,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14172,
      "drug_code": 74232,
      "updated_date": "2025-05-15T04:09:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8340304,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02257106",
      "brand_name": "MYLAN-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563002"
    },
    "created_date": "2017-07-18T12:59:11-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02257106",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2017-09-07T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "The last lot expires on 28-Feb-2018.",
    "fr_supply_disruption_mitigation": "The last lot expires on 28-Feb-2018.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-09-08T14:02:54-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "MYLAN-PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16151,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21950,
      "drug_code": 84306,
      "updated_date": "2025-05-15T04:17:29-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8349407,
          "ingredient": {
            "id": 2640,
            "ingredient_code": 11819,
            "en_name": "RISEDRONATE SODIUM",
            "fr_name": "Risédronate sodique (Hémipentahydrate de risédronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "35",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02357984",
      "brand_name": "MYLAN-RISEDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135301003"
    },
    "created_date": "2017-07-18T13:01:09-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02357984",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "discontinuation_date": "2017-11-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Last Lot expires 31-Jan-2018",
    "fr_discontinuation_comments": "Last Lot expires 31-Jan-2018",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-02T18:07:39-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-RISEDRONATE",
    "en_drug_common_name": "RISEDRONATE",
    "fr_drug_brand_name": "MYLAN-RISEDRONATE",
    "fr_drug_common_name": "RISEDRONATE",
    "en_ingredients": "RISEDRONATE SODIUM",
    "fr_ingredients": "Risédronate sodique",
    "drug_strength": "35MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BT, 4BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16154,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 16002,
      "drug_code": 76790,
      "updated_date": "2025-05-15T04:11:30-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8342866,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02282240",
      "brand_name": "MYLAN-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332006"
    },
    "created_date": "2017-07-18T13:04:16-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02282240",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2018-02-01T00:00:00-05:00",
    "anticipated_discontinuation_date": "2018-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Last Lot # 3054054 and Expires 30-Apr-18",
    "fr_discontinuation_comments": "Last Lot # 3054054 and Expires 30-Apr-18",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-02-15T19:13:52-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "MYLAN-RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16157,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 16004,
      "drug_code": 76791,
      "updated_date": "2025-05-15T04:11:30-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8342867,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02282259",
      "brand_name": "MYLAN-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332007"
    },
    "created_date": "2017-07-18T13:05:37-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02282259",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2018-02-01T00:00:00-05:00",
    "anticipated_discontinuation_date": "2018-02-02T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Last Lot # 3054049 and Expires 30-Apr-18. Resolved/Discontinued in ID 26702",
    "fr_discontinuation_comments": "Last Lot # 3054049 and Expires 30-Apr-18. Resolved/Discontinued in ID 26702",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-02-15T19:15:49-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "MYLAN-RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "0.50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16160,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 16006,
      "drug_code": 76792,
      "updated_date": "2025-05-15T04:11:30-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8342868,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02282267",
      "brand_name": "MYLAN-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332003"
    },
    "created_date": "2017-07-18T13:06:33-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02282267",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2017-09-07T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "The last lot expires on 30-Nov-2017",
    "fr_supply_disruption_mitigation": "The last lot expires on 30-Nov-2017",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-09-08T14:06:44-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "MYLAN-RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "1.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16163,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 16008,
      "drug_code": 76793,
      "updated_date": "2025-05-15T04:11:30-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8342869,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02282275",
      "brand_name": "MYLAN-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332004"
    },
    "created_date": "2017-07-18T13:07:59-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02282275",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2017-10-02T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "The last lot expires on 31-Dec-17.",
    "fr_discontinuation_comments": "The last lot expires on 31-Dec-17.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-03T05:00:08-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "MYLAN-RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "2.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 16166,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 16010,
      "drug_code": 76794,
      "updated_date": "2025-05-15T04:11:30-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8342870,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02282283",
      "brand_name": "MYLAN-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332002"
    },
    "created_date": "2017-07-18T13:09:44-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02282283",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2017-10-02T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "The last lot expires on 31-Dec-17.",
    "fr_discontinuation_comments": "The last lot expires on 31-Dec-17.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-03T05:00:09-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "MYLAN-RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "3.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 16169,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 16012,
      "drug_code": 76795,
      "updated_date": "2025-05-15T04:11:30-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8342871,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02282291",
      "brand_name": "MYLAN-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332005"
    },
    "created_date": "2017-07-18T13:10:46-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02282291",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2017-10-02T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "The last lot expires on  31-Dec-17.",
    "fr_discontinuation_comments": "The last lot expires on  31-Dec-17.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-03T05:00:09-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "MYLAN-RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "4.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 16172,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25310,
      "drug_code": 87783,
      "updated_date": "2025-05-15T04:20:33-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351973,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392577",
      "brand_name": "MYL-SILDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261001"
    },
    "created_date": "2017-07-18T13:12:49-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02392577",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "discontinuation_date": "2017-10-02T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "The last lot expires on 31-Dec-17.",
    "fr_discontinuation_comments": "The last lot expires on 31-Dec-17.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-03T05:00:08-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYL-SILDENAFIL",
    "en_drug_common_name": "SILDENAFIL",
    "fr_drug_brand_name": "MYL-SILDENAFIL",
    "fr_drug_common_name": "SILDENAFIL",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "SILDENAFIL",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 16175,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25312,
      "drug_code": 87784,
      "updated_date": "2025-05-15T04:20:33-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351974,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392585",
      "brand_name": "MYL-SILDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261002"
    },
    "created_date": "2017-07-18T13:14:00-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02392585",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "discontinuation_date": "2018-05-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2018-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Discontinued in shortage ID 5307.  Last Lot # 3057123 and Expires 31-Jul-18",
    "fr_discontinuation_comments": "Discontinued in shortage ID 5307.  Last Lot # 3057123 and Expires 31-Jul-18",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-05-02T17:43:34-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYL-SILDENAFIL",
    "en_drug_common_name": "SILDENAFIL",
    "fr_drug_brand_name": "MYL-SILDENAFIL",
    "fr_drug_common_name": "SILDENAFIL",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "SILDENAFIL",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4BL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16200,
    "drug": {
      "current_status": "MARKETED",
      "id": 16000,
      "drug_code": 76788,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8255721,
          "ingredient": {
            "id": 3310,
            "ingredient_code": 13030,
            "en_name": "ENTECAVIR",
            "fr_name": "Entécavir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02282224",
      "brand_name": "BARACLUDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151648001"
    },
    "created_date": "2017-07-18T13:50:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02282224",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "J05AF",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2017-09-11T00:00:00-04:00",
    "estimated_end_date": "2017-09-08T00:00:00-04:00",
    "actual_end_date": "2017-09-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-09-21T20:11:11-04:00",
    "status": "avoided_shortage",
    "en_comments": "Stock available Sept. 8th.",
    "fr_comments": "Disponible le 8 sept.",
    "en_drug_brand_name": "BARACLUDE",
    "en_drug_common_name": "entecavir",
    "fr_drug_brand_name": "BARACLUDE",
    "fr_drug_common_name": "Entécavir",
    "en_ingredients": "ENTECAVIR",
    "fr_ingredients": "Entécavir",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 BTL X 30",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 16203,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6528,
      "drug_code": 43457,
      "updated_date": "2025-05-15T03:49:54-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8312983,
          "ingredient": {
            "id": 2194,
            "ingredient_code": 2165,
            "en_name": "CIMETIDINE",
            "fr_name": "Cimétidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02227444",
      "brand_name": "MYLAN-CIMETIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9796",
      "number_of_ais": "1",
      "ai_group_no": "0111925001"
    },
    "created_date": "2017-07-18T14:16:51-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02227444",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "discontinuation_date": "2017-09-07T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "The last lot expires on 30-Apr-2018.",
    "fr_supply_disruption_mitigation": "The last lot expires on 30-Apr-2018.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-09-08T13:26:30-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-CIMETIDINE",
    "en_drug_common_name": "CIMETIDINE",
    "fr_drug_brand_name": "MYLAN-CIMETIDINE",
    "fr_drug_common_name": "CIMETIDINE",
    "en_ingredients": "CIMETIDINE",
    "fr_ingredients": "Cimétidine",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 1000BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16206,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6530,
      "drug_code": 43458,
      "updated_date": "2025-05-15T03:49:54-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8312984,
          "ingredient": {
            "id": 2194,
            "ingredient_code": 2165,
            "en_name": "CIMETIDINE",
            "fr_name": "Cimétidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02227452",
      "brand_name": "MYLAN-CIMETIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9797",
      "number_of_ais": "1",
      "ai_group_no": "0111925002"
    },
    "created_date": "2017-07-18T14:20:24-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02227452",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "discontinuation_date": "2017-09-07T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "The last lot expires on 30-Apr-2018.",
    "fr_supply_disruption_mitigation": "The last lot expires on 30-Apr-2018.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-09-08T13:36:51-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-CIMETIDINE",
    "en_drug_common_name": "CIMETIDINE",
    "fr_drug_brand_name": "MYLAN-CIMETIDINE",
    "fr_drug_common_name": "CIMETIDINE",
    "en_ingredients": "CIMETIDINE",
    "fr_ingredients": "Cimétidine",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 500BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16211,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6534,
      "drug_code": 43460,
      "updated_date": "2025-05-15T03:49:54-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8312986,
          "ingredient": {
            "id": 2194,
            "ingredient_code": 2165,
            "en_name": "CIMETIDINE",
            "fr_name": "Cimétidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "800",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02227479",
      "brand_name": "MYLAN-CIMETIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9799",
      "number_of_ais": "1",
      "ai_group_no": "0111925006"
    },
    "created_date": "2017-07-18T14:25:12-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02227479",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "discontinuation_date": "2017-09-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-09-08T13:50:59-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYLAN-CIMETIDINE",
    "en_drug_common_name": "CIMETIDINE",
    "fr_drug_brand_name": "MYLAN-CIMETIDINE",
    "fr_drug_common_name": "CIMETIDINE",
    "en_ingredients": "CIMETIDINE",
    "fr_ingredients": "Cimétidine",
    "drug_strength": "800MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 16239,
    "drug": {
      "current_status": "MARKETED",
      "id": 26954,
      "drug_code": 89214,
      "updated_date": "2025-05-15T02:33:59-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259712,
          "ingredient": {
            "id": 62,
            "ingredient_code": 9412,
            "en_name": "NITROGLYCERIN",
            "fr_name": "Nitroglycérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02407450",
      "brand_name": "MYLAN-NITRO PATCH 0.4",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103615009"
    },
    "created_date": "2017-07-18T15:37:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02407450",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C01DA",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "anticipated_start_date": "2017-08-09T00:00:00-04:00",
    "estimated_end_date": "2017-08-11T00:00:00-04:00",
    "actual_start_date": "2017-08-09T00:00:00-04:00",
    "actual_end_date": "2017-08-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-08-16T11:59:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-NITRO PATCH 0.4",
    "en_drug_common_name": "NITRO PATCH 0.4",
    "fr_drug_brand_name": "MYLAN-NITRO PATCH 0.4",
    "fr_drug_common_name": "NITRO PATCH 0.4",
    "en_ingredients": "NITROGLYCERIN",
    "fr_ingredients": "Nitroglycérine",
    "drug_strength": "41.4MG",
    "drug_dosage_form": "PATCH (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Timbre (à libération prolongée)",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 16246,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23832,
      "drug_code": 86504,
      "updated_date": "2025-05-15T04:19:48-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351196,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379155",
      "brand_name": "MYLAN-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220004"
    },
    "created_date": "2017-07-18T15:45:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379155",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2018-05-07T00:00:00-04:00",
    "actual_start_date": "2018-05-08T00:00:00-04:00",
    "actual_end_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-05T13:32:08-04:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 53611",
    "fr_comments": "Discontinued in ID 53611",
    "en_drug_brand_name": "MYLAN-CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "MYLAN-CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "32MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16249,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25794,
      "drug_code": 88174,
      "updated_date": "2025-12-03T01:30:40-05:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8352396,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02396726",
      "brand_name": "MYLAN-FENTANYL MATRIX PATCH",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302002"
    },
    "created_date": "2017-07-18T15:48:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02396726",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "actual_start_date": "2018-11-19T00:00:00-05:00",
    "actual_end_date": "2018-12-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2019-01-03T18:43:31-05:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 68536.",
    "fr_comments": "Discontinued in ID 68536",
    "en_drug_brand_name": "MYLAN-FENTANYL MATRIX PATCH",
    "en_drug_common_name": "FENTANYL MATRIX PATCH",
    "fr_drug_brand_name": "MYLAN-FENTANYL MATRIX PATCH",
    "fr_drug_common_name": "FENTANYL MATRIX PATCH",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "50MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 16268,
    "drug": {
      "current_status": "MARKETED",
      "id": 15768,
      "drug_code": 76502,
      "updated_date": "2025-05-15T02:31:44-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255643,
          "ingredient": {
            "id": 2138,
            "ingredient_code": 11104,
            "en_name": "ONDANSETRON",
            "fr_name": "Ondansétron"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02279436",
      "brand_name": "ONDANSETRON INJECTION USP   -(WITH PRESERVATIVE)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131120004"
    },
    "created_date": "2017-07-18T19:12:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02279436",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A04AA",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "anticipated_start_date": "2017-07-21T00:00:00-04:00",
    "estimated_end_date": "2017-07-31T00:00:00-04:00",
    "actual_end_date": "2017-08-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-10-19T13:33:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ONDANSETRON INJECTION USP     -(WITH PRESERVATIVE)",
    "en_drug_common_name": "ONDANSETRON",
    "fr_drug_brand_name": "ONDANSETRON",
    "fr_drug_common_name": "ONDANSETRON",
    "en_ingredients": "ONDANSETRON",
    "fr_ingredients": "Ondansétron",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "20ML VIAL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16287,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24036,
      "drug_code": 86669,
      "updated_date": "2025-05-15T04:19:55-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8351291,
          "ingredient": {
            "id": 1254,
            "ingredient_code": 1998,
            "en_name": "ETOPOSIDE",
            "fr_name": "Étoposide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02380935",
      "brand_name": "ETOPOSIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "MULTI-DOSE VIALS OF 100MG(5ML), 200MG(10ML), 500MG(25ML), AND 1G(50ML)",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114567002"
    },
    "created_date": "2017-07-18T19:39:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02380935",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L01CB",
    "atc_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
    "actual_start_date": "2017-07-03T00:00:00-04:00",
    "actual_end_date": "2017-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-08-01T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ETOPOSIDE INJECTION USP",
    "en_drug_common_name": "ETOPOSIDE",
    "fr_drug_brand_name": "ETOPOSIDE",
    "fr_drug_common_name": "ETOPOSIDE",
    "en_ingredients": "ETOPOSIDE",
    "fr_ingredients": "Étoposide",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "5ML VIAL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 16290,
    "drug": {
      "current_status": "MARKETED",
      "id": 7846,
      "drug_code": 51049,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253410,
          "ingredient": {
            "id": 1560,
            "ingredient_code": 5881,
            "en_name": "PROTAMINE SULFATE",
            "fr_name": "Sulfate de protamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02231674",
      "brand_name": "PROTAMINE SULFATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107652001"
    },
    "created_date": "2017-07-18T19:41:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231674",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "V03AB",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2017-07-19T00:00:00-04:00",
    "estimated_end_date": "2017-07-31T00:00:00-04:00",
    "actual_end_date": "2017-07-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-08-03T01:29:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PROTAMINE SULFATE INJECTION USP",
    "en_drug_common_name": "PROTAMINE",
    "fr_drug_brand_name": "PROTAMINE",
    "fr_drug_common_name": "PROTAMINE",
    "en_ingredients": "PROTAMINE SULFATE",
    "fr_ingredients": "Sulfate de protamine",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "25ML VIAL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 16328,
    "drug": {
      "current_status": "MARKETED",
      "id": 18352,
      "drug_code": 79615,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256435,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310538",
      "brand_name": "TARO-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858003"
    },
    "created_date": "2017-07-18T21:12:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310538",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2017-07-18T00:00:00-04:00",
    "estimated_end_date": "2018-10-08T00:00:00-04:00",
    "actual_start_date": "2017-07-18T00:00:00-04:00",
    "actual_end_date": "2017-07-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-04T19:47:14-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "RAN-RAMIPRIL",
    "en_drug_common_name": "RAN-RAMIPRIL",
    "fr_drug_brand_name": "RAN-RAMIPRIL",
    "fr_drug_common_name": "RAN-RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 16331,
    "drug": {
      "current_status": "MARKETED",
      "id": 18688,
      "drug_code": 79955,
      "updated_date": "2025-12-03T00:31:20-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256536,
          "ingredient": {
            "id": 2442,
            "ingredient_code": 11516,
            "en_name": "ROPINIROLE",
            "fr_name": "Ropinirole (Chlorhydrate de ropinirole)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02314037",
      "brand_name": "SPC-ROPINIROLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132618001"
    },
    "created_date": "2017-07-18T21:20:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314037",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2017-07-18T00:00:00-04:00",
    "actual_start_date": "2017-07-18T00:00:00-04:00",
    "actual_end_date": "2018-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-23T19:55:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-ROPINIROLE",
    "en_drug_common_name": "RAN-ROPINIROLE",
    "fr_drug_brand_name": "RAN-ROPINIROLE",
    "fr_drug_common_name": "RAN-ROPINIROLE",
    "en_ingredients": "ROPINIROLE",
    "fr_ingredients": "ROPINIROLE",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16334,
    "drug": {
      "current_status": "MARKETED",
      "id": 16218,
      "drug_code": 77002,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255788,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02284456",
      "brand_name": "TARO-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2017-07-18T21:27:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02284456",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-07-18T00:00:00-04:00",
    "estimated_end_date": "2018-11-02T00:00:00-04:00",
    "actual_start_date": "2017-07-18T00:00:00-04:00",
    "actual_end_date": "2017-07-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-04T19:43:57-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-PRAVASTATIN",
    "en_drug_common_name": "RAN-PRAVASTATIN",
    "fr_drug_brand_name": "RAN-PRAVASTATIN",
    "fr_drug_common_name": "RAN-PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 16365,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8064,
      "drug_code": 5294,
      "updated_date": "2025-05-15T03:28:25-04:00",
      "company": {
        "id": 138,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 13965,
        "mfr_code": "",
        "name": "AMDIPHARM LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "UNIT 17, NORTHWOOD HOUSE, NORTHWOOD CRESCENT",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "NORTHWOOD",
        "postal_code": "D09 V504",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8278265,
          "ingredient": {
            "id": 1790,
            "ingredient_code": 8178,
            "en_name": "SULFISOXAZOLE",
            "fr_name": "Sulfisoxazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8278264,
          "ingredient": {
            "id": 206,
            "ingredient_code": 8618,
            "en_name": "ERYTHROMYCIN",
            "fr_name": "Érythromycine (Stéarate d'érythromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00583405",
      "brand_name": "PEDIAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "60215",
      "number_of_ais": "2",
      "ai_group_no": "0252046001"
    },
    "created_date": "2017-07-19T15:11:37-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00583405",
    "company_name": "AMDIPHARM LIMITED",
    "atc_number": "J01RA",
    "atc_description": "COMBINATIONS OF ANTIBACTERIALS",
    "discontinuation_date": "2017-07-18T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-07-18T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-19T15:16:28-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PEDIAZOLE",
    "en_drug_common_name": "erythromycin ethylsuccinate and sulfisoxazole acetyl for oral suspension USP",
    "fr_drug_brand_name": "PEDIAZOLE",
    "fr_drug_common_name": "erythromycin ethylsuccinate and sulfisoxazole acetyl for oral suspension USP",
    "en_ingredients": "SULFISOXAZOLE\r\nERYTHROMYCIN",
    "fr_ingredients": "Sulfisoxazole\r\nÉrythromycine",
    "drug_strength": "600MG\r\n200MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "105 mL, 150 mL and 200 mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 16371,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11342,
      "drug_code": 67802,
      "updated_date": "2025-05-15T04:03:19-04:00",
      "company": {
        "id": 138,
        "created_date": "2017-03-09T13:22:35-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 13965,
        "mfr_code": "",
        "name": "AMDIPHARM LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "UNIT 17, NORTHWOOD HOUSE, NORTHWOOD CRESCENT",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "NORTHWOOD",
        "postal_code": "D09 V504",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8334177,
          "ingredient": {
            "id": 2484,
            "ingredient_code": 8504,
            "en_name": "FUSIDIC ACID",
            "fr_name": "Acide fusidique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02243861",
      "brand_name": "FUCITHALMIC",
      "brand_name_fr": "",
      "descriptor": "WITHOUT PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114230001"
    },
    "created_date": "2017-07-19T15:24:25-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02243861",
    "company_name": "AMDIPHARM LIMITED",
    "atc_number": "S01AA",
    "atc_description": "ANTIINFECTIVES",
    "discontinuation_date": "2017-07-18T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-07-18T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Fucithalmic in 5 gram tubes (DIN 02243862) will continue to be marketed.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-19T16:25:46-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "FUCITHALMIC",
    "en_drug_common_name": "Fusidic acid",
    "fr_drug_brand_name": "FUCITHALMIC",
    "fr_drug_common_name": "Fusidic acid",
    "en_ingredients": "FUSIDIC ACID",
    "fr_ingredients": "Acide fusidique",
    "drug_strength": "1%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "Unit Dose (0.2 g x 12)",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 16392,
    "drug": {
      "current_status": "MARKETED",
      "id": 10084,
      "drug_code": 64696,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8253832,
          "ingredient": {
            "id": 2740,
            "ingredient_code": 11923,
            "en_name": "TEMOZOLOMIDE",
            "fr_name": "Témozolomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02241093",
      "brand_name": "TEMODAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138781001"
    },
    "created_date": "2017-07-19T18:03:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241093",
    "company_name": "MERCK CANADA INC",
    "atc_number": "L01AX",
    "atc_description": "ALKYLATINGAGENTS",
    "anticipated_start_date": "2017-08-21T00:00:00-04:00",
    "estimated_end_date": "2017-08-29T00:00:00-04:00",
    "actual_start_date": "2017-08-17T00:00:00-04:00",
    "actual_end_date": "2017-08-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-08-23T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "available in 20 cap sachet.",
    "fr_comments": "disponibles en 20 cap sachet",
    "en_drug_brand_name": "TEMODAL",
    "en_drug_common_name": "temozolomide capsules",
    "fr_drug_brand_name": "capsules de témozolomide",
    "fr_drug_common_name": "Témozolomide",
    "en_ingredients": "TEMOZOLOMIDE",
    "fr_ingredients": "Témozolomide",
    "drug_strength": "5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "5 cap sachet",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 16413,
    "drug": {
      "current_status": "MARKETED",
      "id": 22202,
      "drug_code": 84581,
      "updated_date": "2025-12-03T00:31:42-05:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8257944,
          "ingredient": {
            "id": 3370,
            "ingredient_code": 20122,
            "en_name": "DASATINIB",
            "fr_name": "Dasatinib (Monohydrate de dasatinib)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02360810",
      "brand_name": "SPRYCEL",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152198005"
    },
    "created_date": "2017-07-19T18:48:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02360810",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "L01XE",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "anticipated_start_date": "2017-08-04T00:00:00-04:00",
    "estimated_end_date": "2017-08-04T00:00:00-04:00",
    "actual_end_date": "2017-08-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-08-02T20:53:22-04:00",
    "status": "avoided_shortage",
    "en_comments": "Product on allocation, other strengths are available.",
    "fr_comments": "Produit en allocation, les autres concentrations sont disponibles.",
    "en_drug_brand_name": "SPRYCEL",
    "en_drug_common_name": "dasatinib",
    "fr_drug_brand_name": "SPRYCEL",
    "fr_drug_common_name": "Dasatinib",
    "en_ingredients": "DASATINIB",
    "fr_ingredients": "Dasatinib (sous forme monohydratée)",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 BTL X 30",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 16425,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23116,
      "drug_code": 85695,
      "updated_date": "2025-05-15T04:19:14-04:00",
      "company": {
        "id": 1184,
        "created_date": "2017-03-09T13:23:54-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 11271,
        "mfr_code": "",
        "name": "RANBAXY PHARMACEUTICALS CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8350581,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02371820",
      "brand_name": "RAN-FINASTERIDE",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110001"
    },
    "created_date": "2017-07-19T19:07:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02371820",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_start_date": "2017-07-19T00:00:00-04:00",
    "actual_start_date": "2017-07-19T00:00:00-04:00",
    "actual_end_date": "2017-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-04T20:28:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-FINASTERIDE",
    "en_drug_common_name": "RAN-FINASTERIDE",
    "fr_drug_brand_name": "RAN-FINASTERIDE",
    "fr_drug_common_name": "RAN-FINASTERIDE",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 16431,
    "drug": {
      "current_status": "MARKETED",
      "id": 25324,
      "drug_code": 87804,
      "updated_date": "2025-12-03T00:32:06-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259178,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392801",
      "brand_name": "TARO-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121001"
    },
    "created_date": "2017-07-19T19:12:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392801",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-07-19T00:00:00-04:00",
    "estimated_end_date": "2017-12-01T00:00:00-05:00",
    "actual_start_date": "2017-07-19T00:00:00-04:00",
    "actual_end_date": "2018-08-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-15T14:28:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-PREGABALIN",
    "en_drug_common_name": "RAN-PREGABALIN",
    "fr_drug_brand_name": "RAN-PREGABALIN",
    "fr_drug_common_name": "RAN-PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16461,
    "drug": {
      "current_status": "MARKETED",
      "id": 29096,
      "drug_code": 91132,
      "updated_date": "2025-05-15T02:34:23-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8260558,
          "ingredient": {
            "id": 2586,
            "ingredient_code": 11787,
            "en_name": "CAPECITABINE",
            "fr_name": "Capécitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02426757",
      "brand_name": "ACH-CAPECITABINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134120001"
    },
    "created_date": "2017-07-19T20:21:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02426757",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2017-07-19T00:00:00-04:00",
    "actual_start_date": "2017-07-19T00:00:00-04:00",
    "actual_end_date": "2017-12-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-12-20T19:38:12-05:00",
    "status": "resolved",
    "en_comments": "Compliance issue     |  Problème de conformité",
    "fr_comments": "Compliance issue  |  Problème de conformité",
    "en_drug_brand_name": "ACH-CAPECITABINE",
    "en_drug_common_name": "CAPECITABINE",
    "fr_drug_brand_name": "ACH-CAPECITABINE",
    "fr_drug_common_name": "CAPECITABINE",
    "en_ingredients": "CAPECITABINE",
    "fr_ingredients": "Capécitabine",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60 Tabs Blister Pack/Box     |     60 comprimés en plaquette alvéolées /Boîte",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16466,
    "drug": {
      "current_status": "MARKETED",
      "id": 29098,
      "drug_code": 91133,
      "updated_date": "2025-05-15T02:34:23-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8260559,
          "ingredient": {
            "id": 2586,
            "ingredient_code": 11787,
            "en_name": "CAPECITABINE",
            "fr_name": "Capécitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02426765",
      "brand_name": "ACH-CAPECITABINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134120002"
    },
    "created_date": "2017-07-19T20:26:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02426765",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2017-07-19T00:00:00-04:00",
    "actual_start_date": "2017-07-19T00:00:00-04:00",
    "actual_end_date": "2017-12-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-12-20T19:38:52-05:00",
    "status": "resolved",
    "en_comments": "Compliance issue     |     Problème de conformité",
    "fr_comments": "Compliance issue     |     Problème de conformité",
    "en_drug_brand_name": "ACH-CAPECITABINE",
    "en_drug_common_name": "CAPECITABINE",
    "fr_drug_brand_name": "ACh-CAPECITABINE",
    "fr_drug_common_name": "CAPECITABINE",
    "en_ingredients": "CAPECITABINE",
    "fr_ingredients": "Capécitabine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "120 Tabs Blister Pack / Box     |     120 comprimés en plaquettes alvéolées / Boîte",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16495,
    "drug": {
      "current_status": "MARKETED",
      "id": 23380,
      "drug_code": 85980,
      "updated_date": "2025-05-15T02:33:03-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258442,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02374455",
      "brand_name": "FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116847001"
    },
    "created_date": "2017-07-19T21:08:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02374455",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2017-07-05T00:00:00-04:00",
    "actual_end_date": "2017-11-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-11-05T20:12:45-05:00",
    "status": "resolved",
    "en_comments": "Duplicate record",
    "fr_comments": "Entrée dupliquée",
    "en_drug_brand_name": "FLUOXETINE",
    "en_drug_common_name": "FLUOXETINE",
    "fr_drug_brand_name": "FLUOXETINE",
    "fr_drug_common_name": "FLUOXETINE",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "FLUOXETINE",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 16498,
    "drug": {
      "current_status": "MARKETED",
      "id": 12244,
      "drug_code": 70477,
      "updated_date": "2025-05-15T02:31:20-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254512,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246314",
      "brand_name": "GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929001"
    },
    "created_date": "2017-07-19T21:09:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246314",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-04-27T00:00:00-04:00",
    "actual_start_date": "2017-06-15T00:00:00-04:00",
    "actual_end_date": "2018-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-04-30T20:46:27-04:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement non disponible",
    "en_drug_brand_name": "GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 16501,
    "drug": {
      "current_status": "MARKETED",
      "id": 12244,
      "drug_code": 70477,
      "updated_date": "2025-05-15T02:31:20-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254512,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246314",
      "brand_name": "GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929001"
    },
    "created_date": "2017-07-19T21:10:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246314",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-04-27T00:00:00-04:00",
    "actual_start_date": "2017-06-15T00:00:00-04:00",
    "actual_end_date": "2018-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-04-30T20:44:46-04:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement non disponible",
    "en_drug_brand_name": "GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 16504,
    "drug": {
      "current_status": "MARKETED",
      "id": 12248,
      "drug_code": 70479,
      "updated_date": "2025-05-15T02:31:20-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254514,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246316",
      "brand_name": "GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929002"
    },
    "created_date": "2017-07-19T21:11:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246316",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "actual_start_date": "2017-07-17T00:00:00-04:00",
    "actual_end_date": "2017-08-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-08-10T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "400MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16507,
    "drug": {
      "current_status": "MARKETED",
      "id": 12248,
      "drug_code": 70479,
      "updated_date": "2025-05-15T02:31:20-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254514,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246316",
      "brand_name": "GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929002"
    },
    "created_date": "2017-07-19T21:12:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246316",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-04-27T00:00:00-04:00",
    "actual_start_date": "2017-07-17T00:00:00-04:00",
    "actual_end_date": "2018-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-04-30T20:45:06-04:00",
    "status": "resolved",
    "en_comments": "Temporarily unavailable",
    "fr_comments": "Temporairement non disponible",
    "en_drug_brand_name": "GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "400MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16534,
    "drug": {
      "current_status": "MARKETED",
      "id": 31130,
      "drug_code": 933,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 430,
        "created_date": "2017-03-09T13:22:46-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15812,
        "mfr_code": "",
        "name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ZIEGELHOF 24",
        "province": "MECKLENBURG - WEST POMERANIA",
        "country": "GERMANY",
        "city": "GREIFSWALD",
        "postal_code": "17489",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250214,
          "ingredient": {
            "id": 2422,
            "ingredient_code": 8493,
            "en_name": "AMPHOTERICIN B",
            "fr_name": "Amphotéricine b"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "00029149",
      "brand_name": "FUNGIZONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "32540",
      "number_of_ais": "1",
      "ai_group_no": "0105864001"
    },
    "created_date": "2017-07-20T13:53:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00029149",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "J02AA",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "anticipated_start_date": "2018-05-22T00:00:00-04:00",
    "estimated_end_date": "2019-05-22T00:00:00-04:00",
    "actual_start_date": "2018-04-20T00:00:00-04:00",
    "actual_end_date": "2019-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2019-05-23T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Product available",
    "fr_comments": "Produit disponible",
    "en_drug_brand_name": "FUNGIZONE INTRAVENOUS INJECTION 50MG",
    "en_drug_common_name": "Amphotericin B",
    "fr_drug_brand_name": "FUNGIZONE",
    "fr_drug_common_name": "Amphotéricine B",
    "en_ingredients": "AMPHOTERICIN B",
    "fr_ingredients": "Amphotéricine b",
    "drug_strength": "50MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "(1 VL) 15 ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 16538,
    "drug": {
      "current_status": "MARKETED",
      "id": 10012,
      "drug_code": 64428,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253812,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        },
        {
          "id": 8253811,
          "ingredient": {
            "id": 2000,
            "ingredient_code": 11282,
            "en_name": "SALMETEROL",
            "fr_name": "Salmétérol (Xinafoate de salmétérol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02240837",
      "brand_name": "ADVAIR 500 DISKUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0238341003"
    },
    "created_date": "2017-07-20T15:19:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240837",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03AK",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2017-08-14T00:00:00-04:00",
    "actual_start_date": "2017-07-17T00:00:00-04:00",
    "actual_end_date": "2017-08-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-08-04T13:49:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ADVAIR 500 DISKUS",
    "en_drug_common_name": "fluticasone propionate and salmeterol inhalation powder",
    "fr_drug_brand_name": "ADVAIR 500 DISKUS",
    "fr_drug_common_name": "propionate de fluticasone et salmétérol en poudre pour inhalation",
    "en_ingredients": "SALMETEROL\r\nFLUTICASONE PROPIONATE",
    "fr_ingredients": "Salmétérol,\r\nPropionate de fluticasone",
    "drug_strength": "50MCG\r\n500MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "1x28 doses",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 16543,
    "drug": {
      "current_status": "MARKETED",
      "id": 23026,
      "drug_code": 85612,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8258325,
          "ingredient": {
            "id": 3734,
            "ingredient_code": 20882,
            "en_name": "LINAGLIPTIN",
            "fr_name": "Linagliptine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02370921",
      "brand_name": "TRAJENTA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152946001"
    },
    "created_date": "2017-07-20T15:59:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02370921",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "A10BH",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2017-07-21T00:00:00-04:00",
    "estimated_end_date": "2017-07-31T00:00:00-04:00",
    "actual_end_date": "2017-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-01T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TRAJENTA",
    "en_drug_common_name": "Trajenta",
    "fr_drug_brand_name": "Trajenta",
    "fr_drug_common_name": "Trajenta",
    "en_ingredients": "LINAGLIPTIN",
    "fr_ingredients": "Linagliptine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 16549,
    "drug": {
      "current_status": "MARKETED",
      "id": 7618,
      "drug_code": 50436,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253355,
          "ingredient": {
            "id": 2000,
            "ingredient_code": 11282,
            "en_name": "SALMETEROL",
            "fr_name": "Salmétérol (Xinafoate de salmétérol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02231129",
      "brand_name": "SEREVENT DISKUS (50MCG/DOSE)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126960002"
    },
    "created_date": "2017-07-20T16:40:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231129",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03AC",
    "atc_description": "ADRENERGICS, INHALANTS",
    "anticipated_start_date": "2017-08-03T00:00:00-04:00",
    "estimated_end_date": "2017-08-04T00:00:00-04:00",
    "actual_end_date": "2017-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-08-02T18:14:53-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "SEREVENT DISKUS (50MCG/DOSE)",
    "en_drug_common_name": "salmeterol xinafoate dry powder for inhalation",
    "fr_drug_brand_name": "SEREVENT DISKUS",
    "fr_drug_common_name": "xinafoate de salmétérol en poudre sèche pour inhalation",
    "en_ingredients": "SALMETEROL",
    "fr_ingredients": "xinafoate de salmétérol",
    "drug_strength": "50MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "1x60 doses",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 16553,
    "drug": {
      "current_status": "MARKETED",
      "id": 7358,
      "drug_code": 49687,
      "updated_date": "2025-12-03T00:30:39-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253287,
          "ingredient": {
            "id": 36161,
            "ingredient_code": 23888,
            "en_name": "HEPATITIS A VIRUS, INACTIVATED",
            "fr_name": "Virus inactivé contre l'hépatite a, inactivé"
          },
          "ingredient_supplied_ind": "I",
          "strength": "720",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253286,
          "ingredient": {
            "id": 486,
            "ingredient_code": 7746,
            "en_name": "HEPATITIS B SURFACE ANTIGEN",
            "fr_name": "Antigène de surface du virus de l'hépatite b (recombiné)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02230578",
      "brand_name": "TWINRIX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0265323001"
    },
    "created_date": "2017-07-20T16:53:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230578",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07BC",
    "atc_description": "VIRAL VACCINES",
    "estimated_end_date": "2017-12-07T00:00:00-05:00",
    "actual_start_date": "2017-07-18T00:00:00-04:00",
    "actual_end_date": "2017-12-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-12-06T17:48:11-05:00",
    "status": "resolved",
    "en_comments": "Supply released July 10, 2017, August 9, 2017, October 3, 2017, and October 20, 2017 with limited quantity. Supply disruptions may be seen in the private market. Product under allocation.",
    "fr_comments": "Libération des stocks le 10 juillet 2017, 9 août 2017, 3 octobre 2017 et 20 octobre 2017 en quantités limitées. Des ruptures d’approvisionnement pourraient toucher le marché privé. Produit contingenté.",
    "en_drug_brand_name": "TWINRIX",
    "en_drug_common_name": "Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine",
    "fr_drug_brand_name": "TWINRIX",
    "fr_drug_common_name": "Vaccin bivalent contre l’hépatite A (inactivé) et l’hépatite B (recombinant)",
    "en_ingredients": "HEPATITIS A VACCINE, INACTIVATED\r\nHEPATITIS B SURFACE ANTIGEN",
    "fr_ingredients": "Vaccin contre l'hépatite a, inactive, \r\nAntigène de surface de l’hépatite B",
    "drug_strength": "720UNIT\r\n20MCG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "1's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16556,
    "drug": {
      "current_status": "MARKETED",
      "id": 10994,
      "drug_code": 66984,
      "updated_date": "2025-12-03T00:30:46-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8254133,
          "ingredient": {
            "id": 124,
            "ingredient_code": 2585,
            "en_name": "SALBUTAMOL",
            "fr_name": "Salbutamol (Sulfate de salbutamol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02243115",
      "brand_name": "VENTOLIN DISKUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108887005"
    },
    "created_date": "2017-07-20T17:02:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243115",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03AC",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2017-08-25T00:00:00-04:00",
    "actual_start_date": "2017-08-08T00:00:00-04:00",
    "actual_end_date": "2017-08-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-08-17T03:42:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VENTOLIN DISKUS",
    "en_drug_common_name": "salbutamol sulfate dry powder for inhalation",
    "fr_drug_brand_name": "VENTOLIN DISKUS",
    "fr_drug_common_name": "sulfate de salbutamol en poudre sèche pour inhalation",
    "en_ingredients": "SALBUTAMOL",
    "fr_ingredients": "sulfate de salbutamol",
    "drug_strength": "200MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "1x60 doses",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 16559,
    "drug": {
      "current_status": "MARKETED",
      "id": 19526,
      "drug_code": 80855,
      "updated_date": "2025-05-15T02:32:20-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256822,
          "ingredient": {
            "id": 3534,
            "ingredient_code": 20438,
            "en_name": "EPLERENONE",
            "fr_name": "Éplérénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02323052",
      "brand_name": "INSPRA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152537001"
    },
    "created_date": "2017-07-20T19:27:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02323052",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "C03DA",
    "atc_description": "POTASSIUM-SPARING AGENTS",
    "anticipated_start_date": "2017-07-20T00:00:00-04:00",
    "estimated_end_date": "2017-08-10T00:00:00-04:00",
    "actual_end_date": "2017-08-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-11T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Resolved August 10, 2017.\r\nProduct currently under allocation",
    "fr_comments": "Résolu 10 août, 2017.\r\nProduit présentement en allocation",
    "en_drug_brand_name": "INSPRA",
    "en_drug_common_name": "Inspra",
    "fr_drug_brand_name": "INSPRA",
    "fr_drug_common_name": "Inspra",
    "en_ingredients": "EPLERENONE",
    "fr_ingredients": "Éplérénone",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3 x 10 TABS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 16562,
    "drug": {
      "current_status": "MARKETED",
      "id": 11078,
      "drug_code": 67236,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8254163,
          "ingredient": {
            "id": 506,
            "ingredient_code": 309,
            "en_name": "IRON",
            "fr_name": "Fer (Complexe fer-dextran)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02243333",
      "brand_name": "FERRLECIT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108536035"
    },
    "created_date": "2017-07-20T19:58:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243333",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "B03",
    "atc_description": "IRON PREPARATIONS",
    "actual_start_date": "2017-07-17T00:00:00-04:00",
    "actual_end_date": "2017-07-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-07-21T12:19:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FERRLECIT",
    "en_drug_common_name": "Sodium Ferric Gluconate",
    "fr_drug_brand_name": "Ferrlecit 62.5mg/5ml vials",
    "fr_drug_common_name": "Sodium Ferric Gluconate",
    "en_ingredients": "IRON",
    "fr_ingredients": "Fer",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16581,
    "drug": {
      "current_status": "MARKETED",
      "id": 13218,
      "drug_code": 72766,
      "updated_date": "2025-05-15T02:31:29-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8254798,
          "ingredient": {
            "id": 3092,
            "ingredient_code": 13268,
            "en_name": "RASBURICASE",
            "fr_name": "Rasburicase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02248416",
      "brand_name": "FASTURTEC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149668001"
    },
    "created_date": "2017-07-21T12:36:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248416",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "V03AF",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2017-09-04T00:00:00-04:00",
    "actual_start_date": "2017-07-17T00:00:00-04:00",
    "actual_end_date": "2017-08-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-08-17T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "RESOLVED/RELEASED 2017-08-16",
    "fr_comments": "Délai d'approvisionnement avec le site de production",
    "en_drug_brand_name": "FASTURTEC",
    "en_drug_common_name": "Fasturtec 1.5mg vial powder plus 1.0mL solvent",
    "fr_drug_brand_name": "Fasturtec",
    "fr_drug_common_name": "Fasturtec 1.5mg de poudre en fiole plus 1.0mL de solvant",
    "en_ingredients": "RASBURICASE",
    "fr_ingredients": "Rasburicase",
    "drug_strength": "1.5MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "3 vials",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 16588,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23438,
      "drug_code": 86022,
      "updated_date": "2025-05-15T04:19:30-04:00",
      "company": {
        "id": 1184,
        "created_date": "2017-03-09T13:23:54-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 11271,
        "mfr_code": "",
        "name": "RANBAXY PHARMACEUTICALS CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8350834,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02374870",
      "brand_name": "RAN-OMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2017-07-21T14:00:30-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02374870",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "We have exhausted all remaining inventory.",
    "fr_supply_disruption_mitigation": "We have exhausted all remaining inventory.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-21T14:01:56-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "RAN-OMEPRAZOLE",
    "en_drug_common_name": "RAN-OMEPRAZOLE",
    "fr_drug_brand_name": "RAN-OMEPRAZOLE",
    "fr_drug_common_name": "RAN-OMEPRAZOLE",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 16591,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28476,
      "drug_code": 90599,
      "updated_date": "2025-12-03T01:32:10-05:00",
      "company": {
        "id": 1184,
        "created_date": "2017-03-09T13:23:54-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 11271,
        "mfr_code": "",
        "name": "RANBAXY PHARMACEUTICALS CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8354433,
          "ingredient": {
            "id": 3178,
            "ingredient_code": 13366,
            "en_name": "MEMANTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de mémantine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02421364",
      "brand_name": "RAN-MEMANTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150423001"
    },
    "created_date": "2017-07-21T14:04:27-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02421364",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N06DX",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-21T14:05:52-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "RAN-MEMANTINE",
    "en_drug_common_name": "RAN-MEMANTINE",
    "fr_drug_brand_name": "RAN-MEMANTINE",
    "fr_drug_common_name": "RAN-MEMANTINE",
    "en_ingredients": "MEMANTINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de mémantine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 16595,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21958,
      "drug_code": 84314,
      "updated_date": "2025-05-15T04:17:29-04:00",
      "company": {
        "id": 1184,
        "created_date": "2017-03-09T13:23:54-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 11271,
        "mfr_code": "",
        "name": "RANBAXY PHARMACEUTICALS CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8349410,
          "ingredient": {
            "id": 2350,
            "ingredient_code": 2071,
            "en_name": "NABILONE",
            "fr_name": "Nabilone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02358077",
      "brand_name": "RAN-NABILONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115009003"
    },
    "created_date": "2017-07-21T14:07:43-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02358077",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "A04AD",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-21T14:08:28-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "RAN-NABILONE",
    "en_drug_common_name": "RAN-NABILONE",
    "fr_drug_brand_name": "RAN-NABILONE",
    "fr_drug_common_name": "RAN-NABILONE",
    "en_ingredients": "NABILONE",
    "fr_ingredients": "Nabilone",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 16598,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21960,
      "drug_code": 84315,
      "updated_date": "2025-05-15T04:17:29-04:00",
      "company": {
        "id": 1184,
        "created_date": "2017-03-09T13:23:54-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 11271,
        "mfr_code": "",
        "name": "RANBAXY PHARMACEUTICALS CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8349411,
          "ingredient": {
            "id": 2350,
            "ingredient_code": 2071,
            "en_name": "NABILONE",
            "fr_name": "Nabilone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02358085",
      "brand_name": "RAN-NABILONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115009002"
    },
    "created_date": "2017-07-21T14:10:31-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02358085",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "A04AD",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-21T14:11:36-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "RAN-NABILONE",
    "en_drug_common_name": "RAN-NABILONE",
    "fr_drug_brand_name": "RAN-NABILONE",
    "fr_drug_common_name": "RAN-NABILONE",
    "en_ingredients": "NABILONE",
    "fr_ingredients": "Nabilone",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 16605,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21962,
      "drug_code": 84316,
      "updated_date": "2025-05-15T04:17:29-04:00",
      "company": {
        "id": 1184,
        "created_date": "2017-03-09T13:23:54-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 11271,
        "mfr_code": "",
        "name": "RANBAXY PHARMACEUTICALS CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8349412,
          "ingredient": {
            "id": 2350,
            "ingredient_code": 2071,
            "en_name": "NABILONE",
            "fr_name": "Nabilone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02358093",
      "brand_name": "RAN-NABILONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115009001"
    },
    "created_date": "2017-07-21T14:19:22-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02358093",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "A04AD",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "discontinuation_date": "2017-07-12T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-21T14:20:18-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "RAN-NABILONE",
    "en_drug_common_name": "RAN-NABILONE",
    "fr_drug_brand_name": "RAN-NABILONE",
    "fr_drug_common_name": "RAN-NABILONE",
    "en_ingredients": "NABILONE",
    "fr_ingredients": "Nabilone",
    "drug_strength": "1MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 16621,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21072,
      "drug_code": 83319,
      "updated_date": "2025-05-15T04:16:49-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8348672,
          "ingredient": {
            "id": 2292,
            "ingredient_code": 11081,
            "en_name": "ROPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de ropivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02347822",
      "brand_name": "ROPIVACAINE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "CHLORHYDRATE DE ROPIVACAÏNE INJECTABLE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133273003"
    },
    "created_date": "2017-07-21T17:33:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347822",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "actual_start_date": "2017-07-13T00:00:00-04:00",
    "actual_end_date": "2018-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-08T06:00:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ROPIVACAINE HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "Ropivacaine",
    "fr_drug_brand_name": "ROPIVACAINE HYDROCHLORIDE INJECTION USP",
    "fr_drug_common_name": "Ropivacaine",
    "en_ingredients": "ROPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de ropivacaïne",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nEPIDURAL",
    "drug_route_fr": "Bloc/Infiltration\r\nÉpidurale",
    "drug_package_quantity": "10x30mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 16626,
    "drug": {
      "current_status": "MARKETED",
      "id": 798,
      "drug_code": 1181,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250239,
          "ingredient": {
            "id": 162,
            "ingredient_code": 9547,
            "en_name": "MANNITOL",
            "fr_name": "Mannitol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00038024",
      "brand_name": "MANNITOL INJECTION USP",
      "brand_name_fr": "MANNITOL INJECTABLE USP",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "37024",
      "number_of_ais": "1",
      "ai_group_no": "0103277001"
    },
    "created_date": "2017-07-21T17:46:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00038024",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "B05BC",
    "atc_description": "I.V. SOLUTIONS",
    "actual_start_date": "2017-11-28T00:00:00-05:00",
    "actual_end_date": "2018-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-23T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MANNITOL 25%",
    "en_drug_common_name": "Mannitol",
    "fr_drug_brand_name": "MANNITOL 25%",
    "fr_drug_common_name": "Mannitol",
    "en_ingredients": "MANNITOL",
    "fr_ingredients": "Mannitol",
    "drug_strength": "250MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "25x50mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16633,
    "drug": {
      "current_status": "MARKETED",
      "id": 28510,
      "drug_code": 90629,
      "updated_date": "2025-05-15T02:34:15-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8260345,
          "ingredient": {
            "id": 1522,
            "ingredient_code": 1966,
            "en_name": "NIFEDIPINE",
            "fr_name": "Nifédipine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02421658",
      "brand_name": "NIFEDIPINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115253005"
    },
    "created_date": "2017-07-21T18:37:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02421658",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C08CA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "actual_start_date": "2017-07-20T00:00:00-04:00",
    "actual_end_date": "2017-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-10-05T15:48:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NIFEDIPINE ER",
    "en_drug_common_name": "NIFEDIPINE ER 60 MG",
    "fr_drug_brand_name": "NIFEDIPINE ER",
    "fr_drug_common_name": "NIFEDIPINE ER 60 MG",
    "en_ingredients": "NIFEDIPINE",
    "fr_ingredients": "Nifédipine",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30-100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16650,
    "drug": {
      "current_status": "MARKETED",
      "id": 30628,
      "drug_code": 9268,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251138,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00716626",
      "brand_name": "BETADERM CRM 0.1%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68220",
      "number_of_ais": "1",
      "ai_group_no": "0106299001"
    },
    "created_date": "2017-07-21T21:47:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00716626",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2018-03-30T00:00:00-04:00",
    "actual_start_date": "2018-02-22T00:00:00-05:00",
    "actual_end_date": "2018-03-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-29T16:48:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BETADERM CRM 0.1%",
    "en_drug_common_name": "BETADERM CRM 0.1%",
    "fr_drug_brand_name": "BETADERM CRM 0.1%",
    "fr_drug_common_name": "BETADERM CRM 0.1%",
    "en_ingredients": "BETAMETHASONE VALERATE",
    "fr_ingredients": "Valérate de bétaméthasone",
    "drug_strength": ".1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "454G",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16680,
    "drug": {
      "current_status": "MARKETED",
      "id": 16168,
      "drug_code": 76960,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255768,
          "ingredient": {
            "id": 970,
            "ingredient_code": 2155,
            "en_name": "DESMOPRESSIN ACETATE",
            "fr_name": "Acétate de desmopressine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02284030",
      "brand_name": "APO-DESMOPRESSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112050005"
    },
    "created_date": "2017-07-24T13:11:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02284030",
    "company_name": "APOTEX INC",
    "atc_number": "H01BA",
    "atc_description": "POSTERIOR PITUITARY LOBE HORMONES",
    "estimated_end_date": "2018-01-10T00:00:00-05:00",
    "actual_start_date": "2017-07-24T00:00:00-04:00",
    "actual_end_date": "2017-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-20T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DESMOPRESSIN",
    "en_drug_common_name": "DESMOPRESSIN",
    "fr_drug_brand_name": "APO-DESMOPRESSIN",
    "fr_drug_common_name": "DESMOPRESSIN",
    "en_ingredients": "DESMOPRESSIN ACETATE",
    "fr_ingredients": "Acétate de desmopressine",
    "drug_strength": "0.1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16683,
    "drug": {
      "current_status": "MARKETED",
      "id": 16170,
      "drug_code": 76961,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255769,
          "ingredient": {
            "id": 970,
            "ingredient_code": 2155,
            "en_name": "DESMOPRESSIN ACETATE",
            "fr_name": "Acétate de desmopressine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02284049",
      "brand_name": "APO-DESMOPRESSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112050003"
    },
    "created_date": "2017-07-24T13:13:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02284049",
    "company_name": "APOTEX INC",
    "atc_number": "H01BA",
    "atc_description": "POSTERIOR PITUITARY LOBE HORMONES",
    "estimated_end_date": "2018-07-06T00:00:00-04:00",
    "actual_start_date": "2017-07-24T00:00:00-04:00",
    "actual_end_date": "2018-08-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-15T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DESMOPRESSIN",
    "en_drug_common_name": "DESMOPRESSIN",
    "fr_drug_brand_name": "APO-DESMOPRESSIN",
    "fr_drug_common_name": "DESMOPRESSIN",
    "en_ingredients": "DESMOPRESSIN ACETATE",
    "fr_ingredients": "Acétate de desmopressine",
    "drug_strength": "0.2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16716,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14358,
      "drug_code": 74534,
      "updated_date": "2025-05-15T04:09:32-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8340564,
          "ingredient": {
            "id": 2528,
            "ingredient_code": 11707,
            "en_name": "ANAGRELIDE",
            "fr_name": "Anagrélide (Chlorhydrate d'anagrélide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02260107",
      "brand_name": "SANDOZ ANAGRELIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131875001"
    },
    "created_date": "2017-07-24T14:40:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02260107",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L01XX",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "estimated_end_date": "2017-08-21T00:00:00-04:00",
    "actual_start_date": "2017-07-21T00:00:00-04:00",
    "actual_end_date": "2017-08-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-09-06T20:36:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ANAGRELIDE",
    "en_drug_common_name": "ANAGRELIDE",
    "fr_drug_brand_name": "ANAGRELIDE",
    "fr_drug_common_name": "ANAGRELIDE",
    "en_ingredients": "ANAGRELIDE",
    "fr_ingredients": "ANAGRELIDE",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 16719,
    "drug": {
      "current_status": "MARKETED",
      "id": 24612,
      "drug_code": 87202,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258890,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386437",
      "brand_name": "SANDOZ ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434003"
    },
    "created_date": "2017-07-24T14:56:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386437",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2017-11-27T00:00:00-05:00",
    "actual_start_date": "2017-07-28T00:00:00-04:00",
    "actual_end_date": "2017-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-11-28T02:45:33-05:00",
    "status": "resolved",
    "en_comments": "Stock available at some wholesalers/Inventaire disponible chez certains grossistes",
    "fr_comments": "Stock available at some wholesalers/Inventaire disponible chez certains grossistes",
    "en_drug_brand_name": "SANDOZ ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "ATOMOXETINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16722,
    "drug": {
      "current_status": "MARKETED",
      "id": 24614,
      "drug_code": 87203,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258891,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386445",
      "brand_name": "SANDOZ ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434004"
    },
    "created_date": "2017-07-24T14:57:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386445",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2018-02-05T00:00:00-05:00",
    "actual_start_date": "2017-07-28T00:00:00-04:00",
    "actual_end_date": "2018-01-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-02-05T23:41:37-05:00",
    "status": "resolved",
    "en_comments": "Stock available at some wholesalers/Inventaire disponible chez certains grossistes",
    "fr_comments": "Stock available at some wholesalers/Inventaire disponible chez certains grossistes",
    "en_drug_brand_name": "SANDOZ ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "ATOMOXETINE",
    "drug_strength": "40MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16728,
    "drug": {
      "current_status": "MARKETED",
      "id": 24616,
      "drug_code": 87204,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258892,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386453",
      "brand_name": "SANDOZ ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434005"
    },
    "created_date": "2017-07-24T15:34:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386453",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2018-05-04T00:00:00-04:00",
    "actual_start_date": "2017-07-28T00:00:00-04:00",
    "actual_end_date": "2018-04-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-05-03T21:08:13-04:00",
    "status": "resolved",
    "en_comments": "Stock available at some wholesalers/Inventaire disponible chez certains grossistes",
    "fr_comments": "Stock available at some wholesalers/Inventaire disponible chez certains grossistes",
    "en_drug_brand_name": "SANDOZ ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "ATOMOXETINE",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16731,
    "drug": {
      "current_status": "MARKETED",
      "id": 24618,
      "drug_code": 87205,
      "updated_date": "2025-05-15T02:33:27-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258893,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02386461",
      "brand_name": "SANDOZ ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434006"
    },
    "created_date": "2017-07-24T15:35:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386461",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2018-02-05T00:00:00-05:00",
    "actual_start_date": "2017-07-28T00:00:00-04:00",
    "actual_end_date": "2018-01-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2018-02-05T23:42:07-05:00",
    "status": "resolved",
    "en_comments": "Stock available at some wholesalers/Inventaire disponible chez certains grossistes",
    "fr_comments": "Stock available at some wholesalers/Inventaire disponible chez certains grossistes",
    "en_drug_brand_name": "SANDOZ ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "ATOMOXETINE",
    "drug_strength": "80MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16736,
    "drug": {
      "current_status": "MARKETED",
      "id": 17492,
      "drug_code": 78531,
      "updated_date": "2025-05-15T02:32:00-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256167,
          "ingredient": {
            "id": 272,
            "ingredient_code": 20170,
            "en_name": "ENALAPRIL SODIUM",
            "fr_name": "Énalapril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02299976",
      "brand_name": "SANDOZ ENALAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152325003"
    },
    "created_date": "2017-07-24T16:35:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299976",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2017-08-28T00:00:00-04:00",
    "actual_start_date": "2017-07-21T00:00:00-04:00",
    "actual_end_date": "2017-08-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-09-06T20:35:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ENALAPRIL",
    "en_drug_common_name": "ENALAPRIL",
    "fr_drug_brand_name": "ENALAPRIL",
    "fr_drug_common_name": "ENALAPRIL",
    "en_ingredients": "ENALAPRIL SODIUM",
    "fr_ingredients": "Énalapril sodique",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 16739,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 16528,
      "drug_code": 77344,
      "updated_date": "2025-05-15T04:11:48-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8343394,
          "ingredient": {
            "id": 2190,
            "ingredient_code": 1381,
            "en_name": "FENOFIBRATE",
            "fr_name": "Fénofibrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02288052",
      "brand_name": "SANDOZ FENOFIBRATE S",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118895004"
    },
    "created_date": "2017-07-24T16:36:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02288052",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AB",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-09-18T00:00:00-04:00",
    "actual_start_date": "2017-07-21T00:00:00-04:00",
    "actual_end_date": "2017-08-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-09-06T20:33:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ FENOFIBRATE S",
    "en_drug_common_name": "FENOFIBRATE",
    "fr_drug_brand_name": "FENOFIBRATE",
    "fr_drug_common_name": "FENOFIBRATE",
    "en_ingredients": "FENOFIBRATE",
    "fr_ingredients": "Fénofibrate",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 16744,
    "drug": {
      "current_status": "MARKETED",
      "id": 30536,
      "drug_code": 92570,
      "updated_date": "2025-05-15T02:34:48-04:00",
      "company": {
        "id": 1930,
        "created_date": "2017-03-09T13:26:25-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 16088,
        "mfr_code": "",
        "name": "LUPIN PHARMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "550-1111 RUE ST-CHARLES OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LONGUEUIL",
        "postal_code": "J4K 5G4",
        "post_office_box": "",
        "contact_information": "lupin@lsu3pl.ca (Customer service / Service à la clientèle)"
      },
      "drug_ingredients": [
        {
          "id": 8261204,
          "ingredient": {
            "id": 748,
            "ingredient_code": 7500,
            "en_name": "NORETHINDRONE",
            "fr_name": "Noréthindrone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.35",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02441306",
      "brand_name": "JENCYCLA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106372001"
    },
    "created_date": "2017-07-24T16:37:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02441306",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G03AC",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "estimated_end_date": "2017-10-27T00:00:00-04:00",
    "actual_start_date": "2017-07-07T00:00:00-04:00",
    "actual_end_date": "2017-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-28T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JENCYCLA",
    "en_drug_common_name": "JENCYCLA",
    "fr_drug_brand_name": "JENCYCLA",
    "fr_drug_common_name": "JENCYCLA",
    "en_ingredients": "NORETHINDRONE",
    "fr_ingredients": "Noréthindrone",
    "drug_strength": "0.35MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 16747,
    "drug": {
      "current_status": "MARKETED",
      "id": 20068,
      "drug_code": 81411,
      "updated_date": "2025-05-15T02:32:27-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257068,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02328593",
      "brand_name": "SANDOZ MONTELUKAST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823002"
    },
    "created_date": "2017-07-24T16:39:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02328593",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "R03DC",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "estimated_end_date": "2017-08-07T00:00:00-04:00",
    "actual_start_date": "2017-07-21T00:00:00-04:00",
    "actual_end_date": "2017-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2017-09-06T20:33:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ MONTELUKAST TABLET",
    "en_drug_common_name": "MONTELUKAST",
    "fr_drug_brand_name": "MONTELUKAST",
    "fr_drug_common_name": "MONTELUKAST",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "MONTELUKAST",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 16750,
    "drug": {
      "current_status": "MARKETED",
      "id": 50626,
      "drug_code": 92811,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8261322,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443422",
      "brand_name": "SANDOZ OLMESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152496003"
    },
    "created_date": "2017-07-24T16:41:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443422",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2017-08-14T00:00:00-04:00",
    "actual_start_date": "2017-07-14T00:00:00-04:00",
    "actual_end_date": "2017-09-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-09-06T20:30:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ OLMESARTAN",
    "en_drug_common_name": "OLMESARTAN",
    "fr_drug_brand_name": "OLMESARTAN",
    "fr_drug_common_name": "OLMESARTAN",
    "en_ingredients": "OLMESARTAN MEDOXOMIL",
    "fr_ingredients": "OLMESARTAN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 16757,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 29600,
      "drug_code": 91630,
      "updated_date": "2025-05-15T04:22:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8355219,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02431823",
      "brand_name": "SANDOZ TOPIRAMATE TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938006"
    },
    "created_date": "2017-07-24T16:46:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02431823",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-11-09T00:00:00-05:00",
    "actual_start_date": "2017-07-21T00:00:00-04:00",
    "actual_end_date": "2018-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-11-13T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TOPIRAMATE TABLETS",
    "en_drug_common_name": "TOPIRAMATE",
    "fr_drug_brand_name": "TOPIRAMATE",
    "fr_drug_common_name": "TOPIRAMATE",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16762,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9818,
      "drug_code": 63892,
      "updated_date": "2025-05-15T03:59:38-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8329433,
          "ingredient": {
            "id": 2702,
            "ingredient_code": 11891,
            "en_name": "EPTIFIBATIDE",
            "fr_name": "Eptifibatide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02240351",
      "brand_name": "INTEGRILIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137621001"
    },
    "created_date": "2017-07-24T17:09:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240351",
    "company_name": "MERCK CANADA INC",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2017-08-21T00:00:00-04:00",
    "estimated_end_date": "2017-08-31T00:00:00-04:00",
    "actual_end_date": "2017-08-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-08-14T16:42:04-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "INTEGRILIN",
    "en_drug_common_name": "Eptifibatide Injection",
    "fr_drug_brand_name": "INTEGRILIN",
    "fr_drug_common_name": "eptifibatide injectable",
    "en_ingredients": "EPTIFIBATIDE",
    "fr_ingredients": "Eptifibatide",
    "drug_strength": "0.75MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "100ML VIAL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 16777,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 524,
      "drug_code": 11102,
      "updated_date": "2025-05-15T03:37:32-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8287516,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00839396",
      "brand_name": "PRINIVIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71369",
      "number_of_ais": "1",
      "ai_group_no": "0121550001"
    },
    "created_date": "2017-07-24T19:43:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00839396",
    "company_name": "MERCK CANADA INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2017-07-31T00:00:00-04:00",
    "estimated_end_date": "2017-08-18T00:00:00-04:00",
    "actual_start_date": "2017-08-03T00:00:00-04:00",
    "actual_end_date": "2017-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-08-16T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PRINIVIL",
    "en_drug_common_name": "lisinopril tablets",
    "fr_drug_brand_name": "PRINIVIL",
    "fr_drug_common_name": "comprimés de lisinopril",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 16782,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1922,
      "drug_code": 14082,
      "updated_date": "2025-05-15T03:40:14-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8292805,
          "ingredient": {
            "id": 452,
            "ingredient_code": 4068,
            "en_name": "LEVODOPA",
            "fr_name": "Lévodopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8292804,
          "ingredient": {
            "id": 450,
            "ingredient_code": 2370,
            "en_name": "CARBIDOPA",
            "fr_name": "Carbidopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02028786",
      "brand_name": "SINEMET CR 100/25",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75589",
      "number_of_ais": "2",
      "ai_group_no": "0210315003"
    },
    "created_date": "2017-07-24T19:47:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02028786",
    "company_name": "MERCK CANADA INC",
    "atc_number": "N04BA",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2017-08-07T00:00:00-04:00",
    "estimated_end_date": "2017-08-28T00:00:00-04:00",
    "actual_start_date": "2017-08-04T00:00:00-04:00",
    "actual_end_date": "2017-08-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-08-29T05:00:06-04:00",
    "status": "resolved",
    "en_comments": "shortage due to delays at packaging facility",
    "fr_comments": "Rupture d'inventaire causée par des retards au niveau du site d'emballage",
    "en_drug_brand_name": "SINEMET CR 100/25",
    "en_drug_common_name": "levodopa and carbidopa controlled release tablets",
    "fr_drug_brand_name": "SINEMET CR 100/25",
    "fr_drug_common_name": "comprimés de lévodopa et de carbidopa à libération prolongée",
    "en_ingredients": "CARBIDOPA\r\nLEVODOPA",
    "fr_ingredients": "Carbidopa\r\nLévodopa",
    "drug_strength": "25MG\r\n100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 16790,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 686,
      "drug_code": 11481,
      "updated_date": "2025-05-15T03:38:06-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8288209,
          "ingredient": {
            "id": 450,
            "ingredient_code": 2370,
            "en_name": "CARBIDOPA",
            "fr_name": "Carbidopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8288208,
          "ingredient": {
            "id": 452,
            "ingredient_code": 4068,
            "en_name": "LEVODOPA",
            "fr_name": "Lévodopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00870935",
      "brand_name": "SINEMET CR 200/50",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72185",
      "number_of_ais": "2",
      "ai_group_no": "0210315004"
    },
    "created_date": "2017-07-24T19:51:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00870935",
    "company_name": "MERCK CANADA INC",
    "atc_number": "N04BA",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2017-08-28T00:00:00-04:00",
    "actual_start_date": "2017-08-02T00:00:00-04:00",
    "actual_end_date": "2017-08-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-08-29T05:00:06-04:00",
    "status": "resolved",
    "en_comments": "Shortage due to delays at packaging facility",
    "fr_comments": "Rupture d'inventaire causée par des retards au niveau du site d'emballage",
    "en_drug_brand_name": "SINEMET CR 200/50",
    "en_drug_common_name": "levodopa and carbidopa controlledrelease tablets",
    "fr_drug_brand_name": "SINEMET CR 200/50",
    "fr_drug_common_name": "comprimés de lévodopa et de carbidopa à libération prolongée",
    "en_ingredients": "CARBIDOPA\r\nLEVODOPA",
    "fr_ingredients": "Carbidopa\r\nLévodopa",
    "drug_strength": "50MG\r\n200MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 16797,
    "drug": {
      "current_status": "MARKETED",
      "id": 5390,
      "drug_code": 354,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8250146,
          "ingredient": {
            "id": 1168,
            "ingredient_code": 7606,
            "en_name": "BETAMETHASONE ACETATE",
            "fr_name": "Acétate de bétaméthasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250145,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00028096",
      "brand_name": "CELESTONE SOLUSPAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "14400",
      "number_of_ais": "2",
      "ai_group_no": "0206301001"
    },
    "created_date": "2017-07-24T19:52:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00028096",
    "company_name": "MERCK CANADA INC",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "anticipated_start_date": "2017-09-13T00:00:00-04:00",
    "estimated_end_date": "2017-09-29T00:00:00-04:00",
    "actual_start_date": "2017-09-15T00:00:00-04:00",
    "actual_end_date": "2017-09-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-09-29T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CELESTONE SOLUSPAN",
    "en_drug_common_name": "BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE SUSPENSION USP GLUCOCORTICOID",
    "fr_drug_brand_name": "CELESTONE SOLUSPAN",
    "fr_drug_common_name": "PHOSPHATE SODIQUE DE BÉTAMÉTHASONE ET D’ACÉTATE DE BÉTAMÉTHASONE EN SUSPENSION USP GLUCOCORTICOÏDE",
    "en_ingredients": "BETAMETHASONE ACETATE\r\nBETAMETHASONE",
    "fr_ingredients": "Acétate de bétaméthasone\r\nBétaméthasone",
    "drug_strength": "3MG\r\n3MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRA-ARTICULAR\r\nINTRABURSAL\r\nINTRADERMAL\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intra-articulaire\r\nIntrabursique\r\nIntradermique\r\nIntramusculaire",
    "drug_package_quantity": "1mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 16832,
    "drug": {
      "current_status": "MARKETED",
      "id": 22386,
      "drug_code": 84775,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8258019,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258018,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362759",
      "brand_name": "MYLAN-AMLODIPINE/ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251555001"
    },
    "created_date": "2017-07-24T21:20:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362759",
    "company_name": "GENMED A DIVISION OF PFIZER CANADA INC",
    "atc_number": "C10BX",
    "atc_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
    "anticipated_start_date": "2017-07-19T00:00:00-04:00",
    "estimated_end_date": "2017-08-03T00:00:00-04:00",
    "actual_end_date": "2017-08-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-08-04T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Resolved August 3, 2017",
    "fr_comments": "Résolu 3 août 2017",
    "en_drug_brand_name": "GD-AMLODIPINE/ATORVASTATIN",
    "en_drug_common_name": "GD-Amlodipine/Atorvastatin",
    "fr_drug_brand_name": "GD-AMLODIPINE/ATORVASTATIN",
    "fr_drug_common_name": "GD-AMLODIPINE/ATORVASTATIN",
    "en_ingredients": "AMLODIPINE\r\nATORVASTATIN",
    "fr_ingredients": "AMLODIPINE  ATORVASTATIN",
    "drug_strength": "5MG\r\n10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90s",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 16853,
    "drug": {
      "current_status": "MARKETED",
      "id": 16708,
      "drug_code": 77653,
      "updated_date": "2025-05-15T02:31:53-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255914,
          "ingredient": {
            "id": 958,
            "ingredient_code": 951,
            "en_name": "CILAZAPRIL",
            "fr_name": "Cilazapril (Monohydrate de Cilazapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02291150",
      "brand_name": "APO-CILAZAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122806002"
    },
    "created_date": "2017-07-25T12:43:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02291150",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2017-08-18T00:00:00-04:00",
    "actual_start_date": "2017-07-24T00:00:00-04:00",
    "actual_end_date": "2017-08-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-15T15:01:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CILAZAPRIL",
    "en_drug_common_name": "CILAZAPRIL",
    "fr_drug_brand_name": "APO-CILAZAPRIL",
    "fr_drug_common_name": "CILAZAPRIL",
    "en_ingredients": "CILAZAPRIL",
    "fr_ingredients": "Cilazapril",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 16856,
    "drug": {
      "current_status": "DORMANT",
      "id": 30512,
      "drug_code": 92539,
      "updated_date": "2025-05-15T06:55:55-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369295,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02441020",
      "brand_name": "APO-DICLOFENAC OPHTHALMIC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114417004"
    },
    "created_date": "2017-07-25T12:45:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02441020",
    "company_name": "APOTEX INC",
    "atc_number": "S01BC",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2017-08-28T00:00:00-04:00",
    "actual_start_date": "2017-07-24T00:00:00-04:00",
    "actual_end_date": "2017-09-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-22T11:47:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DICLOFENAC OPHTHALMIC",
    "en_drug_common_name": "DICLOFENAC",
    "fr_drug_brand_name": "APO-DICLOFENAC OPHTHALMIC",
    "fr_drug_common_name": "DICLOFENAC",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "0.1%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "10 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 16861,
    "drug": {
      "current_status": "MARKETED",
      "id": 17030,
      "drug_code": 78058,
      "updated_date": "2025-05-15T02:31:56-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256006,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295261",
      "brand_name": "APO-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055001"
    },
    "created_date": "2017-07-25T12:58:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295261",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-08-31T00:00:00-04:00",
    "actual_start_date": "2017-07-24T00:00:00-04:00",
    "actual_end_date": "2017-09-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-22T11:45:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "APO-ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 16867,
    "drug": {
      "current_status": "MARKETED",
      "id": 6608,
      "drug_code": 43813,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253111,
          "ingredient": {
            "id": 824,
            "ingredient_code": 1840,
            "en_name": "DOMPERIDONE",
            "fr_name": "Dompéridone (Maléate de dompéridone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02103613",
      "brand_name": "APO-DOMPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "S9806",
      "number_of_ais": "1",
      "ai_group_no": "0116957001"
    },
    "created_date": "2017-07-25T13:01:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02103613",
    "company_name": "APOTEX INC",
    "atc_number": "A03FA",
    "atc_description": "PROPULSIVES",
    "estimated_end_date": "2017-08-10T00:00:00-04:00",
    "actual_start_date": "2017-07-24T00:00:00-04:00",
    "actual_end_date": "2017-08-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-08T17:20:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DOMPERIDONE - TAB 10MG",
    "en_drug_common_name": "DOMPERIDONE",
    "fr_drug_brand_name": "APO-DOMPERIDONE - TAB 10MG",
    "fr_drug_common_name": "DOMPERIDONE",
    "en_ingredients": "DOMPERIDONE",
    "fr_ingredients": "DOMPERIDONE",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 16871,
    "drug": {
      "current_status": "MARKETED",
      "id": 15290,
      "drug_code": 75834,
      "updated_date": "2025-05-15T02:31:42-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255461,
          "ingredient": {
            "id": 1284,
            "ingredient_code": 1298,
            "en_name": "ISOSORBIDE-5-MONONITRATE",
            "fr_name": "5-mononitrate d'isosorbide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02272830",
      "brand_name": "APO-ISMN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0120456002"
    },
    "created_date": "2017-07-25T13:03:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02272830",
    "company_name": "APOTEX INC",
    "atc_number": "C01DA",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "estimated_end_date": "2018-03-19T00:00:00-04:00",
    "actual_start_date": "2018-01-12T00:00:00-05:00",
    "actual_end_date": "2018-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-23T16:04:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ISMN",
    "en_drug_common_name": "ISMN",
    "fr_drug_brand_name": "APO-ISMN",
    "fr_drug_common_name": "ISMN",
    "en_ingredients": "ISOSORBIDE-5-MONONITRATE",
    "fr_ingredients": "5-mononitrate d'isosorbide",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16874,
    "drug": {
      "current_status": "MARKETED",
      "id": 15290,
      "drug_code": 75834,
      "updated_date": "2025-05-15T02:31:42-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255461,
          "ingredient": {
            "id": 1284,
            "ingredient_code": 1298,
            "en_name": "ISOSORBIDE-5-MONONITRATE",
            "fr_name": "5-mononitrate d'isosorbide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02272830",
      "brand_name": "APO-ISMN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0120456002"
    },
    "created_date": "2017-07-25T13:03:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02272830",
    "company_name": "APOTEX INC",
    "atc_number": "C01DA",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "estimated_end_date": "2017-09-29T00:00:00-04:00",
    "actual_start_date": "2017-07-24T00:00:00-04:00",
    "actual_end_date": "2017-09-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-09-25T15:02:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ISMN",
    "en_drug_common_name": "ISMN",
    "fr_drug_brand_name": "APO-ISMN",
    "fr_drug_common_name": "ISMN",
    "en_ingredients": "ISOSORBIDE-5-MONONITRATE",
    "fr_ingredients": "5-mononitrate d'isosorbide",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 16879,
    "drug": {
      "current_status": "MARKETED",
      "id": 8016,
      "drug_code": 5222,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250723,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00592277",
      "brand_name": "APO-NAPROXEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "60000",
      "number_of_ais": "1",
      "ai_group_no": "0109634003"
    },
    "created_date": "2017-07-25T13:05:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00592277",
    "company_name": "APOTEX INC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2017-08-11T00:00:00-04:00",
    "actual_start_date": "2017-07-24T00:00:00-04:00",
    "actual_end_date": "2017-08-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-22T11:42:21-04:00",
    "status": "resolved",
    "en_comments": "100 BTL available",
    "en_drug_brand_name": "APO NAPROXEN TAB 500MG",
    "en_drug_common_name": "NAPROXEN",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 16881,
    "drug": {
      "current_status": "MARKETED",
      "id": 8016,
      "drug_code": 5222,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250723,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00592277",
      "brand_name": "APO-NAPROXEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "60000",
      "number_of_ais": "1",
      "ai_group_no": "0109634003"
    },
    "created_date": "2017-07-25T13:05:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00592277",
    "company_name": "APOTEX INC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_start_date": "2017-12-18T00:00:00-05:00",
    "actual_end_date": "2017-11-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-09T15:43:13-05:00",
    "status": "avoided_shortage",
    "en_comments": "100 BTL available",
    "fr_comments": "100 BTL disponible",
    "en_drug_brand_name": "APO NAPROXEN TAB 500MG",
    "en_drug_common_name": "NAPROXEN",
    "fr_drug_brand_name": "APO NAPROXEN TAB 500MG",
    "fr_drug_common_name": "NAPROXEN",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16886,
    "drug": {
      "current_status": "DORMANT",
      "id": 20288,
      "drug_code": 81738,
      "updated_date": "2025-05-15T06:55:40-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368358,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02331683",
      "brand_name": "APO-VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294002"
    },
    "created_date": "2017-07-25T13:07:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02331683",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-03-23T00:00:00-04:00",
    "actual_start_date": "2017-07-24T00:00:00-04:00",
    "actual_end_date": "2018-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-08T15:22:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-VENLAFAXINE XR",
    "en_drug_common_name": "VENLAFAXINE",
    "fr_drug_brand_name": "APO-VENLAFAXINE XR",
    "fr_drug_common_name": "VENLAFAXINE",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "VENLAFAXINE",
    "drug_strength": "37.5MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16895,
    "drug": {
      "current_status": "DORMANT",
      "id": 50646,
      "drug_code": 94018,
      "updated_date": "2025-12-03T02:32:39-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369391,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8369390,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02453622",
      "brand_name": "APO-OLMESARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252502003"
    },
    "created_date": "2017-07-25T13:11:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453622",
    "company_name": "APOTEX INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2017-12-29T00:00:00-05:00",
    "actual_start_date": "2017-07-21T00:00:00-04:00",
    "actual_end_date": "2017-11-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-17T13:37:53-05:00",
    "status": "resolved",
    "en_comments": "100 BTL  is available",
    "fr_comments": "100 BTL disponible",
    "en_drug_brand_name": "APO-OLMESARTAN/HCTZ",
    "en_drug_common_name": "OLMESARTAN-HCTZ",
    "fr_drug_brand_name": "APO-OLMESARTAN/HCTZ",
    "fr_drug_common_name": "OLMESARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nOLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "25MG\r\n40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16900,
    "drug": {
      "current_status": "DORMANT",
      "id": 51251,
      "drug_code": 94016,
      "updated_date": "2025-12-03T02:32:39-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369387,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8369386,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02453606",
      "brand_name": "APO-OLMESARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252502001"
    },
    "created_date": "2017-07-25T13:13:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453606",
    "company_name": "APOTEX INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2018-04-30T00:00:00-04:00",
    "actual_start_date": "2017-12-11T00:00:00-05:00",
    "actual_end_date": "2018-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-23T11:54:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLMESARTAN/HCTZ",
    "en_drug_common_name": "OLMESARTAN-HCTZ",
    "fr_drug_brand_name": "APO-OLMESARTAN/HCTZ",
    "fr_drug_common_name": "OLMESARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nOLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "12.5MG\r\n20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16905,
    "drug": {
      "current_status": "DORMANT",
      "id": 50644,
      "drug_code": 94017,
      "updated_date": "2025-12-03T02:32:39-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369389,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8369388,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02453614",
      "brand_name": "APO-OLMESARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252502002"
    },
    "created_date": "2017-07-25T13:14:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453614",
    "company_name": "APOTEX INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2018-04-30T00:00:00-04:00",
    "actual_start_date": "2017-12-18T00:00:00-05:00",
    "actual_end_date": "2018-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-23T11:55:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLMESARTAN/HCTZ",
    "en_drug_common_name": "OLMESARTAN-HCTZ",
    "fr_drug_brand_name": "APO-OLMESARTAN/HCTZ",
    "fr_drug_common_name": "OLMESARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nOLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "12.5MG\r\n40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16912,
    "drug": {
      "current_status": "MARKETED",
      "id": 22630,
      "drug_code": 85157,
      "updated_date": "2025-12-03T00:31:47-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258150,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02366746",
      "brand_name": "APO-OXYCODONE CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107552003"
    },
    "created_date": "2017-07-25T13:16:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02366746",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2017-09-29T00:00:00-04:00",
    "actual_start_date": "2017-07-21T00:00:00-04:00",
    "actual_end_date": "2017-09-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-03T13:19:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OXYCODONE CR",
    "en_drug_common_name": "OXYCODONE",
    "fr_drug_brand_name": "APO-OXYCODONE CR",
    "fr_drug_common_name": "OXYCODONE",
    "en_ingredients": "OXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'oxycodone",
    "drug_strength": "5.0MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 16931,
    "drug": {
      "current_status": "MARKETED",
      "id": 20002,
      "drug_code": 81335,
      "updated_date": "2025-05-15T02:32:26-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257040,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02327856",
      "brand_name": "APO-HYDROCHLOROTHIAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101048004"
    },
    "created_date": "2017-07-25T13:32:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327856",
    "company_name": "APOTEX INC",
    "atc_number": "C03AA",
    "atc_description": "LOW-CEILING DIURETICS, THIAZIDES",
    "estimated_end_date": "2017-09-29T00:00:00-04:00",
    "actual_start_date": "2017-07-17T00:00:00-04:00",
    "actual_end_date": "2017-09-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-15T19:02:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-HYDRO",
    "en_drug_common_name": "HYDROCHLOROTHIAZIDE",
    "fr_drug_brand_name": "APO-HYDRO",
    "fr_drug_common_name": "HYDROCHLOROTHIAZIDE",
    "en_ingredients": "HYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 16933,
    "drug": {
      "current_status": "MARKETED",
      "id": 16148,
      "drug_code": 76936,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8255760,
          "ingredient": {
            "id": 958,
            "ingredient_code": 951,
            "en_name": "CILAZAPRIL",
            "fr_name": "Cilazapril (Monohydrate de Cilazapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02283786",
      "brand_name": "MYLAN-CILAZAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122806004"
    },
    "created_date": "2017-07-25T13:33:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02283786",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2017-11-02T00:00:00-04:00",
    "estimated_end_date": "2017-11-10T00:00:00-05:00",
    "actual_end_date": "2017-11-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-04T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-CILAZAPRIL",
    "en_drug_common_name": "CILAZAPRIL",
    "fr_drug_brand_name": "MYLAN-CILAZAPRIL",
    "fr_drug_common_name": "CILAZAPRIL",
    "en_ingredients": "CILAZAPRIL",
    "fr_ingredients": "Cilazapril",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16938,
    "drug": {
      "current_status": "MARKETED",
      "id": 31598,
      "drug_code": 93915,
      "updated_date": "2025-05-15T02:35:18-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261826,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "27",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452758",
      "brand_name": "APO-METHYLPHENIDATE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548007"
    },
    "created_date": "2017-07-25T13:40:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452758",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2017-11-16T00:00:00-05:00",
    "actual_start_date": "2017-07-24T00:00:00-04:00",
    "actual_end_date": "2017-11-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-03T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "27MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 16942,
    "drug": {
      "current_status": "MARKETED",
      "id": 31600,
      "drug_code": 93916,
      "updated_date": "2025-05-15T02:35:18-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261827,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "36",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452766",
      "brand_name": "APO-METHYLPHENIDATE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548005"
    },
    "created_date": "2017-07-25T13:42:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452766",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2017-09-08T00:00:00-04:00",
    "actual_start_date": "2017-07-24T00:00:00-04:00",
    "actual_end_date": "2017-08-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-31T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "36MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 16969,
    "drug": {
      "current_status": "MARKETED",
      "id": 12894,
      "drug_code": 72043,
      "updated_date": "2025-05-15T02:31:27-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254722,
          "ingredient": {
            "id": 1004,
            "ingredient_code": 11340,
            "en_name": "PAROXETINE",
            "fr_name": "Paroxétine (Chlorhydrate de paroxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247751",
      "brand_name": "PMS-PAROXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123131002"
    },
    "created_date": "2017-07-25T14:08:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247751",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2017-11-22T00:00:00-05:00",
    "actual_start_date": "2016-02-08T00:00:00-05:00",
    "actual_end_date": "2017-11-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2017-12-18T19:20:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-PAROXETINE",
    "en_drug_common_name": "PAROXETINE",
    "fr_drug_brand_name": "PMS-PAROXETINE",
    "fr_drug_common_name": "PAROXETINE",
    "en_ingredients": "PAROXETINE",
    "fr_ingredients": "PAROXETINE",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 17013,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7216,
      "drug_code": 48977,
      "updated_date": "2025-12-03T01:13:46-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8314905,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02230245",
      "brand_name": "PMS-AMOXICILLIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131314002"
    },
    "created_date": "2017-07-25T14:40:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230245",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "J01CA",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2017-09-18T00:00:00-04:00",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2017-10-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-11T15:31:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-AMOXICILLIN",
    "en_drug_common_name": "AMOXICILLIN",
    "fr_drug_brand_name": "PMS-AMOXICILLIN",
    "fr_drug_common_name": "AMOXICILLIN",
    "en_ingredients": "AMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "125MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17017,
    "drug": {
      "current_status": "MARKETED",
      "id": 14440,
      "drug_code": 74701,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255200,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02261634",
      "brand_name": "PMS-AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072001"
    },
    "created_date": "2017-07-25T14:56:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02261634",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2017-11-10T00:00:00-05:00",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2017-09-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-19T21:13:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-AZITHROMYCIN",
    "en_drug_common_name": "AZITHROMYCIN",
    "fr_drug_brand_name": "PMS-AZITHROMYCIN",
    "fr_drug_common_name": "AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17024,
    "drug": {
      "current_status": "MARKETED",
      "id": 25170,
      "drug_code": 87664,
      "updated_date": "2025-05-15T02:33:39-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259116,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259115,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02391295",
      "brand_name": "PMS-CANDESARTAN-HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0244181001"
    },
    "created_date": "2017-07-25T15:09:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02391295",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2018-01-05T00:00:00-05:00",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2018-01-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-26T16:05:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-CANDESARTAN HCTZ",
    "en_drug_common_name": "CANDESARTAN-HCTZ",
    "fr_drug_brand_name": "PMS-CANDESARTAN HCTZ",
    "fr_drug_common_name": "CANDESARTAN HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nCANDESARTAN CILEXETIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nCandésartan cilexétil",
    "drug_strength": "12.5MG\r\n16.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17028,
    "drug": {
      "current_status": "MARKETED",
      "id": 13018,
      "drug_code": 72326,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254754,
          "ingredient": {
            "id": 2658,
            "ingredient_code": 11847,
            "en_name": "CITALOPRAM",
            "fr_name": "Citalopram (Bromhydrate de citalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248010",
      "brand_name": "PMS-CITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136243001"
    },
    "created_date": "2017-07-25T15:11:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248010",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2017-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-15T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-CITALOPRAM",
    "en_drug_common_name": "CITALOPRAM",
    "fr_drug_brand_name": "PMS-CITALOPRAM",
    "fr_drug_common_name": "CITALOPRAM",
    "en_ingredients": "CITALOPRAM",
    "fr_ingredients": "CITALOPRAM",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17031,
    "drug": {
      "current_status": "DORMANT",
      "id": 12808,
      "drug_code": 71829,
      "updated_date": "2025-05-15T06:55:30-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367620,
          "ingredient": {
            "id": 688,
            "ingredient_code": 8318,
            "en_name": "CLARITHROMYCIN",
            "fr_name": "Clarithromycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247574",
      "brand_name": "PMS-CLARITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123752002"
    },
    "created_date": "2017-07-25T15:16:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247574",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2018-01-29T00:00:00-05:00",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2018-02-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-12T20:08:14-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-CLARITHROMYCIN",
    "en_drug_common_name": "CLARITHROMYCIN",
    "fr_drug_brand_name": "PMS-CLARITHROMYCIN",
    "fr_drug_common_name": "CLARITHROMYCIN",
    "en_ingredients": "CLARITHROMYCIN",
    "fr_ingredients": "Clarithromycine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17035,
    "drug": {
      "current_status": "MARKETED",
      "id": 13774,
      "drug_code": 7365,
      "updated_date": "2025-05-15T02:30:39-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251012,
          "ingredient": {
            "id": 186,
            "ingredient_code": 9152,
            "en_name": "DOCUSATE SODIUM",
            "fr_name": "Docusate sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00703494",
      "brand_name": "PMS-DOCUSATE SODIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "65264",
      "number_of_ais": "1",
      "ai_group_no": "0104351002"
    },
    "created_date": "2017-07-25T15:17:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00703494",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A06AA",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "estimated_end_date": "2018-02-20T00:00:00-05:00",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2018-02-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-02-20T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-DOCUSATE SODIUM",
    "en_drug_common_name": "DOCUSATE SODIUM",
    "fr_drug_brand_name": "PMS-DOCUSATE SODIUM",
    "fr_drug_common_name": "DOCUSATE SODIUM",
    "en_ingredients": "DOCUSATE SODIUM",
    "fr_ingredients": "Docusate sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17038,
    "drug": {
      "current_status": "MARKETED",
      "id": 29382,
      "drug_code": 91391,
      "updated_date": "2025-05-15T02:34:28-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260659,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429454",
      "brand_name": "PMS-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350002"
    },
    "created_date": "2017-07-25T15:18:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429454",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-11-07T00:00:00-05:00",
    "estimated_end_date": "2018-03-29T00:00:00-04:00",
    "actual_start_date": "2017-12-15T00:00:00-05:00",
    "actual_end_date": "2018-02-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-22T13:08:23-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-DULOXETINE",
    "en_drug_common_name": "DULOXETINE",
    "fr_drug_brand_name": "PMS-DULOXETINE",
    "fr_drug_common_name": "DULOXETINE",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "DULOXETINE",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17043,
    "drug": {
      "current_status": "DORMANT",
      "id": 25388,
      "drug_code": 87846,
      "updated_date": "2025-05-15T06:55:46-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368836,
          "ingredient": {
            "id": 3066,
            "ingredient_code": 12580,
            "en_name": "DUTASTERIDE",
            "fr_name": "Dutastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02393220",
      "brand_name": "PMS-DUTASTERIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149361001"
    },
    "created_date": "2017-07-25T15:20:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02393220",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "hc_updated_date": "2022-12-09T17:19:30-05:00",
    "estimated_end_date": "2022-06-01T00:00:00-04:00",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2022-07-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-09T17:19:57-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-DUTASTERIDE",
    "en_drug_common_name": "DUTASTERIDE",
    "fr_drug_brand_name": "PMS-DUTASTERIDE",
    "fr_drug_common_name": "DUTASTERIDE",
    "en_ingredients": "DUTASTERIDE",
    "fr_ingredients": "Dutastéride",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17046,
    "drug": {
      "current_status": "MARKETED",
      "id": 11128,
      "drug_code": 67356,
      "updated_date": "2025-12-03T00:30:47-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254180,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243446",
      "brand_name": "PMS-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929001"
    },
    "created_date": "2017-07-25T15:20:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243446",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2017-10-30T00:00:00-04:00",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2017-10-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-26T15:20:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "PMS-GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17049,
    "drug": {
      "current_status": "MARKETED",
      "id": 11128,
      "drug_code": 67356,
      "updated_date": "2025-12-03T00:30:47-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254180,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243446",
      "brand_name": "PMS-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929001"
    },
    "created_date": "2017-07-25T15:23:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243446",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-01-29T00:00:00-05:00",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2018-02-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-12T20:07:18-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "PMS-GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17053,
    "drug": {
      "current_status": "MARKETED",
      "id": 11130,
      "drug_code": 67357,
      "updated_date": "2025-12-03T00:30:47-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254181,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243447",
      "brand_name": "PMS-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929003"
    },
    "created_date": "2017-07-25T15:25:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243447",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-07-30T00:00:00-04:00",
    "estimated_end_date": "2017-11-28T00:00:00-05:00",
    "actual_start_date": "2017-07-30T00:00:00-04:00",
    "actual_end_date": "2017-11-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-17T17:34:34-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "PMS-GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17057,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14088,
      "drug_code": 74112,
      "updated_date": "2025-12-03T01:23:01-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8340201,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "800",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02255901",
      "brand_name": "PMS-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929005"
    },
    "created_date": "2017-07-25T15:26:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02255901",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2020-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-10T11:49:43-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued.",
    "fr_comments": "Product to be discontinued.",
    "en_drug_brand_name": "PMS-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "PMS-GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "800MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17060,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 842,
      "drug_code": 11869,
      "updated_date": "2025-12-03T01:05:27-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8288884,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01916394",
      "brand_name": "PMS HYDROMORPHONE SUPPOSITOIRE 3MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72797",
      "number_of_ais": "1",
      "ai_group_no": "0108698002"
    },
    "created_date": "2017-07-25T15:32:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01916394",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2020-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-08T20:58:43-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued.",
    "fr_comments": "Product to be discontinued.",
    "en_drug_brand_name": "PMS HYDROMORPHONE SUPPOSITOIRE 3MG",
    "en_drug_common_name": "HYDROMORPHONE",
    "fr_drug_brand_name": "PMS HYDROMORPHONE SUPPOSITOIRE 3MG",
    "fr_drug_common_name": "HYDROMORPHONE",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "3MG",
    "drug_dosage_form": "SUPPOSITORY",
    "drug_dosage_form_fr": "Suppositoire",
    "drug_route": "RECTAL",
    "drug_route_fr": "Rectale",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17063,
    "drug": {
      "current_status": "MARKETED",
      "id": 32218,
      "drug_code": 9973,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251251,
          "ingredient": {
            "id": 136,
            "ingredient_code": 8508,
            "en_name": "NYSTATIN",
            "fr_name": "Nystatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00792667",
      "brand_name": "PMS-NYSTATIN SUSPENSION 100000 UNIT/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69548",
      "number_of_ais": "1",
      "ai_group_no": "0105858002"
    },
    "created_date": "2017-07-25T15:33:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00792667",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A07AA",
    "atc_description": "INTESTINALANTIINFECTIVES",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-NYSTATIN SUSPENSION 100000 UNIT/ML",
    "en_drug_common_name": "NYSTATIN",
    "fr_drug_brand_name": "PMS-NYSTATIN SUSPENSION 100000 UNIT/ML",
    "fr_drug_common_name": "NYSTATIN",
    "en_ingredients": "NYSTATIN",
    "fr_ingredients": "Nystatine",
    "drug_strength": "100000UNIT",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17066,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18308,
      "drug_code": 79591,
      "updated_date": "2025-05-15T04:13:47-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8345504,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310260",
      "brand_name": "PMS-OMEPRAZOLE DR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2017-07-25T15:35:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310260",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "hc_updated_date": "2020-06-09T14:45:21-04:00",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2020-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-09T14:45:23-04:00",
    "status": "resolved",
    "en_comments": "Product already discontinued DIN cancelled post market.",
    "en_drug_brand_name": "PMS-OMEPRAZOLE DR",
    "en_drug_common_name": "OMEPRAZOLE",
    "fr_drug_brand_name": "PMS-OMEPRAZOLE DR",
    "fr_drug_common_name": "OMEPRAZOLE",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17069,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18308,
      "drug_code": 79591,
      "updated_date": "2025-05-15T04:13:47-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8345504,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310260",
      "brand_name": "PMS-OMEPRAZOLE DR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2017-07-25T15:36:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310260",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "hc_updated_date": "2020-06-09T14:46:07-04:00",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2020-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-09T14:46:10-04:00",
    "status": "resolved",
    "en_comments": "Product already discontinued DIN cancelled post market.",
    "en_drug_brand_name": "PMS-OMEPRAZOLE DR",
    "en_drug_common_name": "OMEPRAZOLE",
    "fr_drug_brand_name": "PMS-OMEPRAZOLE DR",
    "fr_drug_common_name": "OMEPRAZOLE",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17072,
    "drug": {
      "current_status": "MARKETED",
      "id": 18124,
      "drug_code": 79355,
      "updated_date": "2025-05-15T02:32:07-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256360,
          "ingredient": {
            "id": 2294,
            "ingredient_code": 11086,
            "en_name": "PANTOPRAZOLE",
            "fr_name": "Pantoprazole (Pantoprazole sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02307871",
      "brand_name": "PMS-PANTOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133229001"
    },
    "created_date": "2017-07-25T15:37:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02307871",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "actual_start_date": "2017-08-01T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-PANTOPRAZOLE",
    "en_drug_common_name": "PANTOPRAZOLE",
    "fr_drug_brand_name": "PMS-PANTOPRAZOLE",
    "fr_drug_common_name": "PANTOPRAZOLE",
    "en_ingredients": "PANTOPRAZOLE",
    "fr_ingredients": "PANTOPRAZOLE",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17075,
    "drug": {
      "current_status": "DORMANT",
      "id": 20794,
      "drug_code": 82613,
      "updated_date": "2025-12-03T02:32:26-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368405,
          "ingredient": {
            "id": 584,
            "ingredient_code": 11161,
            "en_name": "QUINAPRIL",
            "fr_name": "Quinapril (Chlorhydrate de quinapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02340550",
      "brand_name": "PMS-QUINAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123206001"
    },
    "created_date": "2017-07-25T15:38:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02340550",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2017-10-15T00:00:00-04:00",
    "estimated_end_date": "2019-09-25T00:00:00-04:00",
    "actual_start_date": "2017-12-15T00:00:00-05:00",
    "actual_end_date": "2019-11-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-11-15T20:02:49-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-QUINAPRIL",
    "en_drug_common_name": "QUINAPRIL",
    "fr_drug_brand_name": "PMS-QUINAPRIL",
    "fr_drug_common_name": "QUINAPRIL",
    "en_ingredients": "QUINAPRIL",
    "fr_ingredients": "QUINAPRILE",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 17078,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10592,
      "drug_code": 66172,
      "updated_date": "2025-12-03T01:19:25-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8332470,
          "ingredient": {
            "id": 1612,
            "ingredient_code": 11096,
            "en_name": "RANITIDINE",
            "fr_name": "Rantidine (Chlorhydrate de ranitidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02242453",
      "brand_name": "PMS-RANITIDINE 150 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115150002"
    },
    "created_date": "2017-07-25T15:48:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242453",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-RANITIDINE 150 MG",
    "en_drug_common_name": "RANITIDINE",
    "fr_drug_brand_name": "PMS-RANITIDINE 150 MG",
    "fr_drug_common_name": "RANITIDINE",
    "en_ingredients": "RANITIDINE",
    "fr_ingredients": "RANITIDINE",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17081,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10592,
      "drug_code": 66172,
      "updated_date": "2025-12-03T01:19:25-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8332470,
          "ingredient": {
            "id": 1612,
            "ingredient_code": 11096,
            "en_name": "RANITIDINE",
            "fr_name": "Rantidine (Chlorhydrate de ranitidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02242453",
      "brand_name": "PMS-RANITIDINE 150 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115150002"
    },
    "created_date": "2017-07-25T15:49:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242453",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-RANITIDINE 150 MG",
    "en_drug_common_name": "RANITIDINE",
    "fr_drug_brand_name": "PMS-RANITIDINE 150 MG",
    "fr_drug_common_name": "RANITIDINE",
    "en_ingredients": "RANITIDINE",
    "fr_ingredients": "RANITIDINE",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17084,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10592,
      "drug_code": 66172,
      "updated_date": "2025-12-03T01:19:25-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8332470,
          "ingredient": {
            "id": 1612,
            "ingredient_code": 11096,
            "en_name": "RANITIDINE",
            "fr_name": "Rantidine (Chlorhydrate de ranitidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02242453",
      "brand_name": "PMS-RANITIDINE 150 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115150002"
    },
    "created_date": "2017-07-25T15:52:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242453",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-RANITIDINE 150 MG",
    "en_drug_common_name": "RANITIDINE",
    "fr_drug_brand_name": "PMS-RANITIDINE 150 MG",
    "fr_drug_common_name": "RANITIDINE",
    "en_ingredients": "RANITIDINE",
    "fr_ingredients": "RANITIDINE",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17088,
    "drug": {
      "current_status": "MARKETED",
      "id": 28772,
      "drug_code": 90889,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260435,
          "ingredient": {
            "id": 2640,
            "ingredient_code": 11819,
            "en_name": "RISEDRONATE SODIUM",
            "fr_name": "Risédronate sodique (Hémipentahydrate de risédronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02424177",
      "brand_name": "PMS-RISEDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135301005"
    },
    "created_date": "2017-07-25T15:53:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02424177",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2017-11-27T00:00:00-05:00",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2017-11-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-17T17:34:52-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-RISEDRONATE",
    "en_drug_common_name": "RISEDRONATE",
    "fr_drug_brand_name": "PMS-RISEDRONATE",
    "fr_drug_common_name": "RISEDRONATE",
    "en_ingredients": "RISEDRONATE SODIUM",
    "fr_ingredients": "Risédronate sodique",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17091,
    "drug": {
      "current_status": "MARKETED",
      "id": 28772,
      "drug_code": 90889,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260435,
          "ingredient": {
            "id": 2640,
            "ingredient_code": 11819,
            "en_name": "RISEDRONATE SODIUM",
            "fr_name": "Risédronate sodique (Hémipentahydrate de risédronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02424177",
      "brand_name": "PMS-RISEDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135301005"
    },
    "created_date": "2017-07-25T15:54:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02424177",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2017-11-22T00:00:00-05:00",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2017-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-28T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-RISEDRONATE",
    "en_drug_common_name": "RISEDRONATE",
    "fr_drug_brand_name": "PMS-RISEDRONATE",
    "fr_drug_common_name": "RISEDRONATE",
    "en_ingredients": "RISEDRONATE SODIUM",
    "fr_ingredients": "Risédronate sodique",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17094,
    "drug": {
      "current_status": "MARKETED",
      "id": 26386,
      "drug_code": 88726,
      "updated_date": "2025-05-15T02:33:50-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259528,
          "ingredient": {
            "id": 2120,
            "ingredient_code": 109,
            "en_name": "TETRABENAZINE",
            "fr_name": "Tétrabénazine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402424",
      "brand_name": "PMS-TETRABENAZINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128227001"
    },
    "created_date": "2017-07-25T15:55:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402424",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N07XX",
    "atc_description": "OTHER NERVOUS SYSTEM DRUGS",
    "estimated_end_date": "2018-04-04T00:00:00-04:00",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2018-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-19T15:04:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-TETRABENAZINE",
    "en_drug_common_name": "TETRABENAZINE",
    "fr_drug_brand_name": "PMS-TETRABENAZINE",
    "fr_drug_common_name": "TETRABENAZINE",
    "en_ingredients": "TETRABENAZINE",
    "fr_ingredients": "Tétrabénazine",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17097,
    "drug": {
      "current_status": "MARKETED",
      "id": 1742,
      "drug_code": 13780,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251807,
          "ingredient": {
            "id": 946,
            "ingredient_code": 1939,
            "en_name": "TRAZODONE HYDROCHLORIDE",
            "fr_name": "Chlohydrate de trazodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01937235",
      "brand_name": "PMS TRAZODONE HCL TAB 100MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75231",
      "number_of_ais": "1",
      "ai_group_no": "0115713002"
    },
    "created_date": "2017-07-25T15:56:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01937235",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS TRAZODONE HCL TAB 100MG",
    "en_drug_common_name": "TRAZADONE",
    "fr_drug_brand_name": "TRAZADONE",
    "fr_drug_common_name": "TRAZADONE",
    "en_ingredients": "TRAZODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlohydrate de trazodone",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17100,
    "drug": {
      "current_status": "MARKETED",
      "id": 15360,
      "drug_code": 75898,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255499,
          "ingredient": {
            "id": 2630,
            "ingredient_code": 952,
            "en_name": "URSODIOL",
            "fr_name": "Ursodiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02273497",
      "brand_name": "PMS-URSODIOL C",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122789001"
    },
    "created_date": "2017-07-25T16:01:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02273497",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A05AA",
    "atc_description": "BILE THERAPY",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-URSODIOL C",
    "en_drug_common_name": "URSODIOL",
    "fr_drug_brand_name": "PMS-URSODIOL C",
    "fr_drug_common_name": "URSODIOL",
    "en_ingredients": "URSODIOL",
    "fr_ingredients": "Ursodiol",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17103,
    "drug": {
      "current_status": "MARKETED",
      "id": 15362,
      "drug_code": 75899,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255500,
          "ingredient": {
            "id": 2630,
            "ingredient_code": 952,
            "en_name": "URSODIOL",
            "fr_name": "Ursodiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02273500",
      "brand_name": "PMS-URSODIOL C",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122789002"
    },
    "created_date": "2017-07-25T16:03:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02273500",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A05AA",
    "atc_description": "BILE THERAPY",
    "estimated_end_date": "2017-10-18T00:00:00-04:00",
    "actual_start_date": "2017-07-01T00:00:00-04:00",
    "actual_end_date": "2017-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-26T15:12:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-URSODIOL C",
    "en_drug_common_name": "URSODIOL",
    "fr_drug_brand_name": "PMS-URSODIOL C",
    "fr_drug_common_name": "URSODIOL",
    "en_ingredients": "URSODIOL",
    "fr_ingredients": "Ursodiol",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17139,
    "drug": {
      "current_status": "DORMANT",
      "id": 25840,
      "drug_code": 88210,
      "updated_date": "2025-05-15T06:55:47-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368878,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02397102",
      "brand_name": "TARO-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858002"
    },
    "created_date": "2017-07-25T17:34:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02397102",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2018-11-28T00:00:00-05:00",
    "estimated_end_date": "2019-05-31T00:00:00-04:00",
    "actual_start_date": "2018-11-28T00:00:00-05:00",
    "actual_end_date": "2019-05-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-05-29T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-QUETIAPINE",
    "en_drug_common_name": "RAN-QUETIAPINE",
    "fr_drug_brand_name": "RAN-QUETIAPINE",
    "fr_drug_common_name": "RAN-QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 17150,
    "drug": {
      "current_status": "DORMANT",
      "id": 6332,
      "drug_code": 43222,
      "updated_date": "2025-05-15T06:55:26-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367206,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02217503",
      "brand_name": "APO-LISINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9549",
      "number_of_ais": "1",
      "ai_group_no": "0121550001"
    },
    "created_date": "2017-07-25T17:47:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02217503",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2017-10-31T00:00:00-04:00",
    "estimated_end_date": "2018-06-29T00:00:00-04:00",
    "actual_start_date": "2017-10-23T00:00:00-04:00",
    "actual_end_date": "2018-02-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-09T14:44:42-05:00",
    "status": "resolved",
    "en_comments": "100 BTL is available",
    "en_drug_brand_name": "APO-LISINOPRIL TABLET 10 MG",
    "en_drug_common_name": "LISINOPRIL",
    "fr_drug_brand_name": "APO-LISINOPRIL TABLET 10 MG",
    "fr_drug_common_name": "LISINOPRIL",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17164,
    "drug": {
      "current_status": "MARKETED",
      "id": 11916,
      "drug_code": 69741,
      "updated_date": "2025-05-15T02:31:18-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8254422,
          "ingredient": {
            "id": 2962,
            "ingredient_code": 12713,
            "en_name": "GANIRELIX",
            "fr_name": "Ganirélix (Acétate de ganirélix)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02245641",
      "brand_name": "ORGALUTRAN",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE PREFILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0146941001"
    },
    "created_date": "2017-07-25T18:07:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245641",
    "company_name": "MERCK CANADA INC",
    "atc_number": "H01CC",
    "atc_description": "HYPOTHALAMIC HORMONES",
    "estimated_end_date": "2017-09-29T00:00:00-04:00",
    "actual_start_date": "2017-08-09T00:00:00-04:00",
    "actual_end_date": "2017-09-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-09-29T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ORGALUTRAN",
    "en_drug_common_name": "Ganirelix Acetate Injection",
    "fr_drug_brand_name": "ORGALUTRAN",
    "fr_drug_common_name": "Injection d’acétate de ganirelix",
    "en_ingredients": "GANIRELIX",
    "fr_ingredients": "GANIRELIX (GANIRELIX ACETATE)",
    "drug_strength": "250MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "0.5ML SYRINGE",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 17167,
    "drug": {
      "current_status": "MARKETED",
      "id": 11382,
      "drug_code": 67891,
      "updated_date": "2025-05-15T02:31:15-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8254250,
          "ingredient": {
            "id": 2798,
            "ingredient_code": 11463,
            "en_name": "FOLLITROPIN BETA",
            "fr_name": "Follitropine bêta"
          },
          "ingredient_supplied_ind": "I",
          "strength": "833",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02243948",
      "brand_name": "PUREGON",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141201009"
    },
    "created_date": "2017-07-25T18:27:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243948",
    "company_name": "MERCK CANADA INC",
    "atc_number": "G03GA",
    "atc_description": "GONADOTROPHINS AND OTHER OVULATION STIMULANTS",
    "estimated_end_date": "2017-09-29T00:00:00-04:00",
    "actual_start_date": "2017-07-26T00:00:00-04:00",
    "actual_end_date": "2017-09-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-09-27T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Limited Quantities available / Quantités limitées disponibles",
    "fr_comments": "Limited Quantities available / Quantités limitées disponibles",
    "en_drug_brand_name": "PUREGON",
    "en_drug_common_name": "follitropin beta Solution for injection-cartriges",
    "fr_drug_brand_name": "PUREGON",
    "fr_drug_common_name": "Solution pour injection en cartouches (FSH rec.) follitropine bêta",
    "en_ingredients": "FOLLITROPIN BETA",
    "fr_ingredients": "Follitropine bêta",
    "drug_strength": "833UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "900IU/1.08ML 1CARTRIDGE",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 17195,
    "drug": {
      "current_status": "MARKETED",
      "id": 22328,
      "drug_code": 84726,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257986,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362244",
      "brand_name": "ACETAMINOPHEN TABLETS USP 500 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102009002"
    },
    "created_date": "2017-07-26T12:16:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362244",
    "company_name": "APOTEX INC",
    "atc_number": "N02BE",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "anticipated_start_date": "2017-08-18T00:00:00-04:00",
    "estimated_end_date": "2017-09-29T00:00:00-04:00",
    "actual_end_date": "2017-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-05T12:20:50-04:00",
    "status": "resolved",
    "en_comments": "APC-ACETAMINOPHEN TAB 500MG 100 BTL  available",
    "en_drug_brand_name": "ACETAMINOPHEN TABLETS USP 500 MG",
    "en_drug_common_name": "ACETAMINOPHEN",
    "fr_drug_brand_name": "ACETAMINOPHEN TABLETS USP 500 MG",
    "fr_drug_common_name": "ACETAMINOPHEN",
    "en_ingredients": "ACETAMINOPHEN",
    "fr_ingredients": "Acétaminophène",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17198,
    "drug": {
      "current_status": "MARKETED",
      "id": 6234,
      "drug_code": 43020,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253026,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "800",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02207656",
      "brand_name": "APO-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9276",
      "number_of_ais": "1",
      "ai_group_no": "0115506005"
    },
    "created_date": "2017-07-26T12:18:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02207656",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2017-08-31T00:00:00-04:00",
    "estimated_end_date": "2018-01-05T00:00:00-05:00",
    "actual_start_date": "2017-08-07T00:00:00-04:00",
    "actual_end_date": "2017-12-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-31T19:08:42-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ACYCLOVIR",
    "en_drug_common_name": "ACYCLOVIR",
    "fr_drug_brand_name": "APO-ACYCLOVIR",
    "fr_drug_common_name": "ACYCLOVIR",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "800MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17202,
    "drug": {
      "current_status": "MARKETED",
      "id": 29730,
      "drug_code": 9174,
      "updated_date": "2025-05-15T02:30:43-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251127,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00773689",
      "brand_name": "APO-ATENOL TAB 50MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68044",
      "number_of_ais": "1",
      "ai_group_no": "0113847002"
    },
    "created_date": "2017-07-26T12:21:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00773689",
    "company_name": "APOTEX INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-08-07T00:00:00-04:00",
    "estimated_end_date": "2017-11-15T00:00:00-05:00",
    "actual_start_date": "2017-08-18T00:00:00-04:00",
    "actual_end_date": "2017-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-07T16:19:45-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ATENOL TAB 50MG",
    "en_drug_common_name": "ATENOLOL",
    "fr_drug_brand_name": "APO-ATENOL TAB 50MG",
    "fr_drug_common_name": "ATENOLOL",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17205,
    "drug": {
      "current_status": "MARKETED",
      "id": 29730,
      "drug_code": 9174,
      "updated_date": "2025-05-15T02:30:43-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251127,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00773689",
      "brand_name": "APO-ATENOL TAB 50MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68044",
      "number_of_ais": "1",
      "ai_group_no": "0113847002"
    },
    "created_date": "2017-07-26T12:23:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00773689",
    "company_name": "APOTEX INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-08-31T00:00:00-04:00",
    "estimated_end_date": "2017-10-31T00:00:00-04:00",
    "actual_start_date": "2017-08-14T00:00:00-04:00",
    "actual_end_date": "2017-10-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-24T14:50:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ATENOL TAB 50MG",
    "en_drug_common_name": "ATENOLOL",
    "fr_drug_brand_name": "APO-ATENOL TAB 50MG",
    "fr_drug_common_name": "ATENOLOL",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17208,
    "drug": {
      "current_status": "MARKETED",
      "id": 14106,
      "drug_code": 74136,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255094,
          "ingredient": {
            "id": 3044,
            "ingredient_code": 1218,
            "en_name": "BISOPROLOL FUMARATE",
            "fr_name": "Fumarate de bisoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02256134",
      "brand_name": "APO-BISOPROLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122418001"
    },
    "created_date": "2017-07-26T12:25:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02256134",
    "company_name": "APOTEX INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-09-18T00:00:00-04:00",
    "estimated_end_date": "2017-12-15T00:00:00-05:00",
    "actual_start_date": "2017-09-22T00:00:00-04:00",
    "actual_end_date": "2017-12-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-14T13:35:13-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-BISOPROLOL",
    "en_drug_common_name": "BISOPROLOL",
    "fr_drug_brand_name": "APO-BISOPROLOL",
    "fr_drug_common_name": "BISOPROLOL",
    "en_ingredients": "BISOPROLOL FUMARATE",
    "fr_ingredients": "Fumarate de bisoprolol",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17228,
    "drug": {
      "current_status": "MARKETED",
      "id": 9634,
      "drug_code": 63352,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253724,
          "ingredient": {
            "id": 2190,
            "ingredient_code": 1381,
            "en_name": "FENOFIBRATE",
            "fr_name": "Fénofibrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239864",
      "brand_name": "AA-FENO-MICRO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118895001"
    },
    "created_date": "2017-07-26T14:02:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239864",
    "company_name": "APOTEX INC",
    "atc_number": "C10AB",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-08-21T00:00:00-04:00",
    "estimated_end_date": "2017-10-13T00:00:00-04:00",
    "actual_end_date": "2017-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-05T12:42:47-04:00",
    "status": "resolved",
    "en_comments": "APO-FENO-MICRO 200 MG CAP 100 BTL  available",
    "en_drug_brand_name": "APO-FENO-MICRO",
    "en_drug_common_name": "FENOFIBRATE",
    "fr_drug_brand_name": "APO-FENO-MICRO",
    "fr_drug_common_name": "FENOFIBRATE",
    "en_ingredients": "FENOFIBRATE",
    "fr_ingredients": "Fénofibrate",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17234,
    "drug": {
      "current_status": "MARKETED",
      "id": 16786,
      "drug_code": 77742,
      "updated_date": "2025-05-15T02:31:53-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255932,
          "ingredient": {
            "id": 1474,
            "ingredient_code": 156,
            "en_name": "FAMCICLOVIR",
            "fr_name": "Famciclovir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292068",
      "brand_name": "APO-FAMCICLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127885002"
    },
    "created_date": "2017-07-26T14:07:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292068",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2017-09-22T00:00:00-04:00",
    "estimated_end_date": "2018-04-10T00:00:00-04:00",
    "actual_start_date": "2017-08-28T00:00:00-04:00",
    "actual_end_date": "2018-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-18T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FAMCICLOVIR",
    "en_drug_common_name": "FAMCICLOVIR",
    "fr_drug_brand_name": "APO-FAMCICLOVIR",
    "fr_drug_common_name": "FAMCICLOVIR",
    "en_ingredients": "FAMCICLOVIR",
    "fr_ingredients": "Famciclovir",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17237,
    "drug": {
      "current_status": "MARKETED",
      "id": 752,
      "drug_code": 11727,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251562,
          "ingredient": {
            "id": 240,
            "ingredient_code": 4007,
            "en_name": "GLYBURIDE",
            "fr_name": "Glyburide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01913662",
      "brand_name": "APO GLYBURIDE TAB 5MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72607",
      "number_of_ais": "1",
      "ai_group_no": "0108708001"
    },
    "created_date": "2017-07-26T15:11:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01913662",
    "company_name": "APOTEX INC",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2017-09-15T00:00:00-04:00",
    "estimated_end_date": "2017-10-31T00:00:00-04:00",
    "actual_end_date": "2017-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-05T12:32:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO GLYBURIDE TAB 5MG",
    "en_drug_common_name": "GLYBURIDE",
    "fr_drug_brand_name": "APO GLYBURIDE TAB 5MG",
    "fr_drug_common_name": "GLYBURIDE",
    "en_ingredients": "GLYBURIDE",
    "fr_ingredients": "Glyburide",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17246,
    "drug": {
      "current_status": "MARKETED",
      "id": 5550,
      "drug_code": 36948,
      "updated_date": "2025-12-03T00:30:35-05:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252871,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02213222",
      "brand_name": "ELTROXIN",
      "brand_name_fr": "ELTROXIN",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4374",
      "number_of_ais": "1",
      "ai_group_no": "0107794003"
    },
    "created_date": "2017-07-26T17:12:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02213222",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "H03AA",
    "atc_description": "THYROID PREPARATIONS",
    "estimated_end_date": "2017-10-17T00:00:00-04:00",
    "actual_start_date": "2017-07-26T00:00:00-04:00",
    "actual_end_date": "2017-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-24T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ELTROXIN",
    "en_drug_common_name": "levothyroxine sodium",
    "fr_drug_brand_name": "Eltroxin 200 mcg",
    "fr_drug_common_name": "Lévothyroxine sodique",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "200MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17251,
    "drug": {
      "current_status": "MARKETED",
      "id": 16358,
      "drug_code": 77142,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255827,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02285932",
      "brand_name": "APO-LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843002"
    },
    "created_date": "2017-07-26T17:44:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02285932",
    "company_name": "APOTEX INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-12-22T00:00:00-05:00",
    "estimated_end_date": "2018-04-06T00:00:00-04:00",
    "actual_start_date": "2017-12-18T00:00:00-05:00",
    "actual_end_date": "2018-03-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-15T11:51:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM",
    "fr_drug_brand_name": "APO-LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17254,
    "drug": {
      "current_status": "MARKETED",
      "id": 10826,
      "drug_code": 66668,
      "updated_date": "2025-05-15T02:31:12-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254090,
          "ingredient": {
            "id": 844,
            "ingredient_code": 10227,
            "en_name": "LITHIUM CARBONATE",
            "fr_name": "Carbonate de lithium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242838",
      "brand_name": "APO-LITHIUM CARBONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101163002"
    },
    "created_date": "2017-07-26T17:46:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242838",
    "company_name": "APOTEX INC",
    "atc_number": "N05AN",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2017-09-08T00:00:00-04:00",
    "estimated_end_date": "2017-11-06T00:00:00-05:00",
    "actual_start_date": "2017-08-15T00:00:00-04:00",
    "actual_end_date": "2017-10-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-31T13:21:30-04:00",
    "status": "resolved",
    "en_comments": "APO-LITHIUM CARBONATE 300 MG CAP 1000BTL    available",
    "en_drug_brand_name": "APO-LITHIUM CARBONATE",
    "en_drug_common_name": "LITHIUM CARBONATE",
    "fr_drug_brand_name": "APO-LITHIUM CARBONATE",
    "fr_drug_common_name": "LITHIUM CARBONATE",
    "en_ingredients": "LITHIUM CARBONATE",
    "fr_ingredients": "Carbonate de lithium",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17257,
    "drug": {
      "current_status": "MARKETED",
      "id": 15966,
      "drug_code": 76747,
      "updated_date": "2025-12-03T00:31:07-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255702,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02281813",
      "brand_name": "APO-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783004"
    },
    "created_date": "2017-07-26T17:50:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02281813",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2017-08-18T00:00:00-04:00",
    "estimated_end_date": "2017-10-06T00:00:00-04:00",
    "actual_start_date": "2017-07-31T00:00:00-04:00",
    "actual_end_date": "2017-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-05T13:00:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17260,
    "drug": {
      "current_status": "MARKETED",
      "id": 18044,
      "drug_code": 79224,
      "updated_date": "2025-12-03T00:31:17-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256347,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02306530",
      "brand_name": "APO-OXYCODONE CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107552005"
    },
    "created_date": "2017-07-26T17:52:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02306530",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2017-08-01T00:00:00-04:00",
    "estimated_end_date": "2017-11-03T00:00:00-04:00",
    "actual_start_date": "2017-07-31T00:00:00-04:00",
    "actual_end_date": "2017-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-24T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OXYCODONE CR",
    "en_drug_common_name": "OXYCODONE",
    "fr_drug_brand_name": "APO-OXYCODONE CR",
    "fr_drug_common_name": "OXYCODONE",
    "en_ingredients": "OXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'oxycodone",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17263,
    "drug": {
      "current_status": "MARKETED",
      "id": 22636,
      "drug_code": 85161,
      "updated_date": "2025-12-03T00:31:47-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258153,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02366789",
      "brand_name": "APO-OXYCODONE CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107552006"
    },
    "created_date": "2017-07-26T17:53:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02366789",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2017-08-08T00:00:00-04:00",
    "estimated_end_date": "2017-09-18T00:00:00-04:00",
    "actual_start_date": "2017-07-31T00:00:00-04:00",
    "actual_end_date": "2017-09-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-22T13:59:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OXYCODONE CR",
    "en_drug_common_name": "OXYCODONE",
    "fr_drug_brand_name": "APO-OXYCODONE CR",
    "fr_drug_common_name": "OXYCODONE",
    "en_ingredients": "OXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'oxycodone",
    "drug_strength": "80.0MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 17266,
    "drug": {
      "current_status": "MARKETED",
      "id": 19648,
      "drug_code": 81005,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256864,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256863,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324628",
      "brand_name": "APO-OXYCODONE/ACET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0215596001"
    },
    "created_date": "2017-07-26T17:59:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02324628",
    "company_name": "APOTEX INC",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2018-03-30T00:00:00-04:00",
    "actual_start_date": "2017-12-18T00:00:00-05:00",
    "actual_end_date": "2018-03-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-17T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OXYCODONE/ACET",
    "en_drug_common_name": "OXYCODONE+ACETAMINOPHEN",
    "fr_drug_brand_name": "APO-OXYCODONE/ACET",
    "fr_drug_common_name": "OXYCODONE/ACET",
    "en_ingredients": "ACETAMINOPHEN\r\nOXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Acétaminophène\r\nChlorhydrate d'oxycodone",
    "drug_strength": "325MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17288,
    "drug": {
      "current_status": "MARKETED",
      "id": 7474,
      "drug_code": 50117,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253320,
          "ingredient": {
            "id": 1944,
            "ingredient_code": 2189,
            "en_name": "LOXAPINE",
            "fr_name": "Loxapine (Succinate de loxapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230839",
      "brand_name": "XYLAC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111557001"
    },
    "created_date": "2017-07-26T18:08:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230839",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2017-09-02T00:00:00-04:00",
    "estimated_end_date": "2017-09-07T00:00:00-04:00",
    "actual_start_date": "2017-09-02T00:00:00-04:00",
    "actual_end_date": "2017-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-05T23:39:22-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "XYLAC",
    "en_drug_common_name": "XYLAC 25mg TABS 100",
    "fr_drug_brand_name": "XYLAC",
    "fr_drug_common_name": "XYLAC 25mg TABS 100",
    "en_ingredients": "LOXAPINE",
    "fr_ingredients": "Loxapine",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17293,
    "drug": {
      "current_status": "MARKETED",
      "id": 5872,
      "drug_code": 407,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250149,
          "ingredient": {
            "id": 2068,
            "ingredient_code": 8282,
            "en_name": "PHENOBARBITAL",
            "fr_name": "Phénobarbital"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00178810",
      "brand_name": "PHENOBARB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "14690",
      "number_of_ais": "1",
      "ai_group_no": "0105950004"
    },
    "created_date": "2017-07-26T18:10:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00178810",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "N03AA",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-08-01T00:00:00-04:00",
    "estimated_end_date": "2017-08-07T00:00:00-04:00",
    "actual_start_date": "2017-08-01T00:00:00-04:00",
    "actual_end_date": "2017-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-05T23:39:55-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "PHENOBARB",
    "en_drug_common_name": "PHENOBARB 60mg TABS 500",
    "fr_drug_brand_name": "PHENOBARB",
    "fr_drug_common_name": "PHENOBARB 60mg TABS 500",
    "en_ingredients": "PHENOBARBITAL",
    "fr_ingredients": "Phénobarbital",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17296,
    "drug": {
      "current_status": "MARKETED",
      "id": 16846,
      "drug_code": 77827,
      "updated_date": "2025-05-15T02:31:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255947,
          "ingredient": {
            "id": 2294,
            "ingredient_code": 11086,
            "en_name": "PANTOPRAZOLE",
            "fr_name": "Pantoprazole (Pantoprazole sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292920",
      "brand_name": "APO-PANTOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133229001"
    },
    "created_date": "2017-07-26T18:14:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292920",
    "company_name": "APOTEX INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2017-07-31T00:00:00-04:00",
    "estimated_end_date": "2017-09-15T00:00:00-04:00",
    "actual_start_date": "2017-07-31T00:00:00-04:00",
    "actual_end_date": "2017-08-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-29T01:39:29-04:00",
    "status": "resolved",
    "en_comments": "APO-PANTOPRAZOLE Na ECT 40MG 100 BTL    available",
    "en_drug_brand_name": "APO-PANTOPRAZOLE",
    "en_drug_common_name": "PANTOPRAZOLE",
    "fr_drug_brand_name": "APO-PANTOPRAZOLE Na ECT 40MG 100 BTL",
    "fr_drug_common_name": "PANTOPRAZOLE",
    "en_ingredients": "PANTOPRAZOLE",
    "fr_ingredients": "PANTOPRAZOLE",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 17309,
    "drug": {
      "current_status": "MARKETED",
      "id": 16814,
      "drug_code": 77773,
      "updated_date": "2025-05-15T02:31:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255941,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292386",
      "brand_name": "APO-PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169002"
    },
    "created_date": "2017-07-26T18:23:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292386",
    "company_name": "APOTEX INC",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2017-08-01T00:00:00-04:00",
    "estimated_end_date": "2017-10-31T00:00:00-04:00",
    "actual_start_date": "2017-07-31T00:00:00-04:00",
    "actual_end_date": "2017-10-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-20T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PRAMIPEXOLE",
    "en_drug_common_name": "PRAMIPEXOLE",
    "fr_drug_brand_name": "APO-PRAMIPEXOLE",
    "fr_drug_common_name": "PRAMIPEXOLE",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17312,
    "drug": {
      "current_status": "MARKETED",
      "id": 16816,
      "drug_code": 77774,
      "updated_date": "2025-05-15T02:31:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255942,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292394",
      "brand_name": "APO-PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169003"
    },
    "created_date": "2017-07-26T18:24:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292394",
    "company_name": "APOTEX INC",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2017-08-18T00:00:00-04:00",
    "estimated_end_date": "2017-10-31T00:00:00-04:00",
    "actual_start_date": "2017-09-04T00:00:00-04:00",
    "actual_end_date": "2017-10-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-20T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PRAMIPEXOLE",
    "en_drug_common_name": "PRAMIPEXOLE",
    "fr_drug_brand_name": "APO-PRAMIPEXOLE",
    "fr_drug_common_name": "PRAMIPEXOLE",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "1.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17315,
    "drug": {
      "current_status": "DORMANT",
      "id": 13276,
      "drug_code": 72852,
      "updated_date": "2025-05-15T06:55:31-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367657,
          "ingredient": {
            "id": 584,
            "ingredient_code": 11161,
            "en_name": "QUINAPRIL",
            "fr_name": "Quinapril (Chlorhydrate de quinapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248500",
      "brand_name": "APO-QUINAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123206002"
    },
    "created_date": "2017-07-26T18:25:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248500",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2017-08-31T00:00:00-04:00",
    "estimated_end_date": "2017-10-20T00:00:00-04:00",
    "actual_start_date": "2017-08-07T00:00:00-04:00",
    "actual_end_date": "2017-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-18T12:20:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-QUINAPRIL",
    "en_drug_common_name": "QUINAPRIL",
    "fr_drug_brand_name": "APO-QUINAPRIL",
    "fr_drug_common_name": "QUINAPRIL",
    "en_ingredients": "QUINAPRIL",
    "fr_ingredients": "QUINAPRIL",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17319,
    "drug": {
      "current_status": "MARKETED",
      "id": 15990,
      "drug_code": 76779,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255716,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02282127",
      "brand_name": "APO-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332007"
    },
    "created_date": "2017-07-26T18:28:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02282127",
    "company_name": "APOTEX INC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2017-09-22T00:00:00-04:00",
    "estimated_end_date": "2017-12-15T00:00:00-05:00",
    "actual_start_date": "2017-08-15T00:00:00-04:00",
    "actual_end_date": "2017-11-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-29T12:41:34-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "APO-RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "0.50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17322,
    "drug": {
      "current_status": "MARKETED",
      "id": 20522,
      "drug_code": 82237,
      "updated_date": "2025-05-15T02:32:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257264,
          "ingredient": {
            "id": 2792,
            "ingredient_code": 11987,
            "en_name": "RIVASTIGMINE",
            "fr_name": "Rivastigmine (Tartrate hydrogénée de rivastigmine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02336758",
      "brand_name": "APO-RIVASTIGMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140521004"
    },
    "created_date": "2017-07-26T18:30:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02336758",
    "company_name": "APOTEX INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2017-09-18T00:00:00-04:00",
    "estimated_end_date": "2018-03-30T00:00:00-04:00",
    "actual_start_date": "2017-08-28T00:00:00-04:00",
    "actual_end_date": "2018-03-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-27T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RIVASTIGMINE",
    "en_drug_common_name": "RIVASTIGMINE",
    "fr_drug_brand_name": "APO-RIVASTIGMINE",
    "fr_drug_common_name": "RIVASTIGMINE",
    "en_ingredients": "RIVASTIGMINE",
    "fr_ingredients": "Rivastigmine",
    "drug_strength": "6MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17325,
    "drug": {
      "current_status": "MARKETED",
      "id": 49632,
      "drug_code": 88817,
      "updated_date": "2025-05-15T02:33:51-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259561,
          "ingredient": {
            "id": 2742,
            "ingredient_code": 11925,
            "en_name": "ROSIGLITAZONE",
            "fr_name": "Rosiglitazone (Maléate de rosiglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02403366",
      "brand_name": "ROSIGLITAZONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138802002"
    },
    "created_date": "2017-07-26T18:35:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403366",
    "company_name": "APOTEX INC",
    "atc_number": "A10BG",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2017-07-31T00:00:00-04:00",
    "estimated_end_date": "2017-10-16T00:00:00-04:00",
    "actual_start_date": "2017-07-31T00:00:00-04:00",
    "actual_end_date": "2017-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-16T11:47:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ROSIGLITAZONE",
    "en_drug_common_name": "ROSIGLITAZONE",
    "fr_drug_brand_name": "APO-ROSIGLITAZONE",
    "fr_drug_common_name": "ROSIGLITAZONE",
    "en_ingredients": "ROSIGLITAZONE",
    "fr_ingredients": "ROSIGLITAZONE",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17328,
    "drug": {
      "current_status": "MARKETED",
      "id": 7378,
      "drug_code": 49813,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253292,
          "ingredient": {
            "id": 1234,
            "ingredient_code": 1294,
            "en_name": "SELEGILINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de sélégiline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230641",
      "brand_name": "SELEGILINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131374001"
    },
    "created_date": "2017-07-26T18:36:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230641",
    "company_name": "APOTEX INC",
    "atc_number": "N04BD",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2017-08-31T00:00:00-04:00",
    "estimated_end_date": "2018-03-30T00:00:00-04:00",
    "actual_start_date": "2017-08-07T00:00:00-04:00",
    "actual_end_date": "2018-03-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-27T15:20:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SELEGILINE",
    "en_drug_common_name": "SELEGILINE",
    "fr_drug_brand_name": "APO-SELEGILINE",
    "fr_drug_common_name": "SELEGILINE",
    "en_ingredients": "SELEGILINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de sélégiline",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17331,
    "drug": {
      "current_status": "MARKETED",
      "id": 22344,
      "drug_code": 84741,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257998,
          "ingredient": {
            "id": 3240,
            "ingredient_code": 11780,
            "en_name": "TAMSULOSIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tamsulosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362406",
      "brand_name": "APO-TAMSULOSIN CR",
      "brand_name_fr": "",
      "descriptor": "CONTROLLED-RELEASE TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133680001"
    },
    "created_date": "2017-07-26T18:38:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362406",
    "company_name": "APOTEX INC",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_start_date": "2017-08-04T00:00:00-04:00",
    "estimated_end_date": "2017-11-14T00:00:00-05:00",
    "actual_start_date": "2017-08-01T00:00:00-04:00",
    "actual_end_date": "2017-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-13T14:02:53-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TAMSULOSIN CR",
    "en_drug_common_name": "TAMSULOSIN",
    "fr_drug_brand_name": "APO-TAMSULOSIN CR",
    "fr_drug_common_name": "TAMSULOSIN",
    "en_ingredients": "TAMSULOSIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tamsulosine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17335,
    "drug": {
      "current_status": "MARKETED",
      "id": 13296,
      "drug_code": 72892,
      "updated_date": "2025-05-15T02:31:30-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254822,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248538",
      "brand_name": "APO-TRYPTOPHAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111038003"
    },
    "created_date": "2017-07-26T18:40:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248538",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-09-28T00:00:00-04:00",
    "estimated_end_date": "2018-03-23T00:00:00-04:00",
    "actual_start_date": "2017-08-14T00:00:00-04:00",
    "actual_end_date": "2018-03-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-25T22:12:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TRYPTOPHAN",
    "en_drug_common_name": "TRYPTOPHAN",
    "fr_drug_brand_name": "APO-TRYPTOPHAN",
    "fr_drug_common_name": "TRYPTOPHAN",
    "en_ingredients": "TRYPTOPHAN",
    "fr_ingredients": "Tryptophane",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17351,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22438,
      "drug_code": 8483,
      "updated_date": "2025-05-15T03:32:55-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8283966,
          "ingredient": {
            "id": 1612,
            "ingredient_code": 11096,
            "en_name": "RANITIDINE",
            "fr_name": "Rantidine (Chlorhydrate de ranitidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "00740756",
      "brand_name": "RANITIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "66984",
      "number_of_ais": "1",
      "ai_group_no": "0115150001"
    },
    "created_date": "2017-07-26T20:50:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00740756",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "actual_start_date": "2017-07-24T00:00:00-04:00",
    "actual_end_date": "2017-08-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-08-04T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RANITIDINE - 300",
    "en_drug_common_name": "RANITIDINE",
    "fr_drug_brand_name": "RANITIDINE 300MG",
    "fr_drug_common_name": "RANITIDINE",
    "en_ingredients": "RANITIDINE",
    "fr_ingredients": "RANITIDINE",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17354,
    "drug": {
      "current_status": "MARKETED",
      "id": 31788,
      "drug_code": 94218,
      "updated_date": "2025-05-15T02:35:24-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8261960,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02455374",
      "brand_name": "TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485002"
    },
    "created_date": "2017-07-26T20:52:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02455374",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "actual_start_date": "2018-11-02T00:00:00-04:00",
    "actual_end_date": "2018-12-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-12-12T06:00:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TADALAFIL",
    "en_drug_common_name": "TADALAFIL",
    "fr_drug_brand_name": "TADALAFIL 20 MG",
    "fr_drug_common_name": "TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17360,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9146,
      "drug_code": 61948,
      "updated_date": "2025-05-15T03:57:33-04:00",
      "company": {
        "id": 448,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 13687,
        "mfr_code": "",
        "name": "TAKEDA PHARMACEUTICALS AMERICA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "500 KENDALL STREET",
        "province": "MASSACHUSETTS",
        "country": "UNITED STATES",
        "city": "CAMBRIDGE",
        "postal_code": "02142",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8326585,
          "ingredient": {
            "id": 688,
            "ingredient_code": 8318,
            "en_name": "CLARITHROMYCIN",
            "fr_name": "Clarithromycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "TAB",
          "base": false
        },
        {
          "id": 8326584,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "CAP",
          "base": false
        },
        {
          "id": 8326583,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "CAP",
          "base": false
        }
      ],
      "din": "02238525",
      "brand_name": "HP-PAC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "3",
      "ai_group_no": "0334201001"
    },
    "created_date": "2017-07-26T21:13:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238525",
    "company_name": "TAKEDA PHARMACEUTICALS AMERICA INC",
    "atc_number": "A02BD",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2017-10-13T00:00:00-04:00",
    "actual_start_date": "2017-09-21T00:00:00-04:00",
    "actual_end_date": "2017-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2017-10-17T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Resolved on Oct 16, 2017",
    "fr_comments": "Résolu le 16 octobre 2017",
    "en_drug_brand_name": "HP-PAC",
    "en_drug_common_name": "Lansoprazole, Clarithromycin, Amoxicillin",
    "fr_drug_brand_name": "Hp-PAC",
    "fr_drug_common_name": "Lansoprazole, Clarithromycine, Amoxicilline",
    "en_ingredients": "AMOXICILLIN\r\nLANSOPRAZOLE\r\nCLARITHROMYCIN",
    "fr_ingredients": "Amoxicilline\r\nLansoprazole\r\nClarithromycine",
    "drug_strength": "500MG\r\n30MG\r\n500MG",
    "drug_dosage_form": "KIT\r\nCAPSULE\r\nCAPSULE (SUSTAINED-RELEASE)\r\nTABLET",
    "drug_dosage_form_fr": "Trousse\r\nCapsule\r\nCapsule (à libération prolongée\r\nComprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "HP-PAC 7-Day",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17373,
    "drug": {
      "current_status": "MARKETED",
      "id": 10088,
      "drug_code": 64698,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8253834,
          "ingredient": {
            "id": 2740,
            "ingredient_code": 11923,
            "en_name": "TEMOZOLOMIDE",
            "fr_name": "Témozolomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02241095",
      "brand_name": "TEMODAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138781003"
    },
    "created_date": "2017-07-27T14:03:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241095",
    "company_name": "MERCK CANADA INC",
    "atc_number": "L01AX",
    "atc_description": "ALKYLATINGAGENTS",
    "anticipated_start_date": "2017-09-28T00:00:00-04:00",
    "estimated_end_date": "2017-09-29T00:00:00-04:00",
    "actual_end_date": "2017-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-10-11T19:30:53-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "TEMODAL",
    "en_drug_common_name": "temozolomide capsules",
    "fr_drug_brand_name": "TEMODAL",
    "fr_drug_common_name": "capsules de témozolomide",
    "en_ingredients": "TEMOZOLOMIDE",
    "fr_ingredients": "Témozolomide",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "5 cap",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17414,
    "drug": {
      "current_status": "MARKETED",
      "id": 446,
      "drug_code": 10971,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8251456,
          "ingredient": {
            "id": 292,
            "ingredient_code": 8565,
            "en_name": "TOBRAMYCIN",
            "fr_name": "Tobramycine (Sulfate de tobramycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8251455,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00778915",
      "brand_name": "TOBRADEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71136",
      "number_of_ais": "2",
      "ai_group_no": "0220325001"
    },
    "created_date": "2017-07-27T20:46:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00778915",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01CA",
    "atc_description": "ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB",
    "estimated_end_date": "2017-09-12T00:00:00-04:00",
    "actual_start_date": "2017-07-20T00:00:00-04:00",
    "actual_end_date": "2017-09-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-09-13T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TOBRADEX",
    "en_drug_common_name": "TOBRADEX OINT 3.5G",
    "fr_drug_brand_name": "TOBRADEX",
    "fr_drug_common_name": "TOBRADEX OINT 3.5G",
    "en_ingredients": "DEXAMETHASONE\r\nTOBRAMYCIN",
    "fr_ingredients": "Dexaméthasone\r\nTobramycine",
    "drug_strength": "0.1%\r\n0.3%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "1",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17417,
    "drug": {
      "current_status": "MARKETED",
      "id": 6872,
      "drug_code": 4591,
      "updated_date": "2025-05-15T02:30:31-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8250651,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00042579",
      "brand_name": "MAXIDEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58173",
      "number_of_ais": "1",
      "ai_group_no": "0106303004"
    },
    "created_date": "2017-07-27T20:57:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00042579",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01BA",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2017-09-11T00:00:00-04:00",
    "actual_start_date": "2017-07-23T00:00:00-04:00",
    "actual_end_date": "2017-09-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-09-08T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAXIDEX",
    "en_drug_common_name": "MAXIDEX OINTMENT 3.5MG",
    "fr_drug_brand_name": "MAXIDEX",
    "fr_drug_common_name": "MAXIDEX OINTMENT 3.5MG",
    "en_ingredients": "DEXAMETHASONE",
    "fr_ingredients": "Dexaméthasone",
    "drug_strength": "0.1%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "3.5 MG",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 17424,
    "drug": {
      "current_status": "DORMANT",
      "id": 5054,
      "drug_code": 3003,
      "updated_date": "2025-05-15T06:55:19-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366126,
          "ingredient": {
            "id": 1890,
            "ingredient_code": 5922,
            "en_name": "BENZTROPINE MESYLATE",
            "fr_name": "Mésylate de benztropine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00426857",
      "brand_name": "PDP-BENZTROPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "52491",
      "number_of_ais": "1",
      "ai_group_no": "0107632002"
    },
    "created_date": "2017-07-28T01:00:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00426857",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "N04AC",
    "atc_description": "ANTICHOLINERGIC AGENTS",
    "anticipated_start_date": "2017-09-26T00:00:00-04:00",
    "actual_start_date": "2017-09-12T00:00:00-04:00",
    "actual_end_date": "2018-08-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-29T17:24:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PDP-BENZTROPINE",
    "en_drug_common_name": "pdp-BENZTROPINE 2mg TABS 1000",
    "fr_drug_brand_name": "pdp-BENZTROPINE",
    "fr_drug_common_name": "pdp-BENZTROPINE 2mg TABS 1000",
    "en_ingredients": "BENZTROPINE MESYLATE",
    "fr_ingredients": "Mésylate de benztropine",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 17427,
    "drug": {
      "current_status": "DORMANT",
      "id": 8350,
      "drug_code": 5725,
      "updated_date": "2025-05-15T06:55:20-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366331,
          "ingredient": {
            "id": 2504,
            "ingredient_code": 6030,
            "en_name": "PROCYCLIDINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de procyclidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00587362",
      "brand_name": "PDP-PROCYCLIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61369",
      "number_of_ais": "1",
      "ai_group_no": "0107590002"
    },
    "created_date": "2017-07-28T01:06:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00587362",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "N04AA",
    "atc_description": "ANTICHOLINERGIC AGENTS",
    "anticipated_start_date": "2017-11-16T00:00:00-05:00",
    "actual_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2018-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-30T13:49:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PDP-PROCYCLIDINE",
    "en_drug_common_name": "pdp-PROCYCLIDINE 2.5mg/5mL 500mL",
    "fr_drug_brand_name": "pdp-PROCYCLIDINE",
    "fr_drug_common_name": "pdp-PROCYCLIDINE 2.5mg/5mL 500mL",
    "en_ingredients": "PROCYCLIDINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de procyclidine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "ELIXIR",
    "drug_dosage_form_fr": "Élixir",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 17430,
    "drug": {
      "current_status": "DORMANT",
      "id": 9838,
      "drug_code": 6392,
      "updated_date": "2025-05-15T06:55:21-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366405,
          "ingredient": {
            "id": 2504,
            "ingredient_code": 6030,
            "en_name": "PROCYCLIDINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de procyclidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00587354",
      "brand_name": "PDP-PROCYCLIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62933",
      "number_of_ais": "1",
      "ai_group_no": "0107590001"
    },
    "created_date": "2017-07-28T01:17:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00587354",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "N04AA",
    "atc_description": "ANTICHOLINERGIC AGENTS",
    "anticipated_start_date": "2017-08-01T00:00:00-04:00",
    "actual_start_date": "2017-07-21T00:00:00-04:00",
    "actual_end_date": "2018-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-07-30T13:51:54-04:00",
    "status": "resolved",
    "en_comments": ".",
    "fr_comments": ".",
    "en_drug_brand_name": "PDP-PROCYCLIDINE",
    "en_drug_common_name": "pdp-PROCYCLIDINE 5mg TABS 100",
    "fr_drug_brand_name": "pdp-PROCYCLIDINE",
    "fr_drug_common_name": "pdp-PROCYCLIDINE 5mg TABS 100",
    "en_ingredients": "PROCYCLIDINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de procyclidine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 17440,
    "drug": {
      "current_status": "MARKETED",
      "id": 10010,
      "drug_code": 64427,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253810,
          "ingredient": {
            "id": 2000,
            "ingredient_code": 11282,
            "en_name": "SALMETEROL",
            "fr_name": "Salmétérol (Xinafoate de salmétérol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        },
        {
          "id": 8253809,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02240836",
      "brand_name": "ADVAIR 250 DISKUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0238341002"
    },
    "created_date": "2017-07-28T14:00:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240836",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03AK",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2017-08-28T00:00:00-04:00",
    "actual_start_date": "2017-08-08T00:00:00-04:00",
    "actual_end_date": "2017-08-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-08-16T20:47:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ADVAIR 250 DISKUS",
    "en_drug_common_name": "fluticasone propionate and salmeterol inhalation powder",
    "fr_drug_brand_name": "ADVAIR 250 DISKUS",
    "fr_drug_common_name": "propionate de fluticasone et salmétérol en poudre pour inhalation",
    "en_ingredients": "SALMETEROL\r\nFLUTICASONE PROPIONATE",
    "fr_ingredients": "Salmétérol,\r\nPropionate de fluticasone",
    "drug_strength": "50MCG\r\n250MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "1x60 doses",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 17444,
    "drug": {
      "current_status": "MARKETED",
      "id": 24258,
      "drug_code": 86863,
      "updated_date": "2025-05-15T02:33:19-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8258726,
          "ingredient": {
            "id": 500,
            "ingredient_code": 6850,
            "en_name": "BENZOYL PEROXIDE",
            "fr_name": "Peroxyde de benzoyle"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8258725,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02382822",
      "brand_name": "CLINDOXYL ADV GEL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0242561002"
    },
    "created_date": "2017-07-28T14:10:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382822",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "D10AF",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2017-10-09T00:00:00-04:00",
    "actual_start_date": "2017-07-26T00:00:00-04:00",
    "actual_end_date": "2017-09-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-27T18:50:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CLINDOXYL ADV GEL",
    "en_drug_common_name": "clindamycin and benzoyl peroxide gel",
    "fr_drug_brand_name": "CLINDOXYL ADV",
    "fr_drug_common_name": "gel de clindamycine et de peroxyde de benzoyle",
    "en_ingredients": "BENZOYL PEROXIDE\r\nCLINDAMYCIN",
    "fr_ingredients": "Peroxyde de benzoyle,\r\nClindamycine",
    "drug_strength": "3%\r\n1%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "45g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 17447,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21266,
      "drug_code": 83668,
      "updated_date": "2025-05-15T04:17:01-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8348886,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02351412",
      "brand_name": "METOPROLOL SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111923001"
    },
    "created_date": "2017-07-28T15:12:36-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02351412",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2017-07-28T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-14T20:59:31-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "METOPROLOL SR",
    "en_drug_common_name": "METOPROLOL SR",
    "fr_drug_brand_name": "METOPROLOL SR",
    "fr_drug_common_name": "METOPROLOL SR",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 17458,
    "drug": {
      "current_status": "MARKETED",
      "id": 27832,
      "drug_code": 90039,
      "updated_date": "2025-05-15T02:34:07-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8260116,
          "ingredient": {
            "id": 2720,
            "ingredient_code": 11899,
            "en_name": "RIZATRIPTAN",
            "fr_name": "Rizatriptan (Benzoate de rizatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415798",
      "brand_name": "RIZATRIPTAN RDT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137841001"
    },
    "created_date": "2017-07-28T15:25:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02415798",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "actual_start_date": "2017-07-27T00:00:00-04:00",
    "actual_end_date": "2017-10-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-12T16:19:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RIZATRIPTAN RDT",
    "en_drug_common_name": "RIZATRIPTAN RDT",
    "fr_drug_brand_name": "RIZATRIPTAN RDT",
    "fr_drug_common_name": "RIZATRIPTAN RDT",
    "en_ingredients": "RIZATRIPTAN",
    "fr_ingredients": "RIZATRIPTAN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17472,
    "drug": {
      "current_status": "MARKETED",
      "id": 6134,
      "drug_code": 42844,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252983,
          "ingredient": {
            "id": 1592,
            "ingredient_code": 5900,
            "en_name": "METHOTREXATE",
            "fr_name": "Méthotrexate (Méthotrexate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02182777",
      "brand_name": "METHOTREXATE INJECTION USP",
      "brand_name_fr": "MÉTHOTREXATE INJECABLE USP",
      "descriptor": "WITH PRESERVATIVE (MULTIDOSE VIALS)",
      "pediatric_flag": false,
      "accession_number": "P9010",
      "number_of_ais": "1",
      "ai_group_no": "0107545002"
    },
    "created_date": "2017-07-28T18:43:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02182777",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "L01BA",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2017-10-02T00:00:00-04:00",
    "estimated_end_date": "2017-10-16T00:00:00-04:00",
    "actual_end_date": "2017-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-13T17:53:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "METHOTREXATE INJECTION USP",
    "en_drug_common_name": "Methotrexate",
    "fr_drug_brand_name": "METHOTREXATE INJECTION USP",
    "fr_drug_common_name": "Methotrexate",
    "en_ingredients": "METHOTREXATE",
    "fr_ingredients": "Méthotrexate",
    "drug_strength": "25MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRA-ARTERIAL\r\nINTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intra-artérielle\r\nIntramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "1x20mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17518,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12864,
      "drug_code": 7199,
      "updated_date": "2025-12-03T01:02:22-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8281717,
          "ingredient": {
            "id": 1418,
            "ingredient_code": 2118,
            "en_name": "COLESTIPOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de colestipol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "SACHET",
          "base": false
        }
      ],
      "din": "00642975",
      "brand_name": "COLESTID GRANULES",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "64933",
      "number_of_ais": "1",
      "ai_group_no": "0113064005"
    },
    "created_date": "2017-07-31T15:26:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00642975",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "C10AC",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-07-28T00:00:00-04:00",
    "estimated_end_date": "2017-08-21T00:00:00-04:00",
    "actual_end_date": "2017-08-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-08-22T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Resolved August 21, 2017.",
    "fr_comments": "Résolu le 21 août 2017.",
    "en_drug_brand_name": "COLESTID GRANULES",
    "en_drug_common_name": "Colestid",
    "fr_drug_brand_name": "COLESTID GRANULES",
    "fr_drug_common_name": "Colestid",
    "en_ingredients": "COLESTIPOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de colestipol",
    "drug_strength": "5G",
    "drug_dosage_form": "GRANULES",
    "drug_dosage_form_fr": "Granules",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 17527,
    "drug": {
      "current_status": "DORMANT",
      "id": 9844,
      "drug_code": 6394,
      "updated_date": "2025-05-15T06:55:21-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366407,
          "ingredient": {
            "id": 2504,
            "ingredient_code": 6030,
            "en_name": "PROCYCLIDINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de procyclidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00649392",
      "brand_name": "PDP-PROCYCLIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62935",
      "number_of_ais": "1",
      "ai_group_no": "0107590003"
    },
    "created_date": "2017-07-31T15:58:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00649392",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "N04AA",
    "atc_description": "ANTICHOLINERGIC AGENTS",
    "anticipated_start_date": "2017-07-31T00:00:00-04:00",
    "actual_start_date": "2017-08-15T00:00:00-04:00",
    "actual_end_date": "2018-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-30T13:52:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PDP-PROCYCLIDINE",
    "en_drug_common_name": "pdp-PROCYCLIDINE 2.5mg TABS 100",
    "fr_drug_brand_name": "pdp-PROCYCLIDINE",
    "fr_drug_common_name": "pdp-PROCYCLIDINE 2.5mg TABS 100",
    "en_ingredients": "PROCYCLIDINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de procyclidine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 17549,
    "drug": {
      "current_status": "MARKETED",
      "id": 18214,
      "drug_code": 79483,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256393,
          "ingredient": {
            "id": 2112,
            "ingredient_code": 20260,
            "en_name": "ESMOLOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'esmolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02309238",
      "brand_name": "BREVIBLOC PREMIXED INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123418003"
    },
    "created_date": "2017-07-31T17:17:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02309238",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-07-27T00:00:00-04:00",
    "estimated_end_date": "2017-08-08T00:00:00-04:00",
    "actual_start_date": "2017-07-27T00:00:00-04:00",
    "actual_end_date": "2017-08-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-08-09T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Product can be subistituted with Brevibloc vials, reconstiued in saline IV infusion bag as per the applicable dosage.  \r\nDrug concentration: 10 mg/ mL (100 mg/10 mL Vials). \r\n- Product code : CA2L9119         \r\n- DIN 02188880          \r\n- Pack size:10 mL     \r\n- Units/ CA: 100 units\r\n- Storage: Store vials at 15˚C to 25˚C",
    "fr_comments": "Le produit peut être substitué avec le Brevibloc injectable reconstitué dans un sac de perfusion saline IV selon la dose applicable\r\n- Drug concentration: 10 mg/ mL (100 mg/10 mL Vials). \r\n- Product code : CA2L9119         \r\n- DIN 02188880          \r\n- Pack size:10 mL              -\r\n- Units/ CA: 100 units\r\n- Storage: Store vials at 15˚C to 25˚C.",
    "en_drug_brand_name": "BREVIBLOC PREMIXED INJECTION",
    "en_drug_common_name": "Brevibloc Premixed Injection",
    "fr_drug_brand_name": "BREVIBLOC PREMIXED INJECTION",
    "fr_drug_common_name": "Brevibloc Premixed Injection",
    "en_ingredients": "ESMOLOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'esmolol",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "250mL Intravia Container",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 17556,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14224,
      "drug_code": 74301,
      "updated_date": "2025-05-15T04:09:12-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8340374,
          "ingredient": {
            "id": 3166,
            "ingredient_code": 11350,
            "en_name": "VINORELBINE",
            "fr_name": "Vinorelbine (Tartrate de vinorelbine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02257777",
      "brand_name": "VINORELBINE TARTRATE FOR INJECTION",
      "brand_name_fr": "TARTRATE DE VINORELBINE POUR INJECTION",
      "descriptor": "1ML AND 5ML SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126071001"
    },
    "created_date": "2017-07-31T18:47:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02257777",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "L01CA",
    "atc_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
    "actual_start_date": "2017-10-18T00:00:00-04:00",
    "actual_end_date": "2018-08-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-08-15T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "The drug has been discontinued.",
    "fr_comments": "Le médicament a été discontinué.",
    "en_drug_brand_name": "VINORELBINE TARTRATE FOR INJECTION",
    "en_drug_common_name": "Vinorelbine",
    "fr_drug_brand_name": "VINORELBINE TARTRATE FOR INJECTION",
    "fr_drug_common_name": "Vinorelbine",
    "en_ingredients": "VINORELBINE",
    "fr_ingredients": "VINORELBINE",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1x1mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 17559,
    "drug": {
      "current_status": "MARKETED",
      "id": 24874,
      "drug_code": 87402,
      "updated_date": "2025-05-15T02:33:33-04:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258992,
          "ingredient": {
            "id": 666,
            "ingredient_code": 1776,
            "en_name": "ENALAPRILAT",
            "fr_name": "Énalaprilate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02388499",
      "brand_name": "ENALAPRILAT INJECTION USP",
      "brand_name_fr": "ÉNALAPRILAT POUR INJECTION USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118001001"
    },
    "created_date": "2017-07-31T18:52:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388499",
    "company_name": "STERIMAX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2017-09-11T00:00:00-04:00",
    "actual_start_date": "2017-07-31T00:00:00-04:00",
    "actual_end_date": "2017-09-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-09-13T19:54:01-04:00",
    "status": "resolved",
    "en_comments": "Product is available",
    "fr_comments": "Produit est disponible",
    "en_drug_brand_name": "ENALAPRILAT INJECTION USP",
    "en_drug_common_name": "VASOTEC IV",
    "fr_drug_brand_name": "VASOTEC IV",
    "fr_drug_common_name": "ÉNALAPRILAT POUR INJECTION USP",
    "en_ingredients": "ENALAPRILAT",
    "fr_ingredients": "Énalaprilate",
    "drug_strength": "1.25MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 VIALS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  }
]